[ 2080203 ? O
Antiglaucoma ? ? I-treatment
ophthalmic ? ? I-treatment
agents ? ? I-treatment
with ? ? O
prolonged ? ? O
action ? ? O
based ? ? O
on ? ? O
macromolecular ? ? I-gene
excipients ? ? I-gene
. ? ? O

1 2080203 ? O
. ? ? O

In 2080203 ? O
vitro ? ? O
studies ? ? O
] ? ? O
. ? ? O

Hydrogels 2080203 ? I-treatment
and ? ? O
Hydrosols ? ? I-treatment
based ? ? O
on ? ? O
sodium ? ? I-treatment
carboxymethyl-cellulose ? ? I-treatment
( ? ? O
NaCMC ? ? I-treatment
) ? ? O
, ? ? O
polyvinylpyrrolidone ? ? I-treatment
( ? ? O
PVP ? ? I-treatment
) ? ? O
and ? ? O
polyacrylic ? ? I-treatment
acids ? ? I-treatment
( ? ? O
PAS ? ? I-treatment
) ? ? O
Carbopol ? ? I-treatment
940 ? ? I-treatment
, ? ? O
Scopacryl ? ? I-treatment
D ? ? I-treatment
339 ? ? I-treatment
( ? ? O
PAS-B ? ? I-treatment
) ? ? O
and ? ? O
PAS-Fluka ? ? I-treatment
( ? ? O
PAS-F ? ? I-treatment
) ? ? O
were ? ? O
investigated ? ? O
in ? ? O
vitro ? ? O
for ? ? O
rheological ? ? O
properties ? ? O
and ? ? O
pilocarpine ? ? I-treatment
release ? ? O
. ? ? O

The 2080203 ? O
gels ? ? O
showed ? ? O
diffusion ? ? O
coefficients ? ? O
in ? ? O
the ? ? O
series ? ? O
Carbopol ? ? I-treatment
940 ? ? I-treatment
1 ? ? O
% ? ? O
greater ? ? O
than ? ? O
NaCMC ? ? I-treatment
3 ? ? O
% ? ? O
greater ? ? O
than ? ? O
PAS-F ? ? I-treatment
3.5 ? ? O
% ? ? O
greater ? ? O
than ? ? O
PVP ? ? I-treatment
K ? ? O
90 ? ? O
23 ? ? O
% ? ? O
greater ? ? O
than ? ? O
PAS-B ? ? I-treatment
8 ? ? O
% ? ? O
greater ? ? O
than ? ? O
PAS-F ? ? I-treatment
7 ? ? O
% ? ? O
. ? ? O

Especially 2080203 ? O
PAS-F ? ? I-treatment
proved ? ? O
suitable ? ? O
for ? ? O
prolonged ? ? O
release ? ? O
, ? ? O
also ? ? O
in ? ? O
liquid ? ? O
preparations ? ? O
. ? ? O

Lyophilizated 2080203 ? I-treatment
pilocarpine ? ? I-treatment
polymer-salts ? ? I-treatment
which ? ? O
were ? ? O
prepared ? ? O
from ? ? O
PAS-F ? ? I-treatment
and ? ? O
pilocarpine ? ? I-treatment
base ? ? O
, ? ? O
both ? ? O
in ? ? O
effect ? ? O
of ? ? O
retardation ? ? I-disease
and ? ? O
in ? ? O
drug ? ? O
stability ? ? O
showed ? ? O
important ? ? O
advantages ? ? O
compared ? ? O
with ? ? O
aqueous ? ? O
solution ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

Modulation 2129161 ? O
of ? ? O
rat ? ? O
salivary ? ? I-gene
carbonic ? ? I-gene
anhydrase ? ? I-gene
by ? ? O
pilocarpine ? ? I-treatment
. ? ? O

Carbonic 2129161 ? I-gene
anhydrase ? ? I-gene
( ? ? O
CA ? ? I-gene
) ? ? O
from ? ? O
pilocarpine-treated ? ? I-treatment
( ? ? O
1.5 ? ? O
mg ? ? O
/ ? ? O
kg ? ? O
body ? ? O
weight ? ? O
; ? ? O
i.p ? ? O
. ? ? O
) ? ? O

rat 2129161 ? O
saliva ? ? O
was ? ? O
purified ? ? O
by ? ? O
inhibitor ? ? O
affinity ? ? O
chromatography ? ? I-treatment
. ? ? O

The 2129161 ? O
purified ? ? O
CA ? ? I-gene
contained ? ? O
Mr ? ? I-gene
42000 ? ? I-gene
and ? ? O
39000 ? ? I-gene
proteins ? ? O
on ? ? O
sodium ? ? I-treatment
dodecyl ? ? I-treatment
sulfate ? ? I-treatment
polyacrylamide ? ? I-treatment
gel ? ? O
electrophoresis ? ? O
. ? ? O

In 2129161 ? O
addition ? ? O
to ? ? O
the ? ? O
erythrocyte ? ? I-gene
isozyme ? ? I-gene
( ? ? O
Mr ? ? I-gene
30000 ? ? I-gene
) ? ? O
, ? ? O
salivary ? ? I-gene
gland ? ? I-gene
CA ? ? I-gene
from ? ? O
rats ? ? O
without ? ? O
pilocarpine ? ? I-treatment
stimulation ? ? O
contained ? ? O
Mr ? ? I-gene
39000 ? ? I-gene
and ? ? I-gene
33000 ? ? I-gene
proteins ? ? I-gene
and ? ? O
that ? ? O
from ? ? O
rats ? ? O
with ? ? O
pilocarpine ? ? I-treatment
stimulation ? ? O
also ? ? O
contained ? ? O
Mr ? ? I-gene
42000 ? ? I-gene
protein ? ? O
. ? ? O

The 2129161 ? O
42000Da ? ? I-gene
and ? ? O
39000Da ? ? I-gene
proteins ? ? O
bound ? ? O
to ? ? O
concanavalin ? ? I-gene
A ? ? I-gene
and ? ? O
were ? ? O
cleaved ? ? O
by ? ? O
endo-beta-N-acetylglucosaminidase ? ? I-gene
F ? ? O
to ? ? O
become ? ? O
39000Da ? ? I-gene
and ? ? O
33000Da ? ? I-gene
proteins ? ? O
. ? ? O

These 2129161 ? O
results ? ? O
suggest ? ? O
that ? ? O
, ? ? O
under ? ? O
the ? ? O
influence ? ? O
of ? ? O
pilocarpine ? ? I-treatment
, ? ? O
salivary ? ? O
gland ? ? O
cells ? ? O
synthesize ? ? O
a ? ? O
new ? ? O
glycoprotein ? ? I-treatment
, ? ? O
Mr ? ? I-gene
42000 ? ? I-gene
, ? ? O
via ? ? O
N-linked ? ? I-treatment
glycosylation ? ? I-treatment
of ? ? O
a ? ? O
39000Da ? ? I-gene
glycoprotein ? ? I-gene
, ? ? O
which ? ? O
is ? ? O
the ? ? O
only ? ? O
secretory ? ? I-treatment
glycoprotein ? ? I-treatment
in ? ? O
the ? ? O
unstimulated ? ? O
salivary ? ? O
gland ? ? O
and ? ? O
is ? ? O
produced ? ? O
by ? ? O
N-linked ? ? I-treatment
glycosylation ? ? I-treatment
of ? ? O
a ? ? O
33000Da ? ? I-gene
polypeptide ? ? O
. ? ? O

Control 2361193 ? O
of ? ? O
intraocular ? ? I-disease
pressure ? ? I-disease
after ? ? O
cataract ? ? I-treatment
extraction ? ? I-treatment
. ? ? O

We 2361193 ? O
carried ? ? O
out ? ? O
a ? ? O
prospective ? ? O
randomized ? ? O
study ? ? O
in ? ? O
172 ? ? O
patients ? ? O
undergoing ? ? O
cataract ? ? I-treatment
extraction ? ? I-treatment
and ? ? O
lens ? ? I-treatment
implantation ? ? I-treatment
to ? ? O
compare ? ? O
the ? ? O
effects ? ? O
of ? ? O
pilocarpine ? ? I-treatment
gel ? ? O
, ? ? O
1 ? ? O
% ? ? O
acetylcholine ? ? I-treatment
chloride ? ? I-treatment
and ? ? O
0.01 ? ? O
% ? ? O
carbachol ? ? I-treatment
on ? ? O
early ? ? O
postoperative ? ? I-disease
intraocular ? ? I-disease
pressure ? ? I-disease
( ? ? O
IOP ? ? I-disease
) ? ? O
, ? ? O
to ? ? O
determine ? ? O
the ? ? O
effect ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
on ? ? O
IOP ? ? I-disease
and ? ? O
to ? ? O
compare ? ? O
the ? ? O
effects ? ? O
of ? ? O
0.01 ? ? O
% ? ? O
carbachol ? ? I-treatment
( ? ? O
full-strength ? ? O
) ? ? O
and ? ? O
0.005 ? ? O
% ? ? O
carbachol ? ? I-treatment
( ? ? O
half-strength ? ? O
) ? ? O
on ? ? O
IOP ? ? I-disease
, ? ? O
pupil ? ? I-disease
size ? ? I-disease
and ? ? O
brow ? ? I-disease
ache ? ? I-disease
. ? ? O

IOP 2361193 ? I-disease
was ? ? O
measured ? ? O
3 ? ? O
, ? ? O
6 ? ? O
, ? ? O
9 ? ? O
and ? ? O
24 ? ? O
hours ? ? O
after ? ? O
surgery ? ? O
, ? ? O
and ? ? O
in ? ? O
the ? ? O
full- ? ? O
and ? ? O
half-strength ? ? O
carbachol ? ? I-treatment
groups ? ? O
pupil ? ? I-disease
size ? ? I-disease
and ? ? O
subjective ? ? O
complaints ? ? O
of ? ? O
brow ? ? I-disease
ache ? ? I-disease
were ? ? O
recorded ? ? O
. ? ? O

The 2361193 ? O
mean ? ? O
IOP ? ? I-disease
3 ? ? O
and ? ? O
6 ? ? O
hours ? ? O
after ? ? O
surgery ? ? O
was ? ? O
significantly ? ? O
lower ? ? O
in ? ? O
all ? ? O
the ? ? O
treatment ? ? O
groups ? ? O
than ? ? O
in ? ? O
the ? ? O
control ? ? O
groups ? ? O
. ? ? O

At 2361193 ? O
9 ? ? O
and ? ? O
24 ? ? O
hours ? ? O
it ? ? O
was ? ? O
significantly ? ? O
lower ? ? O
only ? ? O
in ? ? O
the ? ? O
carbachol ? ? I-treatment
groups ? ? O
. ? ? O

The 2361193 ? O
use ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
was ? ? O
not ? ? O
found ? ? O
to ? ? O
affect ? ? O
the ? ? O
postoperative ? ? O
IOP ? ? I-disease
. ? ? O

There 2361193 ? O
was ? ? O
no ? ? O
difference ? ? O
in ? ? O
postoperative ? ? O
IOP ? ? I-disease
or ? ? O
miosis ? ? I-disease
between ? ? O
the ? ? O
full- ? ? O
and ? ? O
half-strength ? ? O
carbachol ? ? I-treatment
groups ? ? O
, ? ? O
but ? ? O
fewer ? ? O
patients ? ? O
in ? ? O
the ? ? O
half-strength ? ? O
group ? ? O
than ? ? O
in ? ? O
the ? ? O
full-strength ? ? O
group ? ? O
reported ? ? O
brow ? ? I-disease
ache ? ? I-disease
at ? ? O
9 ? ? O
and ? ? O
24 ? ? O
hours ? ? O
. ? ? O

The 2361193 ? O
results ? ? O
suggest ? ? O
that ? ? O
carbachol ? ? I-treatment
is ? ? O
the ? ? O
most ? ? O
effective ? ? O
agent ? ? O
currently ? ? O
available ? ? O
for ? ? O
the ? ? O
management ? ? O
of ? ? O
IOP ? ? I-disease
after ? ? O
cataract ? ? I-disease
extraction ? ? O
. ? ? O

Effect 2478423 ? O
of ? ? O
topical ? ? I-treatment
prostaglandin ? ? I-treatment
D2 ? ? I-treatment
on ? ? O
the ? ? O
aqueous ? ? I-disease
humor ? ? I-disease
dynamics ? ? I-disease
in ? ? O
rabbits ? ? O
. ? ? O

Effects 2478423 ? O
of ? ? O
topically ? ? O
applied ? ? O
prostaglandin ? ? I-treatment
( ? ? I-treatment
PG ? ? I-treatment
) ? ? I-treatment
D2 ? ? I-treatment
on ? ? O
the ? ? O
aqueous ? ? I-disease
outflow ? ? I-disease
facility ? ? I-disease
, ? ? O
uveoscleral ? ? I-disease
flow ? ? I-disease
, ? ? O
and ? ? O
aqueous ? ? I-disease
flow ? ? I-disease
rate ? ? I-disease
were ? ? O
studied ? ? O
in ? ? O
rabbits ? ? O
to ? ? O
reveal ? ? O
its ? ? O
intraocular ? ? I-disease
pressure ? ? I-disease
( ? ? O
IOP ? ? I-disease
) ? ? O
-reducing ? ? O
mechanism ? ? O
. ? ? O

The 2478423 ? O
outflow ? ? O
facility ? ? O
after ? ? O
PGD2 ? ? I-treatment
application ? ? O
( ? ? O
50 ? ? O
micrograms ? ? O
) ? ? O
as ? ? O
measured ? ? O
by ? ? O
2-min ? ? O
tonography ? ? O
was ? ? O
0.19 ? ? O
microliters ? ? O
/ ? ? O
min ? ? O
/ ? ? O
mm ? ? O
Hg ? ? O
and ? ? O
did ? ? O
not ? ? O
differ ? ? O
from ? ? O
that ? ? O
before ? ? O
the ? ? O
application ? ? O
( ? ? O
0.22 ? ? O
) ? ? O
or ? ? O
from ? ? O
that ? ? O
of ? ? O
the ? ? O
control ? ? O
contralateral ? ? O
eye ? ? O
( ? ? O
0.21 ? ? O
) ? ? O
. ? ? O

Direct 2478423 ? O
measurement ? ? O
of ? ? O
the ? ? O
uveoscleral ? ? I-disease
flow ? ? I-disease
by ? ? O
perfusion ? ? O
of ? ? O
the ? ? O
anterior ? ? O
chamber ? ? O
for ? ? O
30 ? ? O
min ? ? O
with ? ? O
fluorescein ? ? I-treatment
isothiocyanate-labeled ? ? I-treatment
dextran ? ? I-treatment
solution ? ? I-treatment
showed ? ? O
the ? ? O
flow ? ? O
rate ? ? O
to ? ? O
be ? ? O
about ? ? O
0.15 ? ? O
microliters ? ? O
/ ? ? O
min ? ? O
in ? ? O
indomethacin-treated ? ? I-treatment
( ? ? O
10 ? ? O
mg ? ? O
/ ? ? O
kg ? ? O
, ? ? O
i.p ? ? O
. ? ? O
) ? ? O

rabbits 2478423 ? O
. ? ? O

In 2478423 ? O
these ? ? O
animals ? ? O
, ? ? O
PGD2 ? ? I-treatment
( ? ? O
50 ? ? O
micrograms ? ? O
) ? ? O
was ? ? O
ineffective ? ? O
in ? ? O
changing ? ? O
the ? ? O
flow ? ? O
rate ? ? O
, ? ? O
while ? ? O
PGF2 ? ? I-treatment
alpha ? ? I-treatment
( ? ? O
50 ? ? O
micrograms ? ? O
) ? ? O
significantly ? ? O
increased ? ? O
the ? ? O
flow ? ? O
by ? ? O
about ? ? O
35 ? ? O
% ? ? O
. ? ? O

Indirect 2478423 ? O
assessment ? ? O
of ? ? O
the ? ? O
effects ? ? O
of ? ? O
PGs ? ? I-treatment
on ? ? O
this ? ? O
flow ? ? O
system ? ? O
was ? ? O
made ? ? O
using ? ? O
the ? ? O
uveoscleral ? ? O
flow-antagonizing ? ? O
ability ? ? O
of ? ? O
topical ? ? O
pilocarpine ? ? I-treatment
( ? ? O
1.5 ? ? O
mg ? ? O
) ? ? O
. ? ? O

IOP 2478423 ? I-disease
reduction ? ? I-disease
by ? ? O
PGD2 ? ? I-treatment
( ? ? O
50 ? ? O
micrograms ? ? O
) ? ? O
was ? ? O
only ? ? O
slightly ? ? O
inhibited ? ? O
by ? ? O
pilocarpine ? ? I-treatment
, ? ? O
while ? ? O
that ? ? O
by ? ? O
PGF2 ? ? I-treatment
alpha ? ? I-treatment
( ? ? O
10 ? ? O
micrograms ? ? O
) ? ? O
was ? ? O
markedly ? ? O
reduced ? ? O
. ? ? O

Aqueous 2478423 ? I-disease
flow ? ? I-disease
rate ? ? I-disease
measured ? ? I-disease
fluorophotometrically ? ? I-disease
was ? ? I-disease
about ? ? I-disease
3.5 ? ? I-disease
microliters ? ? I-disease
/ ? ? I-disease
min ? ? I-disease
in ? ? I-disease
normal ? ? I-disease
eyes ? ? I-disease
. ? ? O

After 2478423 ? O
PGD2 ? ? I-treatment
( ? ? O
50 ? ? O
micrograms ? ? O
) ? ? O
the ? ? O
flow ? ? I-disease
rate ? ? I-disease
was ? ? I-disease
significantly ? ? I-disease
reduced ? ? I-disease
to ? ? O
3.0 ? ? O
microliters ? ? O
/ ? ? O
min ? ? O
. ? ? O

The 2478423 ? O
magnitude ? ? O
of ? ? O
this ? ? O
reduction ? ? O
was ? ? O
estimated ? ? O
to ? ? O
be ? ? O
enough ? ? O
to ? ? O
account ? ? O
for ? ? O
the ? ? O
IOP ? ? I-disease
reduction ? ? I-disease
after ? ? O
application ? ? O
of ? ? O
50 ? ? O
micrograms ? ? O
of ? ? O
PGD2 ? ? I-treatment
. ? ? O

These 2478423 ? O
results ? ? O
indicate ? ? O
that ? ? O
IOP ? ? I-disease
reduction ? ? I-disease
caused ? ? O
by ? ? O
topical ? ? I-treatment
PGD2 ? ? I-treatment
application ? ? O
is ? ? O
due ? ? O
mostly ? ? O
to ? ? O
the ? ? O
inhibition ? ? I-disease
of ? ? I-disease
aqueous ? ? I-disease
flow ? ? I-disease
rate ? ? I-disease
. ? ? O

Sodium 2743795 ? I-treatment
hyaluronate ? ? I-treatment
as ? ? O
an ? ? O
ophthalmic ? ? O
vehicle ? ? O
: ? ? O
some ? ? O
factors ? ? O
governing ? ? O
its ? ? O
effect ? ? O
on ? ? O
the ? ? O
ocular ? ? O
absorption ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

Sodium 2743795 ? I-treatment
hyaluronate ? ? I-treatment
, ? ? O
as ? ? O
an ? ? O
additive ? ? O
to ? ? O
aqueous ? ? I-disease
ophthalmic ? ? I-disease
formulations ? ? I-disease
, ? ? O
has ? ? O
been ? ? O
claimed ? ? O
to ? ? O
increase ? ? O
the ? ? O
ocular ? ? O
contact ? ? O
time ? ? O
and ? ? O
, ? ? O
thereby ? ? O
, ? ? O
the ? ? O
drug ? ? O
bioavailability ? ? O
. ? ? O

In 2743795 ? O
the ? ? O
present ? ? O
study ? ? O
, ? ? O
the ? ? O
effect ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
on ? ? O
corneal ? ? O
residence ? ? O
time ? ? O
and ? ? O
drug ? ? O
absorption ? ? O
in ? ? O
rabbits ? ? O
was ? ? O
investigated ? ? O
. ? ? O

Addition 2743795 ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
( ? ? O
0.125 ? ? O
% ? ? O
) ? ? O
to ? ? O
a ? ? O
3H-pilocarpine ? ? I-treatment
HCl ? ? I-treatment
solution ? ? O
resulted ? ? O
in ? ? O
increased ? ? I-disease
retention ? ? I-disease
of ? ? I-disease
radioactivity ? ? I-disease
in ? ? I-disease
tear ? ? I-disease
fluid ? ? I-disease
and ? ? O
a ? ? O
2-fold ? ? I-disease
increase ? ? I-disease
in ? ? I-disease
drug ? ? I-disease
concentration ? ? I-disease
in ? ? I-disease
the ? ? I-disease
cornea ? ? I-disease
and ? ? I-disease
aqueous ? ? I-disease
humor ? ? I-disease
. ? ? O

Further 2743795 ? O
, ? ? O
the ? ? O
effects ? ? O
of ? ? O
concentration ? ? O
and ? ? O
molecular ? ? O
weight ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
on ? ? O
the ? ? O
miosis ? ? I-disease
induced ? ? O
by ? ? O
pilocarpine ? ? I-treatment
in ? ? O
rabbits ? ? O
were ? ? O
studied ? ? O
. ? ? O

A 2743795 ? O
significant ? ? O
increase ? ? O
of ? ? O
miotic ? ? I-disease
response ? ? I-disease
was ? ? O
seen ? ? O
at ? ? O
concentrations ? ? O
just ? ? O
less ? ? O
than ? ? O
0.1 ? ? O
% ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
. ? ? O

Pilocarpine 2743795 ? I-treatment
solutions ? ? O
prepared ? ? O
from ? ? O
high ? ? O
mol.wt ? ? O
. ? ? O

sodium 2743795 ? I-treatment
hyaluronate ? ? I-treatment
exhibited ? ? O
a ? ? O
greater ? ? O
miotic ? ? I-disease
response ? ? I-disease
than ? ? O
those ? ? O
prepared ? ? O
from ? ? O
lower ? ? O
mol.wt ? ? O
. ? ? O

samples 2743795 ? O
. ? ? O

This 2743795 ? O
might ? ? O
indicate ? ? O
that ? ? O
other ? ? O
physicochemical ? ? O
properties ? ? O
of ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
influence ? ? O
drug ? ? O
bioavailability ? ? O
. ? ? O

Electrolyte 2776293 ? O
composition ? ? O
of ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
and ? ? O
tears ? ? O
of ? ? O
normal ? ? O
and ? ? O
vitamin ? ? I-disease
A-deficient ? ? I-disease
rabbits ? ? O
. ? ? O

Rabbit 2776293 ? O
tears ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
were ? ? O
collected ? ? O
simultaneously ? ? O
during ? ? O
pilocarpine ? ? I-treatment
stimulation ? ? O
with ? ? O
the ? ? O
goal ? ? O
of ? ? O
comparing ? ? O
the ? ? O
ionic ? ? O
composition ? ? O
of ? ? O
these ? ? O
fluids ? ? O
at ? ? O
various ? ? O
flow ? ? O
rates ? ? O
. ? ? O

Ions 2776293 ? O
measured ? ? O
were ? ? O
sodium ? ? I-treatment
, ? ? O
potassium ? ? I-treatment
, ? ? O
calcium ? ? I-treatment
, ? ? O
magnesium ? ? I-treatment
, ? ? O
zinc ? ? I-treatment
, ? ? O
chloride ? ? I-treatment
, ? ? O
and ? ? O
bicarbonate ? ? I-treatment
. ? ? O

Human 2776293 ? O
tears ? ? O
were ? ? O
also ? ? O
analyzed ? ? O
for ? ? O
purposes ? ? O
of ? ? O
comparison ? ? O
. ? ? O

Generally 2776293 ? O
, ? ? O
tears ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
do ? ? O
not ? ? O
differ ? ? O
in ? ? O
ionic ? ? O
composition ? ? O
except ? ? O
for ? ? O
zinc ? ? I-treatment
and ? ? O
bicarbonate ? ? I-treatment
, ? ? O
which ? ? O
are ? ? O
in ? ? O
higher ? ? O
concentration ? ? O
in ? ? O
tears ? ? O
than ? ? O
in ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
. ? ? O

The 2776293 ? O
ionic ? ? O
composition ? ? O
of ? ? O
tears ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
of ? ? O
vitamin ? ? I-disease
A-deficient ? ? I-disease
rabbits ? ? O
was ? ? O
also ? ? O
analyzed ? ? O
. ? ? O

The 2776293 ? O
maximal ? ? O
flow ? ? O
rate ? ? O
of ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
was ? ? O
decreased ? ? O
in ? ? O
vitamin ? ? I-disease
A-deficient ? ? I-disease
rabbits ? ? O
as ? ? O
were ? ? O
calcium ? ? I-treatment
levels ? ? O
in ? ? O
tears ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
fluid ? ? O
, ? ? O
as ? ? O
compared ? ? O
with ? ? O
controls ? ? O
. ? ? O

Concentrations 2776293 ? O
of ? ? O
other ? ? O
ions ? ? O
generally ? ? O
did ? ? O
not ? ? O
differ ? ? O
from ? ? O
normal ? ? O
levels ? ? O
, ? ? O
indicating ? ? O
that ? ? O
vitamin ? ? I-disease
A ? ? I-disease
deficiency ? ? I-disease
has ? ? O
only ? ? O
moderate ? ? O
effects ? ? O
on ? ? O
lacrimal ? ? O
gland ? ? O
function ? ? O
in ? ? O
the ? ? O
rabbit ? ? O
. ? ? O

[ 2814915 ? O
Microcapsules ? ? I-treatment
with ? ? O
modulable ? ? O
properties ? ? O
made ? ? O
with ? ? O
cross-linked ? ? I-treatment
proteins ? ? I-treatment
and ? ? O
polysaccharides ? ? I-treatment
] ? ? O
. ? ? O

A 2814915 ? O
cross-linking ? ? O
process ? ? O
was ? ? O
applied ? ? O
to ? ? O
mixtures ? ? O
of ? ? O
a ? ? O
protein ? ? I-treatment
( ? ? O
gelatin ? ? I-treatment
A ? ? I-treatment
or ? ? I-treatment
B ? ? I-treatment
) ? ? O
and ? ? O
a ? ? O
polysaccharide ? ? I-treatment
. ? ? O

Mixed-walled 2814915 ? I-treatment
microcapsules ? ? I-treatment
were ? ? O
then ? ? O
obtained ? ? O
, ? ? O
which ? ? O
exhibited ? ? O
properties ? ? O
different ? ? O
from ? ? O
those ? ? O
of ? ? O
microcapsules ? ? I-treatment
prepared ? ? O
from ? ? O
the ? ? O
protein ? ? I-treatment
alone ? ? O
. ? ? O

They 2814915 ? O
were ? ? O
shown ? ? O
to ? ? O
be ? ? O
more ? ? O
resistant ? ? O
to ? ? O
enzymatic ? ? O
lysis ? ? O
and ? ? O
this ? ? O
effect ? ? O
depended ? ? O
on ? ? O
the ? ? O
ratio ? ? O
of ? ? O
the ? ? O
polysaccharide ? ? I-treatment
, ? ? O
on ? ? O
its ? ? O
nature ? ? O
and ? ? O
on ? ? O
the ? ? O
cross-linking ? ? O
pH ? ? O
. ? ? O

Very 2814915 ? O
hydrophilic ? ? I-treatment
microcapsules ? ? I-treatment
were ? ? O
obtained ? ? O
through ? ? O
cross-linking ? ? O
of ? ? O
gelatin ? ? I-treatment
admixed ? ? O
with ? ? O
alginate ? ? I-treatment
or ? ? O
carboxymethylcellulose ? ? I-treatment
. ? ? O

The 2814915 ? O
addition ? ? O
of ? ? O
alginate ? ? I-treatment
to ? ? O
gelatin ? ? I-treatment
resulted ? ? O
in ? ? O
a ? ? O
slower ? ? O
release ? ? O
of ? ? O
encapsulated ? ? I-treatment
pilocarpine ? ? I-treatment
. ? ? O

Drug 2916980 ? O
binding ? ? O
of ? ? O
ophthalmic ? ? I-gene
viscoelastic ? ? I-gene
agents ? ? I-gene
. ? ? O

When 2916980 ? O
viscoelastic ? ? I-treatment
agents ? ? I-treatment
that ? ? O
contain ? ? O
hyaluronate ? ? I-treatment
sodium ? ? I-treatment
are ? ? O
used ? ? O
during ? ? O
anterior ? ? I-treatment
segment ? ? I-treatment
surgical ? ? I-treatment
procedures ? ? I-treatment
, ? ? O
it ? ? O
is ? ? O
common ? ? O
for ? ? O
some ? ? O
of ? ? O
the ? ? O
material ? ? O
to ? ? O
remain ? ? O
intraocularly ? ? O
after ? ? O
the ? ? O
surgery ? ? I-treatment
is ? ? O
completed ? ? O
. ? ? O

A 2916980 ? O
variety ? ? O
of ? ? O
drugs ? ? O
, ? ? O
used ? ? O
intracamerally ? ? O
or ? ? O
topically ? ? O
following ? ? O
surgery ? ? I-treatment
, ? ? O
are ? ? O
also ? ? O
present ? ? O
. ? ? O

These 2916980 ? O
drugs ? ? O
may ? ? O
be ? ? O
bound ? ? O
to ? ? O
the ? ? O
polyanionic ? ? I-treatment
hyaluronate ? ? I-treatment
molecule ? ? I-treatment
. ? ? O

This 2916980 ? O
occurrence ? ? O
may ? ? O
cause ? ? O
drug ? ? O
alterations ? ? O
in ? ? O
therapeutic ? ? O
effectiveness ? ? O
, ? ? O
pharmacokinetics ? ? O
, ? ? O
and ? ? O
toxicity ? ? I-disease
. ? ? O

To 2916980 ? O
investigate ? ? O
the ? ? O
possibility ? ? O
for ? ? O
drug-viscoelastic ? ? I-treatment
agent ? ? I-treatment
adsorption ? ? O
, ? ? O
in ? ? O
vitro ? ? O
drug-binding ? ? O
studies ? ? O
were ? ? O
performed ? ? O
on ? ? O
three ? ? O
commercial ? ? O
viscoelastic ? ? I-treatment
agents ? ? I-treatment
; ? ? O
undiluted ? ? O
aliquots ? ? O
of ? ? O
Amvisc ? ? I-treatment
, ? ? O
Healon ? ? I-treatment
, ? ? O
or ? ? O
Viscoat ? ? I-treatment
were ? ? O
mixed ? ? O
with ? ? O
radiolabeled ? ? O
D-threo-chloramphenicol ? ? I-treatment
, ? ? O
dexamethasone ? ? I-treatment
, ? ? O
L-epinephrine ? ? I-treatment
, ? ? O
or ? ? O
pilocarpine ? ? I-treatment
hydrochloride ? ? I-treatment
, ? ? O
placed ? ? O
in ? ? O
dialysis ? ? I-treatment
membranes ? ? O
, ? ? O
and ? ? O
dialyzed ? ? O
for ? ? O
24 ? ? O
hours ? ? O
against ? ? O
an ? ? O
isotonic ? ? O
phosphate ? ? I-treatment
buffer ? ? O
. ? ? O

The 2916980 ? O
calculated ? ? O
drug ? ? O
binding ? ? O
by ? ? O
a ? ? O
viscoelastic ? ? I-treatment
agent ? ? I-treatment
ranged ? ? O
from ? ? O
0 ? ? O
% ? ? O
to ? ? O
1.5 ? ? O
% ? ? O
. ? ? O

These 2916980 ? O
extremely ? ? O
low ? ? O
values ? ? O
for ? ? O
in ? ? O
vitro ? ? O
drug ? ? O
uptake ? ? O
by ? ? O
viscoelastic ? ? I-treatment
agents ? ? I-treatment
made ? ? O
it ? ? O
unlikely ? ? O
that ? ? O
any ? ? O
significant ? ? O
drug-viscoelastic ? ? O
agent ? ? O
interaction ? ? O
would ? ? O
occur ? ? O
in ? ? O
the ? ? O
postoperative ? ? O
eye ? ? O
. ? ? O

Tear 3170794 ? O
secretion ? ? O
and ? ? O
lacrimal ? ? O
gland ? ? O
function ? ? O
of ? ? O
rabbits ? ? O
treated ? ? O
with ? ? O
isotretinoin ? ? I-treatment
. ? ? O

Adverse 3170794 ? I-disease
ocular ? ? I-disease
reactions ? ? I-disease
including ? ? O
dry ? ? I-disease
eye ? ? I-disease
symptoms ? ? I-disease
and ? ? O
blepharoconjunctivitis ? ? I-disease
are ? ? O
common ? ? O
side ? ? O
effects ? ? O
of ? ? O
treatment ? ? O
with ? ? O
isotretinoin ? ? I-treatment
( ? ? O
13-cis-retinoic ? ? I-treatment
acid ? ? I-treatment
) ? ? O
. ? ? O

However 3170794 ? O
, ? ? O
there ? ? O
is ? ? O
little ? ? O
agreement ? ? O
in ? ? O
the ? ? O
literature ? ? O
on ? ? O
the ? ? O
effect ? ? O
of ? ? O
this ? ? O
drug ? ? O
on ? ? O
the ? ? O
tears ? ? O
. ? ? O

Because 3170794 ? O
we ? ? O
have ? ? O
previously ? ? O
shown ? ? O
that ? ? O
the ? ? O
lacrimal ? ? O
gland ? ? O
secretes ? ? O
isotretinoin ? ? I-treatment
, ? ? O
we ? ? O
conducted ? ? O
a ? ? O
study ? ? O
of ? ? O
the ? ? O
effect ? ? O
of ? ? O
isotretinoin ? ? I-treatment
on ? ? O
lacrimal ? ? O
gland ? ? O
function ? ? O
. ? ? O

Rabbits 3170794 ? O
were ? ? O
treated ? ? O
with ? ? O
isotretinoin ? ? I-treatment
for ? ? O
5 ? ? O
months ? ? O
. ? ? O

Throughout 3170794 ? O
the ? ? O
study ? ? O
tear ? ? O
secretion ? ? O
was ? ? O
monitored ? ? O
by ? ? O
the ? ? O
Schirmer ? ? O
test ? ? O
. ? ? O

At 3170794 ? O
the ? ? O
end ? ? O
of ? ? O
the ? ? O
study ? ? O
lacrimal ? ? O
gland ? ? O
function ? ? O
was ? ? O
assessed ? ? O
by ? ? O
measurement ? ? O
of ? ? O
fluid ? ? O
and ? ? O
protein ? ? O
secretion ? ? O
rates ? ? O
and ? ? O
secretion ? ? O
of ? ? O
retinol ? ? I-treatment
in ? ? O
response ? ? O
to ? ? O
a ? ? O
pilocarpine ? ? I-treatment
stimulus ? ? O
. ? ? O

Lacrimal 3170794 ? O
gland ? ? O
function ? ? O
was ? ? O
not ? ? O
affected ? ? O
by ? ? O
isotretinoin ? ? I-treatment
as ? ? O
compared ? ? O
with ? ? O
a ? ? O
group ? ? O
of ? ? O
age-matched ? ? O
control ? ? O
rabbits ? ? O
; ? ? O
however ? ? O
, ? ? O
Schirmer ? ? I-disease
test ? ? I-disease
scores ? ? I-disease
were ? ? I-disease
significantly ? ? I-disease
increased ? ? I-disease
in ? ? O
the ? ? O
treated ? ? O
animals ? ? O
as ? ? O
compared ? ? O
with ? ? O
control ? ? O
values ? ? O
. ? ? O

We 3170794 ? O
conclude ? ? O
that ? ? O
isotretinoin ? ? I-treatment
is ? ? O
not ? ? O
toxic ? ? O
to ? ? O
the ? ? O
lacrimal ? ? O
gland ? ? O
of ? ? O
rabbits ? ? O
. ? ? O

This 3170794 ? O
suggests ? ? O
that ? ? O
ocular ? ? I-disease
irritation ? ? I-disease
in ? ? O
patients ? ? O
treated ? ? O
with ? ? O
isotretinoin ? ? I-treatment
is ? ? O
not ? ? O
caused ? ? O
by ? ? O
decreased ? ? I-disease
tear ? ? I-disease
secretion ? ? I-disease
during ? ? O
therapy ? ? O
. ? ? O

Respiratory 5068007 ? I-disease
responses ? ? I-disease
to ? ? O
chemical ? ? I-treatment
pulses ? ? I-treatment
in ? ? O
the ? ? O
cerebrospinal ? ? O
fluid ? ? O
of ? ? O
cats ? ? O
. ? ? O

1 5068007 ? O
. ? ? O

In 5068007 ? O
cats ? ? O
anaesthetized ? ? O
with ? ? O
pentobarbitone ? ? I-treatment
, ? ? O
the ? ? O
fluid ? ? O
spaces ? ? O
in ? ? O
and ? ? O
around ? ? O
the ? ? O
brain ? ? O
stem ? ? O
were ? ? O
perfused ? ? O
from ? ? O
the ? ? O
third ? ? O
ventricle ? ? O
to ? ? O
the ? ? O
foramen ? ? O
magnum ? ? O
with ? ? O
artificial ? ? I-treatment
cerebrospinal ? ? I-treatment
fluid ? ? I-treatment
( ? ? O
c.s.f ? ? I-treatment
. ? ? O
) ? ? O

flowing 5068007 ? O
usually ? ? O
at ? ? O
the ? ? O
rate ? ? O
of ? ? O
5 ? ? O
ml ? ? O
/ ? ? O
minute ? ? O
. ? ? O

Test 5068007 ? O
solutions ? ? O
were ? ? O
substituted ? ? O
for ? ? O
the ? ? O
artificial ? ? I-treatment
c.s.f ? ? I-treatment
. ? ? O

without 5068007 ? O
switching ? ? O
artifact ? ? O
for ? ? O
periods ? ? O
varying ? ? O
from ? ? O
5 ? ? O
to ? ? O
60 ? ? O
seconds ? ? O
. ? ? O

Observations 5068007 ? O
were ? ? O
made ? ? O
on ? ? O
respiratory ? ? I-disease
excursions ? ? I-disease
, ? ? O
end-expiratory ? ? I-disease
% ? ? I-disease
CO ? ? I-disease
( ? ? O
2 ? ? O
) ? ? O
and ? ? O
arterial ? ? I-disease
blood ? ? I-disease
pressure.2 ? ? I-disease
. ? ? O

Perfusion 5068007 ? I-treatment
with ? ? I-treatment
sucrose ? ? I-treatment
solution ? ? I-treatment
equiosmolar ? ? O
with ? ? O
the ? ? O
c.s.f ? ? I-treatment
. ? ? O

produced 5068007 ? O
no ? ? O
respiratory ? ? O
or ? ? O
cardiovascular ? ? O
response ? ? O
. ? ? O

Replacement 5068007 ? O
of ? ? O
sodium ? ? I-treatment
with ? ? O
potassium ? ? I-treatment
( ? ? O
60 ? ? O
to ? ? O
133 ? ? O
mM ? ? O
) ? ? O
resulted ? ? O
in ? ? O
a ? ? O
prompt ? ? O
but ? ? O
mild ? ? I-disease
respiratory ? ? I-disease
stimulation ? ? I-disease
and ? ? O
a ? ? O
delayed ? ? O
fall ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
associated ? ? O
with ? ? O
a ? ? O
slowing ? ? I-disease
of ? ? I-disease
the ? ? I-disease
heart ? ? I-disease
beat ? ? I-disease
. ? ? O

Replacement 5068007 ? O
of ? ? O
sodium ? ? I-treatment
with ? ? O
magnesium ? ? I-treatment
( ? ? O
40 ? ? O
to ? ? O
131 ? ? O
mM ? ? O
) ? ? O
resulted ? ? O
in ? ? O
a ? ? O
late ? ? O
prolonged ? ? I-disease
apneustic ? ? I-disease
depression ? ? I-disease
of ? ? O
breathing ? ? O
and ? ? O
in ? ? O
an ? ? O
early ? ? O
but ? ? O
slight ? ? I-disease
reduction ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure.3 ? ? I-disease
. ? ? O

Procaine 5068007 ? I-treatment
( ? ? O
1 ? ? O
to ? ? O
50 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
elicited ? ? O
a ? ? O
respiratory ? ? O
response ? ? O
similar ? ? O
to ? ? O
that ? ? O
of ? ? O
excess ? ? I-treatment
magnesium ? ? I-treatment
; ? ? O
however ? ? O
, ? ? O
an ? ? O
initial ? ? I-disease
rise ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
to ? ? O
as ? ? O
high ? ? O
as ? ? O
200 ? ? O
mmHg ? ? O
was ? ? O
evoked ? ? O
with ? ? O
procaine ? ? I-treatment
. ? ? O

Nicotine 5068007 ? I-treatment
( ? ? O
0.05 ? ? O
to ? ? O
0.5 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
produced ? ? O
an ? ? O
immediate ? ? O
brief ? ? O
bradypnea ? ? I-disease
followed ? ? O
by ? ? O
a ? ? O
vigorous ? ? I-disease
and ? ? I-disease
slowly ? ? I-disease
reversing ? ? I-disease
hyperpnea ? ? I-disease
accompanied ? ? O
most ? ? O
often ? ? O
by ? ? O
a ? ? O
fall ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
. ? ? O

Tachyphylaxis 5068007 ? I-disease
was ? ? O
observed ? ? O
in ? ? O
the ? ? O
response ? ? O
to ? ? O
nicotine ? ? I-treatment
. ? ? O

Noradrenaline 5068007 ? I-treatment
( ? ? O
0.001 ? ? O
and ? ? O
0.1 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
did ? ? O
not ? ? O
produce ? ? O
any ? ? O
effect ? ? O
, ? ? O
and ? ? O
it ? ? O
did ? ? O
not ? ? O
alter ? ? O
the ? ? O
responses ? ? O
elicited ? ? O
by ? ? O
procaine ? ? I-treatment
and ? ? O
nicotine ? ? I-treatment
given ? ? O
by ? ? O
perfusion ? ? O
either ? ? O
simultaneous ? ? O
with ? ? O
or ? ? O
subsequent ? ? O
to ? ? O
the ? ? O
noradrenaline ? ? I-treatment
. ? ? O

Acetylcholine 5068007 ? I-treatment
( ? ? O
0.5 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
produced ? ? O
weak ? ? I-disease
transient ? ? I-disease
respiratory ? ? I-disease
stimulation ? ? I-disease
and ? ? O
a ? ? O
small ? ? I-disease
fluctuation ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
which ? ? O
disappeared ? ? O
in ? ? O
repeated ? ? O
tests ? ? O
. ? ? O

Methacholine 5068007 ? I-treatment
( ? ? O
1 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
caused ? ? O
a ? ? O
brief ? ? I-disease
hyperpnea ? ? I-disease
and ? ? O
a ? ? O
fall ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
both ? ? O
of ? ? O
which ? ? O
were ? ? O
abolished ? ? O
after ? ? O
atropine ? ? I-treatment
( ? ? O
0.2 ? ? O
mg ? ? O
) ? ? O
was ? ? O
injected ? ? O
into ? ? O
the ? ? O
third ? ? O
ventricle ? ? O
. ? ? O

Pilocarpine 5068007 ? I-treatment
( ? ? O
10 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
elicited ? ? O
no ? ? O
change ? ? O
in ? ? O
respiration ? ? O
or ? ? O
blood ? ? O
pressure ? ? O
. ? ? O

Respiratory 5068007 ? I-disease
and ? ? I-disease
cardiovascular ? ? I-disease
effects ? ? I-disease
produced ? ? O
by ? ? O
strychnine ? ? I-treatment
( ? ? O
1 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
were ? ? O
attributable ? ? O
non-specifically ? ? O
to ? ? O
convulsive ? ? I-disease
movements ? ? I-disease
of ? ? O
the ? ? O
animal ? ? O
. ? ? O

Ethamivan 5068007 ? I-treatment
( ? ? O
1 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
produced ? ? O
a ? ? O
single ? ? I-disease
deep ? ? I-disease
breath ? ? I-disease
and ? ? O
a ? ? O
slowly ? ? I-disease
reversing ? ? I-disease
rise ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
. ? ? O

Cyanide 5068007 ? I-treatment
( ? ? O
0.5 ? ? O
mg ? ? O
/ ? ? O
ml ? ? O
) ? ? O
barely ? ? O
stimulated ? ? O
the ? ? O
respiration ? ? O
but ? ? O
it ? ? O
produced ? ? O
a ? ? O
long ? ? I-disease
lasting ? ? I-disease
rise ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure ? ? I-disease
. ? ? O

Ethyl 5068007 ? I-treatment
alcohol ? ? I-treatment
( ? ? O
0.1 ? ? O
ml ? ? O
/ ? ? O
ml ? ? O
) ? ? O
elicited ? ? O
brisk ? ? O
though ? ? O
brief ? ? I-disease
respiratory ? ? I-disease
stimulation ? ? I-disease
and ? ? O
a ? ? O
short ? ? I-disease
lasting ? ? I-disease
fall ? ? I-disease
in ? ? I-disease
blood ? ? I-disease
pressure.4 ? ? I-disease
. ? ? O

It 5068007 ? O
was ? ? O
shown ? ? O
that ? ? O
the ? ? O
effects ? ? O
of ? ? O
procaine ? ? I-treatment
and ? ? O
nicotine ? ? I-treatment
were ? ? O
not ? ? O
qualitatively ? ? O
altered ? ? O
when ? ? O
the ? ? O
perfusion ? ? O
effluent ? ? O
was ? ? O
collected ? ? O
through ? ? O
a ? ? O
ventral ? ? I-treatment
craniotomy ? ? I-treatment
instead ? ? O
of ? ? O
the ? ? O
cisterna ? ? O
magna ? ? O
. ? ? O

Epithelial 7499407 ? I-gene
membrane ? ? I-gene
protein-1 ? ? I-gene
, ? ? O
peripheral ? ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
, ? ? O
and ? ? O
lens ? ? I-gene
membrane ? ? I-gene
protein ? ? I-gene
20 ? ? I-gene
define ? ? O
a ? ? O
novel ? ? O
gene ? ? O
family ? ? O
. ? ? O

Peripheral 7499407 ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
( ? ? O
PMP22 ? ? I-gene
) ? ? O
is ? ? O
expressed ? ? O
in ? ? O
many ? ? O
tissues ? ? O
but ? ? O
mainly ? ? O
by ? ? O
Schwann ? ? O
cells ? ? O
as ? ? O
a ? ? O
component ? ? O
of ? ? O
compact ? ? O
myelin ? ? O
of ? ? O
the ? ? O
peripheral ? ? I-disease
nervous ? ? I-disease
system ? ? I-disease
( ? ? O
PNS ? ? I-disease
) ? ? O
. ? ? O

Mutations 7499407 ? I-gene
affecting ? ? I-gene
PMP22 ? ? I-gene
are ? ? O
associated ? ? O
with ? ? O
hereditary ? ? I-disease
motor ? ? I-disease
and ? ? I-disease
sensory ? ? I-disease
neuropathies ? ? I-disease
. ? ? O

Although 7499407 ? O
these ? ? O
phenotypes ? ? O
are ? ? O
restricted ? ? O
to ? ? O
the ? ? O
PNS ? ? I-disease
, ? ? O
PMP22 ? ? I-gene
is ? ? O
thought ? ? O
to ? ? O
play ? ? O
a ? ? O
dual ? ? O
role ? ? O
in ? ? O
myelin ? ? O
formation ? ? O
and ? ? O
in ? ? O
cell ? ? O
proliferation ? ? O
. ? ? O

We 7499407 ? O
describe ? ? O
the ? ? O
cloning ? ? O
and ? ? O
characterization ? ? O
of ? ? O
epithelial ? ? I-gene
membrane ? ? I-gene
protein-1 ? ? I-gene
( ? ? O
EMP-1 ? ? I-gene
) ? ? O
, ? ? O
a ? ? O
putative ? ? I-gene
four-transmembrane ? ? I-gene
protein ? ? I-gene
of ? ? O
160 ? ? O
amino ? ? O
acids ? ? O
with ? ? O
40 ? ? O
% ? ? O
amino ? ? O
acid ? ? O
identity ? ? O
to ? ? O
PMP22 ? ? I-gene
. ? ? O

EMP-1 7499407 ? I-gene
and ? ? O
PMP22 ? ? I-gene
are ? ? O
co-expressed ? ? O
in ? ? O
most ? ? O
tissues ? ? O
but ? ? O
with ? ? O
differences ? ? O
in ? ? O
relative ? ? O
expression ? ? O
levels ? ? O
. ? ? O

EMP-1 7499407 ? I-gene
is ? ? O
most ? ? O
prominently ? ? O
found ? ? O
in ? ? O
the ? ? O
gastrointestinal ? ? I-disease
tract ? ? I-disease
, ? ? O
skin ? ? I-disease
, ? ? O
lung ? ? I-disease
, ? ? O
and ? ? O
brain ? ? I-disease
but ? ? O
not ? ? I-disease
in ? ? I-disease
liver ? ? I-disease
. ? ? O

In 7499407 ? O
the ? ? O
corpus ? ? O
gastricum ? ? O
, ? ? O
EMP-1 ? ? I-gene
protein ? ? O
can ? ? O
be ? ? O
detected ? ? O
in ? ? O
epithelial ? ? O
cells ? ? O
of ? ? O
the ? ? O
gastric ? ? I-disease
pit ? ? I-disease
and ? ? O
isthmus ? ? I-disease
of ? ? I-disease
the ? ? I-disease
gastric ? ? I-disease
gland ? ? I-disease
in ? ? O
a ? ? O
pattern ? ? O
consistent ? ? O
with ? ? O
plasma ? ? O
membrane ? ? O
association ? ? O
. ? ? O

EMP-1 7499407 ? I-gene
and ? ? O
PMP22 ? ? I-gene
mRNA ? ? I-gene
levels ? ? O
are ? ? O
inversely ? ? O
regulated ? ? O
in ? ? O
the ? ? O
degenerating ? ? I-disease
rat ? ? I-disease
sciatic ? ? I-disease
nerve ? ? I-disease
after ? ? O
injury ? ? O
and ? ? O
by ? ? O
growth ? ? I-disease
arrest ? ? I-disease
in ? ? O
NIH ? ? I-gene
3T3 ? ? I-gene
fibroblasts ? ? I-gene
. ? ? O

The 7499407 ? O
discovery ? ? O
of ? ? O
EMP-1 ? ? I-gene
as ? ? O
the ? ? O
second ? ? O
member ? ? O
of ? ? O
a ? ? O
novel ? ? O
gene ? ? O
family ? ? O
led ? ? O
to ? ? O
the ? ? O
identification ? ? O
of ? ? O
the ? ? O
lens-specific ? ? I-gene
membrane ? ? I-gene
protein ? ? I-gene
20 ? ? I-gene
( ? ? O
MP20 ? ? I-gene
) ? ? O
as ? ? O
a ? ? O
third ? ? O
but ? ? O
distant ? ? O
relative ? ? O
. ? ? O

The 7499407 ? O
proteins ? ? O
of ? ? O
this ? ? O
family ? ? O
are ? ? O
likely ? ? O
to ? ? O
serve ? ? O
similar ? ? O
functions ? ? O
possibly ? ? O
related ? ? O
to ? ? O
cell ? ? O
proliferation ? ? O
and ? ? O
differentiation ? ? O
in ? ? O
a ? ? O
variety ? ? O
of ? ? O
cell ? ? O
types ? ? O
. ? ? O

Dejerine-Sottas 8995589 ? I-disease
neuropathy ? ? I-disease
in ? ? O
mother ? ? O
and ? ? O
son ? ? O
with ? ? O
same ? ? O
point ? ? I-disease
mutation ? ? I-disease
of ? ? O
PMP22 ? ? I-gene
gene ? ? O
. ? ? O

We 8995589 ? O
studied ? ? O
a ? ? O
25-year-old ? ? O
black ? ? O
woman ? ? O
with ? ? O
healthy ? ? O
parents ? ? O
and ? ? O
her ? ? O
2-year ? ? O
, ? ? O
11-month-old ? ? O
son ? ? O
. ? ? O

Her 8995589 ? O
motor ? ? I-disease
development ? ? I-disease
was ? ? I-disease
delayed ? ? I-disease
and ? ? O
she ? ? O
started ? ? O
to ? ? O
walk ? ? I-disease
with ? ? I-disease
support ? ? I-disease
when ? ? O
she ? ? O
was ? ? O
6 ? ? O
years ? ? O
old ? ? O
. ? ? O

She 8995589 ? O
never ? ? I-disease
walked ? ? I-disease
independently ? ? I-disease
and ? ? O
had ? ? O
always ? ? I-disease
used ? ? I-disease
a ? ? I-disease
wheelchair ? ? I-disease
. ? ? O

Neurological 8995589 ? I-disease
evaluation ? ? I-disease
showed ? ? O
severe ? ? I-disease
weakness ? ? I-disease
and ? ? I-disease
atrophy ? ? I-disease
of ? ? I-disease
her ? ? I-disease
feet ? ? I-disease
, ? ? I-disease
legs ? ? I-disease
, ? ? I-disease
and ? ? I-disease
hands ? ? I-disease
, ? ? O
bilateral ? ? I-disease
pes ? ? I-disease
cavus ? ? I-disease
and ? ? O
hammertoes ? ? I-disease
, ? ? O
corrected ? ? O
scoliosis ? ? I-disease
, ? ? O
hypesthesia ? ? I-disease
for ? ? I-disease
proprioception ? ? I-disease
and ? ? I-disease
vibration ? ? I-disease
sense ? ? I-disease
in ? ? I-disease
both ? ? I-disease
feet ? ? I-disease
and ? ? I-disease
ankles ? ? I-disease
, ? ? O
and ? ? O
areflexia ? ? I-disease
. ? ? O

She 8995589 ? O
had ? ? O
normal ? ? O
intelligence ? ? O
. ? ? O

Her 8995589 ? O
son ? ? O
also ? ? O
had ? ? O
delayed ? ? I-disease
motor ? ? I-disease
milestones ? ? I-disease
and ? ? O
was ? ? O
still ? ? O
unable ? ? I-disease
to ? ? I-disease
stand ? ? I-disease
and ? ? I-disease
walk ? ? I-disease
independently ? ? I-disease
at ? ? O
almost ? ? O
3 ? ? O
years ? ? O
. ? ? O

Neurological 8995589 ? I-disease
evaluation ? ? I-disease
revealed ? ? O
diffuse ? ? I-disease
muscle ? ? I-disease
hypotonia ? ? I-disease
and ? ? O
weakness ? ? O
with ? ? O
generalized ? ? I-disease
areflexia ? ? I-disease
and ? ? O
normal ? ? O
intelligence ? ? O
. ? ? O

No 8995589 ? O
muscle ? ? I-disease
atrophies ? ? I-disease
or ? ? O
feet ? ? I-disease
deformities ? ? I-disease
were ? ? O
noticed ? ? O
. ? ? O

Nerve 8995589 ? I-disease
conduction ? ? I-disease
velocities ? ? I-disease
showed ? ? I-disease
significant ? ? I-disease
slowing ? ? I-disease
( ? ? O
less ? ? O
than ? ? O
5 ? ? O
m ? ? O
/ ? ? O
s ? ? O
) ? ? O
with ? ? O
prolonged ? ? I-disease
distal ? ? I-disease
latencies ? ? I-disease
( ? ? O
above ? ? O
30 ? ? O
ms ? ? O
) ? ? O
. ? ? O

Compound 8995589 ? I-disease
motor ? ? I-disease
action ? ? I-disease
potential ? ? I-disease
amplitudes ? ? I-disease
were ? ? I-disease
markedly ? ? I-disease
reduced ? ? I-disease
. ? ? O

Electromyography 8995589 ? I-disease
revealed ? ? O
polyphasic ? ? I-disease
motor ? ? I-disease
unit ? ? I-disease
potentials ? ? I-disease
. ? ? O

Molecular 8995589 ? O
genetic ? ? O
studies ? ? O
indicated ? ? O
a ? ? O
Trembler ? ? I-disease
type ? ? O
missense ? ? O
point ? ? I-disease
mutation ? ? O
of ? ? O
exon ? ? I-gene
4 ? ? I-gene
of ? ? I-gene
the ? ? I-gene
peripheral ? ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
gene ? ? I-gene
that ? ? O
led ? ? O
to ? ? O
the ? ? O
substitution ? ? O
of ? ? O
a ? ? O
spartic ? ? I-treatment
acid ? ? O
for ? ? O
glycine ? ? I-treatment
in ? ? O
both ? ? O
the ? ? O
mother ? ? O
and ? ? O
her ? ? O
son ? ? O
. ? ? O

Her 8995589 ? O
parents ? ? O
showed ? ? O
normal ? ? O
DNA ? ? O
studies ? ? O
. ? ? O

Neurons 9315897 ? O
promote ? ? O
the ? ? O
translocation ? ? O
of ? ? O
peripheral ? ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
into ? ? O
myelin ? ? O
. ? ? O

Schwann 9315897 ? O
cells ? ? O
express ? ? O
low ? ? O
levels ? ? O
of ? ? O
myelin ? ? O
proteins ? ? O
in ? ? O
the ? ? O
absence ? ? O
of ? ? O
neurons ? ? O
. ? ? O

When 9315897 ? O
Schwann ? ? O
cells ? ? O
and ? ? O
neurons ? ? O
are ? ? O
cultured ? ? O
together ? ? O
the ? ? O
production ? ? O
of ? ? O
myelin ? ? O
proteins ? ? O
is ? ? O
elevated ? ? O
, ? ? O
and ? ? O
myelin ? ? O
is ? ? O
formed ? ? O
. ? ? O

For 9315897 ? O
peripheral ? ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
( ? ? O
PMP22 ? ? I-gene
) ? ? O
, ? ? O
the ? ? O
exact ? ? O
amount ? ? O
of ? ? O
protein ? ? O
produced ? ? O
is ? ? O
critical ? ? O
, ? ? O
because ? ? O
peripheral ? ? I-disease
neuropathies ? ? I-disease
result ? ? O
from ? ? O
its ? ? O
underexpression ? ? O
or ? ? O
overexpression ? ? O
. ? ? O

In 9315897 ? O
this ? ? O
study ? ? O
we ? ? O
examined ? ? O
the ? ? O
effect ? ? O
of ? ? O
neurons ? ? O
on ? ? O
Schwann ? ? O
cell ? ? O
PMP22 ? ? I-gene
production ? ? O
in ? ? O
culture ? ? O
and ? ? O
in ? ? O
peripheral ? ? O
nerve ? ? O
using ? ? O
metabolic ? ? O
labeling ? ? O
and ? ? O
pulse-chase ? ? O
studies ? ? O
as ? ? O
well ? ? O
as ? ? O
immunocytochemistry ? ? O
. ? ? O

Most 9315897 ? O
of ? ? O
the ? ? O
newly ? ? O
synthesized ? ? O
PMP22 ? ? I-gene
in ? ? O
Schwann ? ? O
cells ? ? O
is ? ? O
rapidly ? ? O
degraded ? ? O
in ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
. ? ? O

Only 9315897 ? O
a ? ? O
small ? ? O
proportion ? ? O
of ? ? O
the ? ? O
total ? ? O
PMP22 ? ? I-gene
acquires ? ? O
complex ? ? O
glycosylation ? ? O
and ? ? O
accumulates ? ? O
in ? ? O
the ? ? O
Golgi ? ? O
compartment ? ? O
. ? ? O

This 9315897 ? O
material ? ? O
is ? ? O
translocated ? ? O
to ? ? O
the ? ? O
Schwann ? ? O
cell ? ? O
membrane ? ? O
in ? ? O
detectable ? ? O
amounts ? ? O
only ? ? O
when ? ? O
axonal ? ? O
contact ? ? O
and ? ? O
myelination ? ? O
occur ? ? O
. ? ? O

Myelination 9315897 ? O
does ? ? O
not ? ? O
, ? ? O
however ? ? O
, ? ? O
alter ? ? O
the ? ? O
rapid ? ? O
turnover ? ? O
of ? ? O
PMP22 ? ? I-gene
in ? ? O
Schwann ? ? O
cells ? ? O
. ? ? O

PMP22 9315897 ? I-gene
may ? ? O
therefore ? ? O
be ? ? O
a ? ? O
unique ? ? O
myelin ? ? O
protein ? ? O
in ? ? O
that ? ? O
axonal ? ? O
contact ? ? O
promotes ? ? O
its ? ? O
insertion ? ? O
into ? ? O
the ? ? O
Schwann ? ? O
cell ? ? O
membrane ? ? O
and ? ? O
myelin ? ? O
without ? ? O
altering ? ? O
its ? ? O
rapid ? ? O
turnover ? ? O
rate ? ? O
within ? ? O
the ? ? O
cell ? ? O
. ? ? O

Trisomy 11903333 ? I-gene
17p10-p12 ? ? I-gene
resulting ? ? O
from ? ? O
a ? ? O
supernumerary ? ? I-gene
marker ? ? I-gene
chromosome ? ? O
derived ? ? O
from ? ? O
chromosome ? ? O
17 ? ? O
: ? ? O
molecular ? ? O
analysis ? ? O
and ? ? O
delineation ? ? O
of ? ? O
the ? ? O
phenotype ? ? O
. ? ? O

We 11903333 ? O
report ? ? O
a ? ? O
5-year-old ? ? O
boy ? ? O
with ? ? O
a ? ? O
small ? ? O
de ? ? I-gene
novo ? ? I-gene
marker ? ? I-gene
chromosome ? ? I-gene
derived ? ? O
from ? ? O
the ? ? O
proximal ? ? I-gene
short ? ? I-gene
arm ? ? I-gene
of ? ? I-gene
chromosome ? ? I-gene
17 ? ? I-gene
. ? ? O

His 11903333 ? O
clinical ? ? O
features ? ? O
include ? ? O
hypotonia ? ? I-disease
, ? ? O
global ? ? I-disease
developmental ? ? I-disease
delay ? ? I-disease
, ? ? O
oval ? ? I-disease
face ? ? I-disease
with ? ? I-disease
large ? ? I-disease
nose ? ? I-disease
and ? ? I-disease
prominent ? ? I-disease
ears ? ? I-disease
, ? ? O
and ? ? O
ligamentous ? ? I-disease
laxity ? ? I-disease
of ? ? I-disease
the ? ? I-disease
fingers ? ? I-disease
. ? ? O

Magnetic 11903333 ? I-disease
resonance ? ? I-disease
imaging ? ? I-disease
of ? ? I-disease
the ? ? I-disease
brain ? ? I-disease
demonstrated ? ? O
mildly ? ? I-disease
delayed ? ? I-disease
myelination ? ? I-disease
. ? ? O

G-band 11903333 ? I-disease
chromosome ? ? I-disease
analysis ? ? I-disease
revealed ? ? O
mosaicism ? ? I-disease
for ? ? O
a ? ? O
small ? ? O
marker ? ? O
chromosome ? ? O
in ? ? O
85 ? ? O
% ? ? O
of ? ? O
the ? ? O
peripheral ? ? O
blood ? ? O
cells ? ? O
analyzed ? ? O
. ? ? O

Fluorescence 11903333 ? I-disease
in ? ? I-disease
situ ? ? I-disease
hybridization ? ? I-disease
and ? ? O
microsatellite ? ? I-disease
polymorphism ? ? I-disease
studies ? ? I-disease
showed ? ? O
that ? ? O
the ? ? O
der ? ? O
( ? ? O
17 ? ? I-gene
) ? ? O
was ? ? O
of ? ? O
maternal ? ? I-disease
origin ? ? I-disease
and ? ? O
included ? ? O
genetic ? ? O
material ? ? O
from ? ? O
the ? ? O
17p10-p12 ? ? I-gene
region ? ? O
, ? ? O
but ? ? O
did ? ? O
not ? ? O
contain ? ? O
the ? ? O
PMP22 ? ? I-gene
gene ? ? O
. ? ? O

One 11903333 ? O
breakpoint ? ? O
mapped ? ? O
within ? ? O
the ? ? O
centromere ? ? I-gene
and ? ? O
the ? ? O
second ? ? O
breakpoint ? ? O
mapped ? ? O
adjacent ? ? O
to ? ? O
the ? ? O
Charcot-Marie-Tooth ? ? I-disease
disease ? ? I-disease
type ? ? I-disease
1A ? ? I-disease
proximal ? ? O
low-copy ? ? O
repeat ? ? O
( ? ? O
CMT1A-REP ? ? I-gene
) ? ? O
. ? ? O

We 11903333 ? O
compare ? ? O
the ? ? O
clinical ? ? O
characteristics ? ? O
of ? ? O
our ? ? O
patient ? ? O
with ? ? O
those ? ? O
previously ? ? O
reported ? ? O
to ? ? O
have ? ? O
a ? ? O
duplication ? ? O
involving ? ? O
the ? ? O
proximal ? ? I-gene
short ? ? I-gene
arm ? ? I-gene
region ? ? I-gene
of ? ? I-gene
chromosome ? ? I-gene
17 ? ? I-gene
to ? ? O
further ? ? O
delineate ? ? O
the ? ? O
phenotype ? ? O
of ? ? O
trisomy ? ? I-gene
17pl0-p12 ? ? I-gene
. ? ? O

Influence 12648019 ? O
of ? ? O
hydroxypropyl ? ? I-treatment
beta-cyclodextrin ? ? I-treatment
on ? ? O
the ? ? O
corneal ? ? O
permeation ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

The 12648019 ? O
influence ? ? O
of ? ? O
hydroxypropyl ? ? I-treatment
beta-cyclodextrin ? ? I-treatment
( ? ? O
HPbetaCD ? ? I-treatment
) ? ? O
on ? ? O
the ? ? O
corneal ? ? I-disease
permeation ? ? I-disease
of ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
was ? ? O
investigated ? ? O
by ? ? O
an ? ? O
in ? ? O
vitro ? ? O
permeability ? ? O
study ? ? O
using ? ? O
isolated ? ? O
rabbit ? ? O
cornea ? ? O
. ? ? O

Pupillary-response 12648019 ? O
pattern ? ? O
to ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
with ? ? O
and ? ? O
without ? ? O
HPbetaCD ? ? I-treatment
was ? ? O
examined ? ? O
in ? ? O
rabbit ? ? O
eye ? ? O
. ? ? O

Corneal 12648019 ? I-disease
permeation ? ? I-disease
of ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
was ? ? O
found ? ? O
to ? ? O
be ? ? O
four ? ? O
times ? ? O
higher ? ? O
after ? ? O
adding ? ? O
HPbetaCD ? ? I-treatment
into ? ? O
the ? ? O
formulation ? ? O
. ? ? O

The 12648019 ? O
reduction ? ? I-disease
of ? ? I-disease
pupil ? ? I-disease
diameter ? ? I-disease
( ? ? O
miosis ? ? I-disease
) ? ? O
by ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
was ? ? O
significantly ? ? O
increased ? ? O
as ? ? O
a ? ? O
result ? ? O
of ? ? O
HPbetaCD ? ? I-treatment
addition ? ? O
into ? ? O
the ? ? O
simple ? ? O
aqueous ? ? O
solution ? ? O
of ? ? O
the ? ? O
active ? ? O
substance ? ? O
. ? ? O

The 12648019 ? O
highest ? ? O
miotic ? ? I-disease
response ? ? I-disease
was ? ? O
obtained ? ? O
with ? ? O
the ? ? O
formulation ? ? O
prepared ? ? O
in ? ? O
a ? ? O
vehicle ? ? O
of ? ? O
Carbopol ? ? I-treatment
940 ? ? I-treatment
. ? ? O

It 12648019 ? O
is ? ? O
suggested ? ? O
that ? ? O
ocular ? ? O
bioavailability ? ? O
of ? ? O
pilocarpine ? ? I-treatment
nitrate ? ? I-treatment
could ? ? O
be ? ? O
improved ? ? O
by ? ? O
the ? ? O
addition ? ? O
of ? ? O
HPbetaCD ? ? I-treatment
. ? ? O

Current 12673460 ? O
therapies ? ? O
for ? ? O
xerostomia ? ? I-disease
and ? ? O
salivary ? ? I-disease
gland ? ? I-disease
hypofunction ? ? I-disease
associated ? ? O
with ? ? O
cancer ? ? I-disease
therapies ? ? O
. ? ? O

In 12673460 ? O
cancer ? ? I-disease
patients ? ? O
, ? ? O
as ? ? O
in ? ? O
the ? ? O
general ? ? O
population ? ? O
, ? ? O
medication ? ? O
is ? ? O
the ? ? O
most ? ? O
common ? ? O
cause ? ? O
of ? ? O
xerostomia ? ? I-disease
. ? ? O

In 12673460 ? O
general ? ? O
, ? ? O
saliva ? ? O
flow ? ? O
in ? ? O
these ? ? O
patients ? ? O
can ? ? O
be ? ? O
stimulated ? ? O
by ? ? O
mechanical ? ? I-treatment
or ? ? I-treatment
pharmacological ? ? I-treatment
stimulation ? ? I-treatment
of ? ? O
the ? ? O
salivary ? ? O
glands ? ? O
. ? ? O

Painful 12673460 ? I-disease
damaged ? ? I-disease
oral ? ? I-disease
mucosa ? ? I-disease
can ? ? O
be ? ? O
treated ? ? O
by ? ? O
softening ? ? I-treatment
, ? ? I-treatment
lubricating ? ? I-treatment
mouthwashes ? ? I-treatment
or ? ? I-treatment
gels ? ? I-treatment
. ? ? O

A 12673460 ? O
specific ? ? O
group ? ? O
of ? ? O
patients ? ? O
are ? ? O
those ? ? O
receiving ? ? O
radiotherapy ? ? I-treatment
for ? ? O
malignant ? ? I-disease
tumours ? ? I-disease
in ? ? I-disease
the ? ? I-disease
head ? ? I-disease
and ? ? I-disease
neck ? ? I-disease
region ? ? O
. ? ? O

This 12673460 ? O
treatment ? ? O
is ? ? O
inevitably ? ? O
associated ? ? O
with ? ? O
damages ? ? I-disease
to ? ? I-disease
the ? ? I-disease
oral ? ? I-disease
tissues ? ? I-disease
, ? ? O
including ? ? O
the ? ? O
salivary ? ? O
glands ? ? O
, ? ? O
resulting ? ? O
in ? ? O
salivary ? ? I-disease
gland ? ? I-disease
hypofunction ? ? I-disease
. ? ? O

When 12673460 ? O
residual ? ? O
secretory ? ? O
capacity ? ? O
is ? ? O
present ? ? O
, ? ? O
it ? ? O
is ? ? O
advisable ? ? O
to ? ? O
stimulate ? ? O
the ? ? O
salivary ? ? O
glands ? ? O
by ? ? O
mechanical ? ? I-treatment
or ? ? I-treatment
gustatory ? ? I-treatment
stimuli ? ? I-treatment
regularly ? ? O
in ? ? O
these ? ? O
patients ? ? O
as ? ? O
supportive ? ? I-treatment
oral ? ? I-treatment
care ? ? I-treatment
. ? ? O

Alternatively 12673460 ? O
, ? ? O
salivary ? ? O
flow ? ? O
can ? ? O
be ? ? O
stimulated ? ? O
by ? ? O
the ? ? O
use ? ? O
of ? ? O
cholinergic ? ? I-treatment
pharmaceutical ? ? I-treatment
preparations ? ? I-treatment
, ? ? O
such ? ? O
as ? ? O
pilocarpine ? ? I-treatment
or ? ? O
cevimeline ? ? I-treatment
. ? ? O

After 12673460 ? O
the ? ? O
radiation ? ? I-treatment
therapy ? ? I-treatment
is ? ? O
ended ? ? O
, ? ? O
a ? ? O
dental ? ? I-treatment
check-up ? ? I-treatment
should ? ? O
be ? ? O
done ? ? O
every ? ? O
3 ? ? O
months ? ? O
to ? ? O
allow ? ? O
control ? ? O
of ? ? O
any ? ? O
incipient ? ? O
oral ? ? I-disease
inflammation ? ? I-disease
and ? ? O
dental ? ? I-disease
decay ? ? I-disease
. ? ? O

For 12673460 ? O
daily ? ? O
use ? ? O
, ? ? O
a ? ? O
special ? ? O
dentifrice ? ? I-treatment
( ? ? O
e.g ? ? O
. ? ? O

children 12673460 ? O
's ? ? O
toothpaste ? ? O
) ? ? O
is ? ? O
recommended ? ? O
, ? ? O
since ? ? O
the ? ? O
taste ? ? O
of ? ? O
a ? ? O
regular ? ? O
dentifrice ? ? I-treatment
may ? ? O
be ? ? O
too ? ? O
strong ? ? O
for ? ? O
these ? ? O
patients ? ? O
. ? ? O

Nocturnal 12673460 ? I-disease
oral ? ? I-disease
dryness ? ? I-disease
can ? ? O
be ? ? O
alleviated ? ? O
by ? ? O
spraying ? ? I-treatment
the ? ? I-treatment
oral ? ? I-treatment
surfaces ? ? I-treatment
with ? ? I-treatment
water ? ? I-treatment
, ? ? O
or ? ? O
by ? ? O
applying ? ? O
a ? ? O
small ? ? O
amount ? ? O
of ? ? O
dentifrice ? ? I-treatment
on ? ? O
the ? ? O
dental ? ? O
smooth ? ? O
surfaces ? ? O
. ? ? O

When 12673460 ? O
stimulation ? ? I-treatment
of ? ? I-treatment
salivary ? ? I-treatment
secretion ? ? I-treatment
fails ? ? O
, ? ? O
patients ? ? O
can ? ? O
be ? ? O
given ? ? O
palliative ? ? I-treatment
oral ? ? I-treatment
care ? ? I-treatment
in ? ? O
the ? ? O
form ? ? O
of ? ? O
application ? ? O
of ? ? O
mouthwashes ? ? I-treatment
and ? ? O
saliva ? ? I-treatment
substitutes ? ? I-treatment
. ? ? O

The 12673460 ? O
daily ? ? O
use ? ? O
of ? ? O
a ? ? O
mouthwash ? ? I-treatment
, ? ? O
e.g ? ? O
. ? ? O

Biotene 12673460 ? I-treatment
, ? ? O
Oral ? ? I-treatment
Balance ? ? I-treatment
or ? ? O
Zendium ? ? I-treatment
, ? ? O
or ? ? O
one ? ? O
of ? ? O
the ? ? O
saliva ? ? I-treatment
substitutes ? ? I-treatment
is ? ? O
indicated ? ? O
. ? ? O

Different 12673460 ? O
types ? ? O
of ? ? O
saliva ? ? I-treatment
substitutes ? ? I-treatment
are ? ? O
now ? ? O
commercially ? ? O
available ? ? O
, ? ? O
containing ? ? O
different ? ? O
polymers ? ? O
as ? ? O
thickening ? ? O
agents ? ? O
, ? ? O
e.g ? ? O
. ? ? O

carboxymethylcellulose 12673460 ? I-treatment
( ? ? O
Oralube ? ? I-treatment
and ? ? O
Glandosane ? ? I-treatment
) ? ? O
, ? ? O
polyacrylic ? ? I-treatment
acid ? ? I-treatment
, ? ? O
and ? ? O
xanthan ? ? I-treatment
gum ? ? I-treatment
( ? ? O
Xialine ? ? I-treatment
) ? ? O
. ? ? O

Recent 12673460 ? O
developments ? ? O
, ? ? O
which ? ? O
are ? ? O
, ? ? O
however ? ? O
, ? ? O
still ? ? O
in ? ? O
the ? ? O
experimental ? ? O
stage ? ? O
, ? ? O
are ? ? O
bio-active ? ? I-treatment
saliva ? ? I-treatment
substitutes ? ? I-treatment
and ? ? O
mouthwashes ? ? I-treatment
containing ? ? O
antimicrobial ? ? O
peptides ? ? O
to ? ? O
protect ? ? O
the ? ? O
oral ? ? O
tissues ? ? O
against ? ? O
microbial ? ? I-disease
colonization ? ? I-disease
and ? ? O
to ? ? O
suppress ? ? O
and ? ? O
to ? ? O
cure ? ? O
mucosal ? ? I-disease
and ? ? I-disease
gingival ? ? I-disease
inflammation ? ? I-disease
. ? ? O

[ 12789773 ? O
Effect ? ? O
of ? ? O
pilocarpine ? ? I-treatment
chloride ? ? I-treatment
on ? ? O
pseudoplastic ? ? O
hydrogel ? ? I-treatment
] ? ? O
. ? ? O

Colloidal 12789773 ? O
aqueous ? ? O
dispersions ? ? O
of ? ? O
2 ? ? O
to ? ? O
5 ? ? O
% ? ? O
( ? ? O
weight ? ? O
) ? ? O
of ? ? O
hydroxypropylmethylcellulose ? ? I-treatment
( ? ? O
HMPC ? ? I-treatment
4000 ? ? I-treatment
) ? ? O
yield ? ? O
pseudoplastic ? ? O
mucilages ? ? O
and ? ? O
gels ? ? O
. ? ? O

Rotational 12789773 ? O
viscosimetry ? ? O
in ? ? O
the ? ? O
cone-plate ? ? O
arrangement ? ? O
enables ? ? O
rapid ? ? O
and ? ? O
reproducible ? ? O
evaluation ? ? O
of ? ? O
the ? ? O
transitional ? ? O
region ? ? O
between ? ? O
pseudoplastic ? ? I-disease
and ? ? O
plastic ? ? I-disease
deformation ? ? I-disease
, ? ? O
characterized ? ? O
by ? ? O
Herschel-Bulkley ? ? O
equation ? ? O
. ? ? O

To 12789773 ? O
the ? ? O
traditional ? ? O
Ostwald ? ? O
's ? ? O
two-parameter ? ? O
relationship ? ? O
it ? ? O
adds ? ? O
a ? ? O
third ? ? O
one ? ? O
, ? ? O
revealing ? ? O
a ? ? O
deviation ? ? O
from ? ? O
the ? ? O
beginning ? ? O
of ? ? O
the ? ? O
coordinates ? ? O
of ? ? O
the ? ? O
rheogram ? ? I-disease
caused ? ? O
by ? ? O
the ? ? O
limiting ? ? O
yield ? ? O
stress ? ? O
. ? ? O

The 12789773 ? O
obtained ? ? O
equations ? ? O
make ? ? O
it ? ? O
possible ? ? O
not ? ? O
only ? ? O
to ? ? O
estimate ? ? O
apparent ? ? O
and ? ? O
real ? ? O
viscosity ? ? O
, ? ? O
but ? ? O
also ? ? O
the ? ? O
area ? ? O
under ? ? O
the ? ? O
curve ? ? O
of ? ? O
the ? ? O
pseudoplastic ? ? I-disease
rheogram ? ? I-disease
. ? ? O

The 12789773 ? O
actual ? ? O
precondition ? ? O
of ? ? O
integration ? ? O
, ? ? O
however ? ? O
, ? ? O
is ? ? O
the ? ? O
estimation ? ? O
of ? ? O
the ? ? O
limiting ? ? O
yield ? ? O
stress ? ? O
as ? ? O
the ? ? O
shear ? ? O
rate ? ? O
for ? ? O
the ? ? O
zero ? ? O
shear ? ? O
stress ? ? O
. ? ? O

Experimental 12789773 ? O
estimation ? ? O
of ? ? O
the ? ? O
bottom ? ? O
margin ? ? O
for ? ? O
the ? ? O
integration ? ? O
of ? ? O
the ? ? O
area ? ? O
under ? ? O
the ? ? O
curve ? ? O
makes ? ? O
mutual ? ? O
comparability ? ? O
of ? ? O
rheograms ? ? I-disease
possible ? ? O
. ? ? O

At 12789773 ? O
a ? ? O
temperature ? ? O
of ? ? O
32 ? ? O
degrees ? ? O
C ? ? O
, ? ? O
analysis ? ? O
of ? ? O
variance ? ? O
demonstrated ? ? O
a ? ? O
significant ? ? O
diminution ? ? O
of ? ? O
this ? ? O
area ? ? O
in ? ? O
the ? ? O
presence ? ? O
of ? ? O
about ? ? O
2 ? ? O
% ? ? O
of ? ? O
pilocarpinium ? ? I-treatment
chloride ? ? I-treatment
. ? ? O

Hereditary 12849887 ? I-disease
neuropathy ? ? I-disease
with ? ? O
liability ? ? O
to ? ? O
pressure ? ? I-disease
palsies ? ? I-disease
in ? ? O
infancy ? ? O
. ? ? O

Hereditary 12849887 ? I-disease
neuropathy ? ? I-disease
with ? ? O
liability ? ? O
to ? ? O
pressure ? ? I-disease
palsies ? ? I-disease
is ? ? O
an ? ? O
autosomal-dominant ? ? I-disease
disorder ? ? I-disease
, ? ? O
classically ? ? O
characterized ? ? O
by ? ? O
recurrent ? ? I-disease
mononeuropathies ? ? I-disease
, ? ? O
associated ? ? O
with ? ? O
a ? ? O
deletion ? ? O
at ? ? O
17p11.2 ? ? I-gene
, ? ? O
encompassing ? ? O
the ? ? O
peripheral ? ? I-gene
myelin ? ? I-gene
protein ? ? I-gene
22 ? ? I-gene
gene ? ? O
. ? ? O

The 12849887 ? O
typical ? ? O
clinical ? ? O
episodes ? ? O
of ? ? O
pressure ? ? I-disease
palsy ? ? I-disease
are ? ? O
usually ? ? O
noted ? ? O
for ? ? O
the ? ? O
first ? ? O
time ? ? O
during ? ? O
the ? ? O
2nd ? ? O
or ? ? O
3rd ? ? O
decade ? ? O
of ? ? O
life ? ? O
. ? ? O

We 12849887 ? O
found ? ? O
only ? ? O
few ? ? O
reports ? ? O
in ? ? O
prepubertal ? ? O
children ? ? O
. ? ? O

We 12849887 ? O
report ? ? O
a ? ? O
case ? ? O
of ? ? O
a ? ? O
7.5-year-old ? ? O
child ? ? O
with ? ? O
muscle ? ? I-disease
weakness ? ? I-disease
and ? ? O
severe ? ? I-disease
hypotonia ? ? I-disease
associated ? ? O
with ? ? O
developmental ? ? I-disease
gross ? ? I-disease
motor ? ? I-disease
delay ? ? I-disease
. ? ? O

We 12849887 ? O
suspect ? ? O
that ? ? O
bilateral ? ? I-disease
peroneal ? ? I-disease
nerve ? ? I-disease
palsies ? ? I-disease
after ? ? O
birth ? ? O
were ? ? O
the ? ? O
first ? ? O
episode ? ? O
of ? ? O
pressure ? ? I-disease
palsy ? ? I-disease
. ? ? O

Nerve 12849887 ? I-disease
conduction ? ? I-disease
studies ? ? I-disease
demonstrated ? ? O
slightly ? ? I-disease
prolonged ? ? I-disease
distal ? ? I-disease
latencies ? ? I-disease
with ? ? O
normal ? ? O
conduction ? ? O
velocity ? ? O
. ? ? O

Typical 12849887 ? O
features ? ? O
of ? ? O
hereditary ? ? I-disease
neuropathy ? ? I-disease
with ? ? O
liability ? ? O
to ? ? O
pressure ? ? I-disease
palsies ? ? I-disease
with ? ? O
recurrent ? ? I-disease
mononeuropathies ? ? I-disease
were ? ? O
found ? ? O
in ? ? O
the ? ? O
father ? ? O
. ? ? O

DNA 12849887 ? O
analysis ? ? O
revealed ? ? O
1.5-Mb ? ? O
deletion ? ? O
at ? ? O
17p11.2 ? ? I-gene
in ? ? O
both ? ? O
father ? ? O
and ? ? O
child ? ? O
. ? ? O

To 12849887 ? O
the ? ? O
best ? ? O
of ? ? O
our ? ? O
knowledge ? ? O
, ? ? O
this ? ? O
patient ? ? O
is ? ? O
one ? ? O
of ? ? O
the ? ? O
youngest ? ? O
ever ? ? O
found ? ? O
with ? ? O
this ? ? O
disease ? ? O
. ? ? O

Plasminogen 14609555 ? I-gene
activator ? ? I-gene
activity ? ? I-gene
and ? ? O
inhibition ? ? O
in ? ? O
rabbit ? ? O
tears ? ? O
after ? ? O
photorefractive ? ? I-treatment
keratectomy ? ? I-treatment
. ? ? O

Plasminogen 14609555 ? I-gene
activator ? ? I-gene
is ? ? O
a ? ? O
normal ? ? O
component ? ? O
of ? ? O
tear ? ? O
fluid ? ? O
that ? ? O
plays ? ? O
a ? ? O
role ? ? O
in ? ? O
corneal ? ? I-disease
wound ? ? I-disease
healing ? ? I-disease
processes ? ? O
. ? ? O

This 14609555 ? O
work ? ? O
examines ? ? O
whether ? ? O
inhibitor-induced ? ? O
low ? ? O
levels ? ? O
of ? ? O
plasminogen ? ? I-gene
activator ? ? I-gene
activity ? ? I-gene
( ? ? O
PAA ? ? I-gene
) ? ? O
during ? ? O
corneal ? ? I-disease
re-epithelialization ? ? I-disease
after ? ? O
excimer ? ? I-treatment
laser ? ? I-treatment
photorefractive ? ? I-treatment
keratectomy ? ? I-treatment
( ? ? O
PRK ? ? I-treatment
) ? ? O
correlates ? ? O
with ? ? O
the ? ? O
eventual ? ? O
occurrence ? ? O
of ? ? O
haze ? ? I-disease
in ? ? O
rabbit ? ? O
eyes ? ? O
. ? ? O

Tear 14609555 ? O
samples ? ? O
were ? ? O
collected ? ? O
with ? ? O
glass ? ? O
capillaries ? ? O
from ? ? O
16 ? ? O
eyes ? ? O
of ? ? O
eight ? ? O
New ? ? O
Zealand ? ? O
rabbits ? ? O
, ? ? O
using ? ? O
i.m ? ? O
. ? ? O

injection 14609555 ? O
of ? ? O
pilocarpine ? ? I-treatment
hydrochloride ? ? I-treatment
for ? ? O
stimulation ? ? O
. ? ? O

Tears 14609555 ? O
were ? ? O
collected ? ? O
before ? ? O
and ? ? O
after ? ? O
PRK ? ? I-treatment
surgery ? ? O
, ? ? O
and ? ? O
then ? ? O
daily ? ? O
for ? ? O
5 ? ? O
days ? ? O
, ? ? O
and ? ? O
every ? ? O
fourth ? ? O
day ? ? O
thereafter ? ? O
for ? ? O
3 ? ? O
months ? ? O
. ? ? O

Both 14609555 ? O
eyes ? ? O
underwent ? ? O
PRK ? ? I-treatment
treatment ? ? O
. ? ? O

One 14609555 ? O
eye ? ? O
of ? ? O
each ? ? O
rabbit ? ? O
was ? ? O
treated ? ? O
as ? ? O
a ? ? O
control ? ? O
while ? ? O
the ? ? O
contralateral ? ? O
eye ? ? O
was ? ? O
treated ? ? O
with ? ? O
aprotinin ? ? I-treatment
, ? ? O
a ? ? O
serine ? ? I-gene
protease ? ? I-gene
inhibitor ? ? I-gene
, ? ? O
over ? ? O
the ? ? O
first ? ? O
7 ? ? O
days ? ? O
. ? ? O

PAA 14609555 ? I-gene
in ? ? O
the ? ? O
tear ? ? O
samples ? ? O
was ? ? O
measured ? ? O
by ? ? O
a ? ? O
spectrophotometric ? ? O
method ? ? O
using ? ? O
human ? ? O
plasminogen ? ? I-gene
and ? ? O
chromogenic ? ? I-gene
peptide ? ? I-gene
substrate ? ? I-gene
S-2251 ? ? I-gene
. ? ? O

For 14609555 ? O
the ? ? O
eight ? ? O
control ? ? O
eyes ? ? O
after ? ? O
PRK ? ? I-treatment
, ? ? O
the ? ? O
PAA ? ? I-gene
values ? ? O
were ? ? O
significantly ? ? O
lower ? ? O
( ? ? O
day ? ? O
1 ? ? O
) ? ? O
and ? ? O
higher ? ? O
( ? ? O
days ? ? O
2 ? ? O
and ? ? O
3 ? ? O
) ? ? O
than ? ? O
the ? ? O
equilibrium ? ? I-gene
PAA ? ? I-gene
( ? ? O
p ? ? O
< ? ? O
0.001 ? ? O
) ? ? O
. ? ? O

The 14609555 ? O
corneas ? ? O
remained ? ? O
clear ? ? O
in ? ? O
each ? ? O
of ? ? O
these ? ? O
control ? ? O
eyes ? ? O
. ? ? O

For 14609555 ? O
the ? ? O
eight ? ? O
contralateral ? ? O
aprotinin-treated ? ? I-treatment
eyes ? ? O
after ? ? O
PRK ? ? I-treatment
, ? ? O
the ? ? O
PAA ? ? I-disease
values ? ? I-disease
on ? ? I-disease
days ? ? I-disease
1-7 ? ? I-disease
were ? ? I-disease
significantly ? ? I-disease
lower ? ? I-disease
than ? ? O
the ? ? O
equilibrium ? ? I-gene
PAA ? ? I-gene
( ? ? O
p ? ? O
< ? ? O
0.001 ? ? O
) ? ? O
. ? ? O

All 14609555 ? O
eight ? ? O
of ? ? O
these ? ? O
aprotinin-treated ? ? I-treatment
eyes ? ? O
developed ? ? O
corneal ? ? I-disease
haze ? ? I-disease
after ? ? O
2 ? ? O
months ? ? O
. ? ? O

There 14609555 ? O
was ? ? O
no ? ? O
significant ? ? O
difference ? ? O
( ? ? O
p=0.06 ? ? O
) ? ? O
between ? ? O
control ? ? O
and ? ? O
aprotinin-treated ? ? I-treatment
eyes ? ? O
for ? ? O
the ? ? O
equilibrium ? ? I-gene
PAA ? ? I-gene
after ? ? O
19 ? ? O
days ? ? O
. ? ? O

We 14609555 ? O
conclude ? ? O
that ? ? O
a ? ? O
corneal ? ? I-disease
wound ? ? I-disease
healing ? ? I-disease
abnormality ? ? I-disease
( ? ? O
haze ? ? I-disease
) ? ? O
develops ? ? O
in ? ? O
rabbit ? ? O
eyes ? ? O
after ? ? O
PRK ? ? I-treatment
when ? ? O
PAA ? ? I-gene
levels ? ? O
are ? ? O
reduced ? ? O
using ? ? O
aprotinin ? ? I-treatment
for ? ? O
a ? ? O
week ? ? O
following ? ? O
PRK ? ? I-treatment
. ? ? O

Oral 14644860 ? I-treatment
pilocarpine ? ? I-treatment
for ? ? O
the ? ? O
treatment ? ? O
of ? ? O
ocular ? ? I-disease
symptoms ? ? I-disease
in ? ? O
patients ? ? O
with ? ? O
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
: ? ? O
a ? ? O
randomised ? ? O
12 ? ? O
week ? ? O
controlled ? ? O
study ? ? O
. ? ? O

OBJECTIVE 14644860 ? O
: ? ? O
To ? ? O
evaluate ? ? O
the ? ? O
efficacy ? ? O
and ? ? O
side ? ? O
effects ? ? O
of ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
for ? ? O
the ? ? O
treatment ? ? O
of ? ? O
ocular ? ? I-disease
symptoms ? ? I-disease
in ? ? O
patients ? ? O
with ? ? O
primary ? ? I-disease
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
( ? ? O
SS ? ? I-disease
) ? ? O
. ? ? O

METHODS 14644860 ? O
: ? ? O
A ? ? O
12 ? ? O
week ? ? O
, ? ? O
single ? ? O
centre ? ? O
, ? ? O
randomised ? ? O
controlled ? ? O
study ? ? O
was ? ? O
performed ? ? O
. ? ? O

Twenty 14644860 ? O
nine ? ? O
patients ? ? O
were ? ? O
randomly ? ? O
assigned ? ? O
to ? ? O
receive ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
( ? ? O
5 ? ? O
mg ? ? O
twice ? ? O
a ? ? O
day ? ? O
) ? ? O
, ? ? O
28 ? ? O
only ? ? O
artificial ? ? I-treatment
tears ? ? I-treatment
, ? ? O
and ? ? O
28 ? ? O
inferior ? ? I-treatment
puncta ? ? I-treatment
occlusion ? ? I-treatment
. ? ? O

Patients 14644860 ? O
receiving ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
and ? ? O
those ? ? O
with ? ? O
inferior ? ? I-treatment
puncta ? ? I-treatment
occlusion ? ? I-treatment
also ? ? O
received ? ? O
artificial ? ? I-treatment
tears ? ? I-treatment
. ? ? O

Patients 14644860 ? O
were ? ? O
evaluated ? ? O
at ? ? O
baseline ? ? O
and ? ? O
throughout ? ? O
the ? ? O
study ? ? O
for ? ? O
their ? ? O
subjective ? ? O
global ? ? O
assessment ? ? O
of ? ? O
dry ? ? I-disease
eyes ? ? I-disease
and ? ? O
for ? ? O
their ? ? O
objective ? ? O
assessment ? ? O
of ? ? O
dry ? ? I-disease
eyes ? ? I-disease
( ? ? O
Schirmer's-I ? ? O
test ? ? O
, ? ? O
rose ? ? O
bengal ? ? O
test ? ? O
, ? ? O
and ? ? O
imprint ? ? O
test ? ? O
) ? ? O
. ? ? O

RESULTS 14644860 ? O
: ? ? O
Patients ? ? O
taking ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
had ? ? O
significant ? ? O
improvement ? ? O
in ? ? O
subjective ? ? O
global ? ? O
assessment ? ? O
of ? ? O
dry ? ? I-disease
eyes ? ? I-disease
, ? ? O
as ? ? O
was ? ? O
evaluated ? ? O
by ? ? O
improvement ? ? I-disease
of ? ? I-disease
> ? ? I-disease
55 ? ? I-disease
mm ? ? I-disease
on ? ? I-disease
a ? ? I-disease
visual ? ? I-disease
analogue ? ? I-disease
scale ? ? I-disease
( ? ? O
VAS ? ? O
) ? ? O
for ? ? O
responses ? ? O
to ? ? O
the ? ? O
eye ? ? O
questionnaire ? ? O
, ? ? O
compared ? ? O
with ? ? O
patients ? ? O
treated ? ? O
with ? ? O
artificial ? ? I-treatment
tears ? ? I-treatment
( ? ? O
p ? ? O
< ? ? O
0.001 ? ? O
) ? ? O
and ? ? O
those ? ? O
with ? ? O
inferior ? ? I-treatment
puncta ? ? I-treatment
occlusion ? ? I-treatment
( ? ? O
p ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
. ? ? O

Furthermore 14644860 ? O
, ? ? O
patients ? ? O
receiving ? ? O
oral ? ? I-treatment
pilocarpine ? ? I-treatment
also ? ? O
showed ? ? O
greater ? ? I-disease
objective ? ? I-disease
improvement ? ? I-disease
, ? ? O
as ? ? O
measured ? ? O
by ? ? O
the ? ? O
rose ? ? O
bengal ? ? O
test ? ? O
( ? ? O
p ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
, ? ? O
while ? ? O
Schirmer's-I ? ? O
test ? ? O
showed ? ? O
no ? ? O
differences ? ? O
between ? ? O
the ? ? O
treated ? ? O
groups ? ? O
. ? ? O

Commonly 14644860 ? O
reported ? ? O
adverse ? ? O
events ? ? O
were ? ? O
headache ? ? I-disease
, ? ? O
increased ? ? I-disease
sweating ? ? I-disease
, ? ? O
nausea ? ? I-disease
, ? ? O
and ? ? O
vomiting ? ? I-disease
in ? ? O
the ? ? O
pilocarpine ? ? I-treatment
group ? ? O
, ? ? O
while ? ? O
one ? ? O
patient ? ? O
in ? ? O
the ? ? O
inferior ? ? I-treatment
puncta ? ? I-treatment
occlusion ? ? I-treatment
group ? ? O
had ? ? O
blepharitis ? ? I-disease
and ? ? O
was ? ? O
withdrawn ? ? O
from ? ? O
the ? ? O
study ? ? O
. ? ? O

CONCLUSION 14644860 ? O
: ? ? O
10 ? ? O
mg ? ? O
of ? ? O
pilocarpine ? ? I-treatment
daily ? ? O
given ? ? O
to ? ? O
patients ? ? O
with ? ? O
SS ? ? I-disease
for ? ? O
12 ? ? O
weeks ? ? O
had ? ? O
a ? ? O
beneficial ? ? O
effect ? ? O
on ? ? O
subjective ? ? O
eye ? ? O
symptoms ? ? O
, ? ? O
as ? ? O
evaluated ? ? O
by ? ? O
improvement ? ? I-disease
> ? ? I-disease
55 ? ? I-disease
mm ? ? I-disease
on ? ? I-disease
a ? ? I-disease
VAS ? ? I-disease
. ? ? O

Additionally 14644860 ? O
, ? ? O
an ? ? O
improvement ? ? I-disease
of ? ? I-disease
rose ? ? I-disease
bengal ? ? I-disease
staining ? ? I-disease
was ? ? O
noted ? ? O
, ? ? O
but ? ? O
an ? ? O
increase ? ? I-disease
in ? ? I-disease
tear ? ? I-disease
production ? ? I-disease
, ? ? O
as ? ? O
measured ? ? O
by ? ? O
the ? ? O
Schirmer-I ? ? O
test ? ? O
, ? ? O
was ? ? O
not ? ? O
substantiated ? ? O
. ? ? O

Dual-stimuli-responsive 14698590 ? O
hydrogels ? ? I-treatment
based ? ? O
on ? ? O
poly ? ? O
( ? ? O
N-isopropylacrylamide ? ? I-treatment
) ? ? O
/ ? ? O
chitosan ? ? I-treatment
semi-interpenetrating ? ? O
networks ? ? O
. ? ? O

The 14698590 ? O
synthesis ? ? O
and ? ? O
characterisation ? ? O
of ? ? O
semi-interpenetrating ? ? O
polymeric ? ? O
networks ? ? O
obtained ? ? O
by ? ? O
the ? ? O
radical-induced ? ? O
polymerisation ? ? O
of ? ? O
N-isopropylacrylamide ? ? I-treatment
in ? ? O
the ? ? O
presence ? ? O
of ? ? O
chitosan ? ? I-treatment
using ? ? O
tetraethyleneglycoldiacrylate ? ? I-treatment
as ? ? O
the ? ? O
crosslinker ? ? O
is ? ? O
described ? ? O
. ? ? O

The 14698590 ? O
influence ? ? O
of ? ? O
the ? ? O
degree ? ? O
of ? ? O
crosslinking ? ? O
and ? ? O
that ? ? O
of ? ? O
the ? ? O
ratio ? ? O
of ? ? O
chitosan ? ? I-treatment
to ? ? O
poly ? ? I-treatment
( ? ? I-treatment
N-isopropylacrylamide ? ? I-treatment
) ? ? O
on ? ? O
the ? ? O
`` ? ? O
pH ? ? O
/ ? ? O
temperature ? ? O
induced ? ? O
'' ? ? O
phase ? ? O
transition ? ? O
behaviour ? ? O
and ? ? O
swelling ? ? I-disease
characteristics ? ? O
of ? ? O
the ? ? O
hydrogel ? ? I-treatment
system ? ? O
are ? ? O
investigated ? ? O
. ? ? O

The 14698590 ? O
ability ? ? O
of ? ? O
the ? ? O
same ? ? O
system ? ? O
to ? ? O
act ? ? O
as ? ? O
a ? ? O
controlled ? ? O
release ? ? O
vehicle ? ? O
for ? ? O
pilocarpine ? ? I-treatment
hydrochloride ? ? I-treatment
is ? ? O
evaluated ? ? O
. ? ? O

[ 15059558 ? O
Ocular ? ? O
pharmacokinetics ? ? O
of ? ? O
0.5 ? ? O
% ? ? O
pilocarpine ? ? I-treatment
with ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
in ? ? O
rabbits ? ? O
] ? ? O
. ? ? O

OBJECTIVE 15059558 ? O
: ? ? O
To ? ? O
compare ? ? O
the ? ? O
pharmacokinetics ? ? O
of ? ? O
0.5 ? ? O
% ? ? O
pilocarpine ? ? I-treatment
containing ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
with ? ? O
1 ? ? O
% ? ? O
generic ? ? O
pilocarpine ? ? I-treatment
solution ? ? O
. ? ? O

METHODS 15059558 ? O
: ? ? O
One ? ? O
hundred ? ? O
albino ? ? I-gene
rabbits ? ? O
were ? ? O
divided ? ? O
into ? ? O
20 ? ? O
groups ? ? O
, ? ? O
each ? ? O
consisting ? ? O
of ? ? O
5 ? ? O
animals ? ? O
. ? ? O

Ten 15059558 ? O
groups ? ? O
received ? ? O
0.5 ? ? O
% ? ? O
pilocarpine ? ? I-treatment
containing ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
and ? ? O
10 ? ? O
groups ? ? O
received ? ? O
1 ? ? O
% ? ? O
generic ? ? O
pilocarpine ? ? I-treatment
solution ? ? O
as ? ? O
control ? ? O
. ? ? O

The 15059558 ? O
aqueous ? ? O
humor ? ? O
was ? ? O
withdrawn ? ? O
at ? ? O
5 ? ? O
, ? ? O
10 ? ? O
, ? ? O
20 ? ? O
, ? ? O
30 ? ? O
, ? ? O
40 ? ? O
, ? ? O
60 ? ? O
, ? ? O
90 ? ? O
, ? ? O
120 ? ? O
, ? ? O
150 ? ? O
, ? ? O
and ? ? O
180 ? ? O
min ? ? O
after ? ? O
instillation ? ? O
. ? ? O

The 15059558 ? O
drug ? ? O
was ? ? O
extracted ? ? O
from ? ? O
aqueous ? ? O
humor ? ? O
with ? ? O
dichloromethane ? ? I-treatment
and ? ? O
was ? ? O
detected ? ? O
by ? ? O
reversed ? ? O
phase ? ? O
high ? ? O
performance ? ? O
liquid ? ? O
chromatography ? ? O
( ? ? O
HPLC ? ? O
) ? ? O
. ? ? O

RESULTS 15059558 ? O
: ? ? O
The ? ? O
average ? ? O
recovery ? ? O
rate ? ? O
of ? ? O
pilocarpine ? ? I-treatment
from ? ? O
aqueous ? ? O
humor ? ? O
was ? ? O
98.2 ? ? O
% ? ? O
. ? ? O

The 15059558 ? O
minimum ? ? O
detectable ? ? O
concentration ? ? O
was ? ? O
0.025 ? ? O
micro ? ? O
g ? ? O
/ ? ? O
ml ? ? O
. ? ? O

The 15059558 ? O
peak ? ? O
concentration ? ? O
and ? ? O
half-life ? ? O
of ? ? O
pilocarpine ? ? I-treatment
in ? ? O
aqueous ? ? O
humor ? ? O
were ? ? O
4.46 ? ? O
micro ? ? O
g ? ? O
/ ? ? O
ml ? ? O
at ? ? O
10 ? ? O
min ? ? O
and ? ? O
31.83 ? ? O
min ? ? O
, ? ? O
respectively ? ? O
, ? ? O
in ? ? O
the ? ? O
experimental ? ? O
group ? ? O
. ? ? O

Whereas 15059558 ? O
, ? ? O
the ? ? O
peak ? ? O
concentration ? ? O
and ? ? O
half-life ? ? O
of ? ? O
pilocarpine ? ? I-treatment
in ? ? O
aqueous ? ? O
humor ? ? O
were ? ? O
2.25 ? ? O
micro ? ? O
g ? ? O
/ ? ? O
ml ? ? O
at ? ? O
20 ? ? O
min ? ? O
and ? ? O
22.98 ? ? O
min ? ? O
, ? ? O
respectively ? ? O
, ? ? O
in ? ? O
the ? ? O
control ? ? O
group ? ? O
. ? ? O

The 15059558 ? O
peak ? ? O
concentration ? ? O
of ? ? O
pilocarpine ? ? I-treatment
in ? ? O
aqueous ? ? O
humor ? ? O
in ? ? O
the ? ? O
experimental ? ? O
group ? ? O
was ? ? O
1.98 ? ? O
( ? ? O
P ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
times ? ? O
higher ? ? O
than ? ? O
the ? ? O
control ? ? O
group ? ? O
. ? ? O

The 15059558 ? O
area ? ? O
under ? ? O
curve ? ? O
of ? ? O
the ? ? O
drug ? ? O
concentration-time ? ? O
( ? ? O
AUC ? ? O
( ? ? O
0 ? ? O
- ? ? O
180 ? ? O
) ? ? O
) ? ? O
in ? ? O
the ? ? O
experimental ? ? O
group ? ? O
was ? ? O
1.75 ? ? O
times ? ? O
higher ? ? O
than ? ? O
the ? ? O
control ? ? O
group ? ? O
. ? ? O

CONCLUSION 15059558 ? O
: ? ? O
Pilocarpine ? ? I-treatment
( ? ? O
0.5 ? ? O
% ? ? O
) ? ? O
containing ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
significantly ? ? O
increased ? ? O
the ? ? O
peak ? ? O
concentration ? ? O
of ? ? O
pilocarpine ? ? I-treatment
, ? ? O
shortened ? ? O
the ? ? O
time ? ? O
of ? ? O
reaching ? ? O
peak ? ? O
concentration ? ? O
and ? ? O
prolonged ? ? O
the ? ? O
half-life ? ? O
in ? ? O
aqueous ? ? O
humor ? ? O
. ? ? O

These 15059558 ? O
results ? ? O
indicate ? ? O
that ? ? O
0.5 ? ? O
% ? ? O
pilocarpine ? ? I-treatment
with ? ? O
sodium ? ? I-treatment
hyaluronate ? ? I-treatment
significantly ? ? O
increases ? ? O
ocular ? ? O
bioavailability ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

[ 15110955 ? O
Current ? ? O
treatments ? ? O
of ? ? O
xerophthalmia ? ? I-disease
in ? ? O
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
] ? ? O
. ? ? O

PURPOSE 15110955 ? O
: ? ? O
To ? ? O
describe ? ? O
the ? ? O
large ? ? O
variety ? ? O
of ? ? O
treatments ? ? O
currently ? ? O
used ? ? O
in ? ? O
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
for ? ? O
one ? ? O
of ? ? O
its ? ? O
major ? ? O
manifestations ? ? O
, ? ? O
keratoconjunctivitis ? ? I-disease
sicca ? ? I-disease
or ? ? O
xerophthalmia ? ? I-disease
. ? ? O

CURRENT 15110955 ? O
KNOWLEDGE ? ? O
AND ? ? O
KEY ? ? O
POINTS ? ? O
: ? ? O
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
causes ? ? O
a ? ? O
diffuse ? ? I-disease
immunoinflammatory ? ? I-disease
disturbance ? ? I-disease
of ? ? O
main ? ? O
lacrimal ? ? O
glands ? ? O
and ? ? O
the ? ? O
whole ? ? O
ocular ? ? O
surface ? ? O
. ? ? O

Dry 15110955 ? I-disease
eye ? ? I-disease
syndrome ? ? I-disease
is ? ? O
responsible ? ? O
for ? ? O
chronic ? ? O
and ? ? O
deep ? ? O
impairment ? ? O
of ? ? O
quality ? ? O
of ? ? O
life ? ? O
. ? ? O

Many 15110955 ? O
different ? ? O
tear ? ? I-treatment
substitutes ? ? I-treatment
have ? ? O
been ? ? O
widely ? ? O
developed ? ? O
that ? ? O
are ? ? O
poorly ? ? O
efficient ? ? O
for ? ? O
relieving ? ? O
patients ? ? O
from ? ? O
their ? ? O
complaints ? ? O
. ? ? O

Tear 15110955 ? I-treatment
substitutes ? ? I-treatment
of ? ? O
various ? ? O
viscosity ? ? O
from ? ? O
standard ? ? O
artificial ? ? I-treatment
tears ? ? I-treatment
to ? ? O
synthetic ? ? I-treatment
gels ? ? I-treatment
may ? ? O
be ? ? O
used ? ? O
. ? ? O

Hyaluronic 15110955 ? I-treatment
acid ? ? I-treatment
is ? ? O
currently ? ? O
the ? ? O
most ? ? O
promising ? ? O
tear ? ? I-treatment
substitute ? ? I-treatment
, ? ? O
but ? ? O
all ? ? O
eye ? ? I-treatment
drops ? ? I-treatment
and ? ? I-treatment
gels ? ? I-treatment
are ? ? O
only ? ? O
efficient ? ? O
in ? ? O
mild ? ? I-disease
to ? ? I-disease
moderate ? ? I-disease
dry ? ? I-disease
eyes ? ? I-disease
and ? ? O
keratoconjunctivitis ? ? I-disease
sicca ? ? I-disease
mostly ? ? O
resists ? ? O
to ? ? O
lubricants ? ? I-treatment
. ? ? O

Moreover 15110955 ? O
, ? ? O
the ? ? O
latter ? ? O
may ? ? O
increase ? ? O
patients ? ? O
' ? ? O
complaints ? ? O
when ? ? O
they ? ? O
are ? ? O
associated ? ? O
to ? ? O
preservatives ? ? I-treatment
, ? ? O
antiseptic ? ? I-treatment
drugs ? ? I-treatment
that ? ? O
have ? ? O
widely ? ? O
demonstrated ? ? O
their ? ? O
toxic ? ? O
or ? ? O
irritating ? ? O
potential ? ? O
. ? ? O

Preservatives 15110955 ? I-treatment
are ? ? O
, ? ? O
therefore ? ? O
, ? ? O
to ? ? O
be ? ? O
avoided ? ? O
whenever ? ? O
possible ? ? O
in ? ? O
keratoconjunctivitis ? ? I-disease
sicca ? ? I-disease
, ? ? O
by ? ? O
using ? ? O
monodose ? ? I-treatment
disposable ? ? I-treatment
packaging ? ? I-treatment
or ? ? O
specific ? ? I-treatment
bottle ? ? I-treatment
filtering ? ? I-treatment
or ? ? O
eliminating ? ? I-treatment
the ? ? I-treatment
preservative ? ? I-treatment
. ? ? O

Stimulation 15110955 ? I-treatment
of ? ? I-treatment
lacrimal ? ? I-treatment
and ? ? I-treatment
salivary ? ? I-treatment
secretions ? ? I-treatment
with ? ? O
systemic ? ? I-treatment
pilocarpine ? ? I-treatment
, ? ? O
or ? ? O
obturation ? ? I-treatment
of ? ? I-treatment
lacrimal ? ? I-treatment
puncta ? ? I-treatment
in ? ? O
order ? ? O
to ? ? O
limit ? ? O
the ? ? O
drainage ? ? O
of ? ? O
tears ? ? O
in ? ? O
lachrymal ? ? O
ducts ? ? O
may ? ? O
be ? ? O
useful ? ? O
in ? ? O
most ? ? O
severe ? ? O
forms ? ? O
of ? ? O
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
. ? ? O

However 15110955 ? O
, ? ? O
the ? ? O
development ? ? O
of ? ? O
topical ? ? I-treatment
cyclosporine ? ? I-treatment
and ? ? O
other ? ? O
immunomodulating ? ? I-treatment
agents ? ? I-treatment
is ? ? O
the ? ? O
most ? ? O
relevant ? ? O
progress ? ? O
in ? ? O
the ? ? O
treatment ? ? O
of ? ? O
keratoconjunctivitis ? ? I-disease
sicca ? ? I-disease
in ? ? O
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
. ? ? O

PERSPECTIVES 15110955 ? O
: ? ? O
The ? ? O
future ? ? O
for ? ? O
treating ? ? O
Sjogren ? ? I-disease
's ? ? I-disease
syndrome ? ? I-disease
is ? ? O
most ? ? O
likely ? ? O
to ? ? O
pass ? ? O
through ? ? O
the ? ? O
use ? ? O
of ? ? O
new ? ? O
drugs ? ? O
capable ? ? O
of ? ? O
treating ? ? O
the ? ? O
disease ? ? O
or ? ? O
at ? ? O
least ? ? O
its ? ? O
mechanisms ? ? O
, ? ? O
and ? ? O
not ? ? O
only ? ? O
to ? ? O
try ? ? O
to ? ? O
relieve ? ? O
symptoms ? ? O
with ? ? O
poorly ? ? O
efficient ? ? O
tear ? ? I-treatment
substitutes ? ? I-treatment
. ? ? O

Lipopolysaccharide-induced 15509232 ? I-treatment
febrile ? ? I-disease
convulsions ? ? I-disease
in ? ? O
the ? ? O
rat ? ? O
: ? ? O
short-term ? ? O
sequelae ? ? O
. ? ? O

PURPOSE 15509232 ? O
: ? ? O
Febrile ? ? I-disease
convulsions ? ? I-disease
( ? ? O
FCs ? ? I-disease
) ? ? O
occur ? ? O
in ? ? O
children ? ? O
as ? ? O
a ? ? O
result ? ? O
of ? ? O
fever ? ? I-disease
. ? ? O

The 15509232 ? O
mechanisms ? ? O
involved ? ? O
in ? ? O
the ? ? O
genesis ? ? O
of ? ? O
FCs ? ? I-disease
and ? ? O
their ? ? O
long-term ? ? O
consequences ? ? O
on ? ? O
brain ? ? O
development ? ? O
remain ? ? O
unclear ? ? O
. ? ? O

We 15509232 ? O
have ? ? O
developed ? ? O
a ? ? O
model ? ? O
of ? ? O
FC ? ? I-disease
, ? ? O
by ? ? O
using ? ? O
fever ? ? I-disease
as ? ? O
a ? ? O
parameter ? ? O
, ? ? O
to ? ? O
test ? ? O
the ? ? O
hypothesis ? ? O
that ? ? O
fever ? ? I-disease
can ? ? O
lower ? ? O
seizure ? ? I-disease
threshold ? ? O
and ? ? O
to ? ? O
examine ? ? O
the ? ? O
neurologic ? ? O
sequelae ? ? O
of ? ? O
FCs ? ? I-disease
. ? ? O

METHODS 15509232 ? O
: ? ? O
Fourteen-day-old ? ? O
rat ? ? O
pups ? ? O
equipped ? ? O
with ? ? O
body-temperature ? ? O
telemetry ? ? O
devices ? ? O
exhibited ? ? O
approximately ? ? O
1.5 ? ? O
degrees ? ? O
C ? ? O
fevers ? ? I-disease
after ? ? O
lipopolysaccharide ? ? I-treatment
( ? ? O
Escherichia ? ? I-disease
coli ? ? I-disease
, ? ? O
200 ? ? O
microg ? ? O
/ ? ? O
kg ? ? O
) ? ? O
. ? ? O

During 15509232 ? O
such ? ? O
fevers ? ? I-disease
, ? ? O
concurrently ? ? O
administered ? ? O
doses ? ? O
of ? ? O
kainic ? ? I-treatment
acid ? ? I-treatment
that ? ? O
are ? ? O
normally ? ? O
subconvulsant ? ? O
were ? ? O
used ? ? O
to ? ? O
induce ? ? O
convulsions ? ? I-disease
with ? ? I-disease
fever ? ? I-disease
. ? ? O

Animals 15509232 ? O
were ? ? O
then ? ? O
killed ? ? O
at ? ? O
varying ? ? O
times ? ? O
for ? ? O
pathological ? ? O
and ? ? O
immunohistochemical ? ? O
studies ? ? O
. ? ? O

RESULTS 15509232 ? O
: ? ? O
The ? ? O
pairing ? ? O
of ? ? O
lipopolysaccharide ? ? I-treatment
and ? ? O
subconvulsant ? ? O
kainic ? ? I-treatment
acid ? ? I-treatment
resulted ? ? O
in ? ? O
convulsions ? ? I-disease
in ? ? O
approximately ? ? O
50 ? ? O
% ? ? O
of ? ? O
febrile ? ? I-disease
animals ? ? O
, ? ? O
with ? ? O
very ? ? O
low ? ? O
mortality ? ? I-disease
. ? ? O

To 15509232 ? O
study ? ? O
the ? ? O
neural ? ? O
correlates ? ? O
of ? ? O
these ? ? O
FCs ? ? I-disease
, ? ? O
we ? ? O
used ? ? O
fos ? ? O
immunohistochemistry ? ? O
and ? ? O
found ? ? O
that ? ? O
animals ? ? O
with ? ? O
FCs ? ? I-disease
had ? ? O
fos-positive ? ? I-disease
immunoreactivity ? ? I-disease
in ? ? O
brain ? ? O
regions ? ? O
involved ? ? O
in ? ? O
seizures ? ? I-disease
. ? ? O

After 15509232 ? O
a ? ? O
period ? ? O
of ? ? O
72 ? ? O
h ? ? O
, ? ? O
we ? ? O
also ? ? O
examined ? ? O
brains ? ? O
for ? ? O
pathologic ? ? O
changes ? ? O
and ? ? O
found ? ? O
no ? ? O
differences ? ? O
among ? ? O
our ? ? O
groups ? ? O
. ? ? O

CONCLUSIONS 15509232 ? O
: ? ? O
Our ? ? O
data ? ? O
indicate ? ? O
that ? ? O
a ? ? O
neuroimmune ? ? I-disease
challenge ? ? I-disease
and ? ? O
its ? ? O
accompanying ? ? O
fever ? ? I-disease
reduce ? ? O
the ? ? O
seizure ? ? I-disease
threshold ? ? O
. ? ? O

Furthermore 15509232 ? O
, ? ? O
the ? ? O
FCs ? ? I-disease
induced ? ? O
by ? ? O
fever ? ? I-disease
in ? ? O
this ? ? O
model ? ? O
do ? ? O
not ? ? O
have ? ? O
short-term ? ? O
adverse ? ? O
effects ? ? O
on ? ? O
the ? ? O
brain ? ? O
. ? ? O

In 15509232 ? O
addition ? ? O
, ? ? O
this ? ? O
model ? ? O
, ? ? O
by ? ? O
incorporating ? ? O
physiologic ? ? O
fever ? ? I-disease
, ? ? O
may ? ? O
be ? ? O
useful ? ? O
for ? ? O
examining ? ? O
the ? ? O
role ? ? O
of ? ? O
fever ? ? I-disease
and ? ? O
its ? ? O
constituent ? ? O
mediators ? ? O
in ? ? O
the ? ? O
genesis ? ? O
of ? ? O
FCs ? ? I-disease
. ? ? O

In 15530052 ? O
situ ? ? O
gelling ? ? O
of ? ? O
alginate ? ? I-treatment
/ ? ? I-treatment
pluronic ? ? I-treatment
solutions ? ? I-treatment
for ? ? O
ophthalmic ? ? O
delivery ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

We 15530052 ? O
prepared ? ? O
a ? ? O
series ? ? O
of ? ? O
alginate ? ? I-treatment
and ? ? O
Pluronic-based ? ? I-treatment
solutions ? ? I-treatment
as ? ? O
the ? ? O
in ? ? O
situ ? ? O
gelling ? ? O
vehicles ? ? O
for ? ? O
ophthalmic ? ? O
delivery ? ? O
of ? ? O
pilocarpine ? ? I-treatment
. ? ? O

The 15530052 ? O
rheological ? ? O
properties ? ? O
, ? ? O
in ? ? O
vitro ? ? O
release ? ? O
as ? ? O
well ? ? O
as ? ? O
in ? ? O
vivo ? ? O
pharmacological ? ? O
response ? ? O
of ? ? O
polymer ? ? O
solutions ? ? O
, ? ? O
including ? ? O
alginate ? ? I-treatment
, ? ? O
Pluronic ? ? I-treatment
solution ? ? I-treatment
, ? ? O
and ? ? O
alginate ? ? I-treatment
/ ? ? I-treatment
Pluronic ? ? I-treatment
solution ? ? I-treatment
, ? ? O
were ? ? O
evaluated ? ? O
. ? ? O

The 15530052 ? O
optimum ? ? O
concentration ? ? O
of ? ? O
alginate ? ? I-treatment
solution ? ? I-treatment
for ? ? O
the ? ? O
in ? ? O
situ ? ? O
gel-forming ? ? O
delivery ? ? O
systems ? ? O
was ? ? O
2 ? ? O
% ? ? O
( ? ? O
w ? ? O
/ ? ? O
w ? ? O
) ? ? O
and ? ? O
that ? ? O
for ? ? O
Pluronic ? ? I-treatment
solution ? ? I-treatment
was ? ? O
14 ? ? O
% ? ? O
( ? ? O
w ? ? O
/ ? ? O
w ? ? O
) ? ? O
. ? ? O

The 15530052 ? O
mixture ? ? O
of ? ? O
0.1 ? ? O
% ? ? O
alginate ? ? I-treatment
and ? ? O
14 ? ? O
% ? ? O
Pluronic ? ? I-treatment
solutions ? ? I-treatment
showed ? ? O
a ? ? O
significant ? ? O
increase ? ? O
in ? ? O
gel ? ? O
strength ? ? O
in ? ? O
the ? ? O
physiological ? ? O
condition ? ? O
; ? ? O
this ? ? O
gel ? ? O
mixture ? ? O
was ? ? O
also ? ? O
found ? ? O
to ? ? O
be ? ? O
free ? ? O
flowing ? ? O
at ? ? O
pH ? ? O
4.0 ? ? O
and ? ? O
25 ? ? O
degrees ? ? O
C. ? ? O
Both ? ? O
in ? ? O
vitro ? ? O
release ? ? O
and ? ? O
in ? ? O
vivo ? ? O
pharmacological ? ? O
studies ? ? O
indicated ? ? O
that ? ? O
the ? ? O
alginate ? ? I-treatment
/ ? ? I-treatment
Pluronic ? ? I-treatment
solution ? ? I-treatment
retained ? ? O
pilocarpine ? ? I-treatment
better ? ? O
than ? ? O
the ? ? O
alginate ? ? I-treatment
or ? ? O
Pluronic ? ? I-treatment
solutions ? ? I-treatment
alone ? ? O
. ? ? O

The 15530052 ? O
results ? ? O
demonstrated ? ? O
that ? ? O
the ? ? O
alginate ? ? I-treatment
/ ? ? I-treatment
Pluronic ? ? I-treatment
mixture ? ? O
can ? ? O
be ? ? O
used ? ? O
as ? ? O
an ? ? O
in ? ? O
situ ? ? O
gelling ? ? O
vehicle ? ? O
to ? ? O
increase ? ? O
ocular ? ? O
bioavailability ? ? O
. ? ? O

An 19657941 ? O
axon ? ? O
regeneration ? ? O
signature ? ? O
in ? ? O
a ? ? O
Charcot-Marie-Tooth ? ? I-disease
disease ? ? I-disease
type ? ? I-disease
2 ? ? I-disease
patient ? ? O
. ? ? O

Charcot-Marie-Tooth 19657941 ? I-disease
disease ? ? I-disease
( ? ? O
CMT ? ? I-disease
) ? ? O
is ? ? O
one ? ? O
of ? ? O
the ? ? O
most ? ? O
common ? ? O
inherited ? ? I-disease
peripheral ? ? I-disease
neuropathies ? ? I-disease
. ? ? O

The 19657941 ? O
underlying ? ? O
mutations ? ? I-gene
in ? ? I-gene
demyelinating ? ? I-gene
forms ? ? I-gene
tend ? ? O
to ? ? O
affect ? ? O
genes ? ? O
expressed ? ? O
in ? ? O
Schwann ? ? O
cells ? ? O
( ? ? O
CMT ? ? I-disease
types ? ? I-disease
1 ? ? I-disease
, ? ? I-disease
3 ? ? I-disease
, ? ? I-disease
and ? ? I-disease
4 ? ? O
) ? ? O
, ? ? O
while ? ? O
axonal ? ? I-disease
forms ? ? I-disease
of ? ? I-disease
the ? ? I-disease
disease ? ? I-disease
usually ? ? O
have ? ? O
their ? ? O
origins ? ? O
in ? ? O
genes ? ? O
expressed ? ? O
in ? ? O
the ? ? O
affected ? ? O
neurons ? ? O
( ? ? O
CMT ? ? I-disease
type ? ? I-disease
2 ? ? I-disease
) ? ? O
. ? ? O

Repeated 19657941 ? I-disease
rounds ? ? I-disease
of ? ? I-disease
nerve ? ? I-disease
degeneration ? ? I-disease
and ? ? I-disease
regeneration ? ? I-disease
characterize ? ? O
CMT2 ? ? I-disease
, ? ? O
but ? ? O
evidence ? ? O
for ? ? O
regeneration ? ? O
has ? ? O
not ? ? O
been ? ? O
demonstrated ? ? O
at ? ? O
a ? ? O
molecular ? ? O
level ? ? O
. ? ? O

Subtractive 19657941 ? O
hybridization ? ? O
was ? ? O
performed ? ? O
on ? ? O
sural ? ? I-treatment
nerve ? ? I-treatment
biopsies ? ? I-treatment
from ? ? O
a ? ? O
patient ? ? O
presenting ? ? O
an ? ? O
axonal ? ? I-disease
form ? ? I-disease
of ? ? I-disease
CMT ? ? I-disease
and ? ? O
an ? ? O
unaffected ? ? O
sibling ? ? O
, ? ? O
which ? ? O
revealed ? ? O
an ? ? O
overexpression ? ? I-gene
of ? ? I-gene
genes ? ? I-gene
associated ? ? I-gene
with ? ? I-gene
the ? ? I-gene
regeneration ? ? I-gene
of ? ? I-gene
axons ? ? I-gene
, ? ? O
including ? ? O
PMP22 ? ? I-gene
, ? ? O
SPARC ? ? I-gene
/ ? ? O
osteonectin ? ? O
, ? ? O
CD9 ? ? I-gene
, ? ? O
CD44 ? ? I-gene
, ? ? O
EEF1A1 ? ? I-gene
, ? ? O
and ? ? O
gamma-actin ? ? I-gene
. ? ? O

These 19657941 ? O
results ? ? O
suggest ? ? O
that ? ? O
axonal ? ? I-disease
degeneration ? ? I-disease
elicits ? ? O
a ? ? O
regeneration ? ? I-disease
transcriptional ? ? I-disease
response ? ? I-disease
in ? ? O
the ? ? O
surrounding ? ? O
Schwann ? ? O
cells ? ? O
. ? ? O

This 19657941 ? O
response ? ? O
contrasts ? ? O
with ? ? O
other ? ? O
neurodegenerative ? ? I-disease
diseases ? ? I-disease
, ? ? O
in ? ? O
which ? ? O
programmed ? ? I-disease
cell ? ? I-disease
death ? ? I-disease
or ? ? O
an ? ? O
inappropriate ? ? I-disease
immune ? ? I-disease
response ? ? I-disease
are ? ? O
activated ? ? O
. ? ? O

Additionally 19657941 ? O
, ? ? O
Lamin ? ? I-gene
A ? ? I-gene
/ ? ? I-gene
C ? ? I-gene
, ? ? O
which ? ? O
is ? ? O
mutated ? ? I-disease
in ? ? O
CMT2B1 ? ? I-gene
, ? ? O
was ? ? O
overexpressed ? ? O
in ? ? O
the ? ? O
patient ? ? O
, ? ? O
suggesting ? ? O
that ? ? O
CMT-causing ? ? I-disease
genes ? ? O
may ? ? O
interact ? ? O
in ? ? O
a ? ? O
regulatory ? ? O
network ? ? O
. ? ? O

No 21741418 ? O
increase ? ? O
in ? ? O
the ? ? O
expression ? ? O
of ? ? O
key ? ? O
unfolded ? ? O
protein ? ? O
response ? ? O
genes ? ? O
in ? ? O
HCV ? ? I-gene
genotype ? ? I-gene
3 ? ? I-gene
patients ? ? O
with ? ? O
severe ? ? O
steatosis ? ? I-disease
. ? ? O

Although 21741418 ? O
hepatic ? ? I-disease
steatosis ? ? I-disease
is ? ? O
common ? ? O
in ? ? O
patients ? ? O
infected ? ? O
with ? ? O
HCV ? ? I-disease
, ? ? O
the ? ? O
mechanisms ? ? O
leading ? ? O
to ? ? O
cellular ? ? I-disease
triglyceride ? ? I-disease
retention ? ? I-disease
are ? ? O
obscure ? ? O
. ? ? O

A 21741418 ? O
role ? ? O
for ? ? O
the ? ? O
Unfolded ? ? I-gene
Protein ? ? I-gene
Response ? ? I-gene
( ? ? O
UPR ? ? I-gene
) ? ? O
has ? ? O
been ? ? O
postulated ? ? O
, ? ? O
either ? ? O
through ? ? O
its ? ? O
activation ? ? O
or ? ? O
dysfunction ? ? I-disease
. ? ? O

In 21741418 ? O
this ? ? O
study ? ? O
we ? ? O
set ? ? O
out ? ? O
to ? ? O
investigate ? ? O
the ? ? O
expression ? ? O
of ? ? O
key ? ? O
UPR ? ? I-gene
genes ? ? O
in ? ? O
HCV ? ? I-disease
genotype ? ? I-disease
3 ? ? O
patients ? ? O
with ? ? O
moderate ? ? O
to ? ? O
severe ? ? O
steatosis ? ? I-disease
. ? ? O

RNA 21741418 ? O
was ? ? O
extracted ? ? O
from ? ? O
liver ? ? O
obtained ? ? O
by ? ? O
percutaneous ? ? I-treatment
biopsy ? ? I-treatment
and ? ? O
key ? ? O
genes ? ? O
from ? ? O
the ? ? O
UPR ? ? I-gene
were ? ? O
semi ? ? O
quantified ? ? O
using ? ? O
real-time ? ? I-treatment
PCR ? ? I-treatment
. ? ? O

We 21741418 ? O
compared ? ? O
values ? ? O
in ? ? O
patients ? ? O
with ? ? O
minimal ? ? O
steatosis ? ? I-disease
to ? ? O
those ? ? O
with ? ? O
high ? ? O
steatosis ? ? I-disease
. ? ? O

Patients 21741418 ? O
with ? ? O
high ? ? O
steatosis ? ? I-disease
were ? ? O
younger ? ? O
( ? ? O
44.6 ? ? O
+ ? ? O
/ ? ? O
- ? ? O
2.4 ? ? O
vs. ? ? O
37.4 ? ? O
+ ? ? O
/ ? ? O
- ? ? O
2.1 ? ? O
, ? ? O
p ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
and ? ? O
had ? ? O
higher ? ? O
hepatic ? ? I-disease
viral ? ? I-disease
RNA ? ? I-disease
loads ? ? O
( ? ? O
1.00 ? ? O
+ ? ? O
/ ? ? O
- ? ? O
0.21 ? ? O
vs. ? ? O
3.98 ? ? O
+ ? ? O
/ ? ? O
- ? ? O
0.22 ? ? O
, ? ? O
p ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
. ? ? O

We 21741418 ? O
found ? ? O
no ? ? O
significant ? ? O
difference ? ? O
in ? ? O
the ? ? O
expression ? ? O
of ? ? O
UPR ? ? I-gene
genes ? ? O
, ? ? O
except ? ? O
for ? ? O
a ? ? O
small ? ? O
increase ? ? O
in ? ? O
EDEM1 ? ? I-gene
in ? ? O
the ? ? O
high ? ? O
steatosis ? ? I-disease
group ? ? O
( ? ? O
1.00 ? ? O
+ ? ? O
/ ? ? O
- ? ? O
0.13 ? ? O
vs. ? ? O
1.38 ? ? O
+ ? ? O
/ ? ? O
- ? ? O
0.09 ? ? O
, ? ? O
p ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
. ? ? O

In 21741418 ? O
conclusion ? ? O
, ? ? O
despite ? ? O
a ? ? O
four-fold ? ? O
greater ? ? O
concentration ? ? O
of ? ? O
HCV ? ? I-disease
RNA ? ? O
in ? ? O
tissue ? ? O
with ? ? O
a ? ? O
high ? ? O
level ? ? O
of ? ? O
steatosis ? ? I-disease
, ? ? O
we ? ? O
found ? ? O
no ? ? O
change ? ? O
in ? ? O
the ? ? O
expression ? ? O
of ? ? O
key ? ? O
UPR ? ? I-gene
related ? ? O
genes ? ? O
, ? ? O
except ? ? O
for ? ? O
a ? ? O
only ? ? O
a ? ? O
modest ? ? O
up-regulation ? ? O
of ? ? O
EDEM1 ? ? I-gene
. ? ? O

Our 21741418 ? O
data ? ? O
does ? ? O
not ? ? O
support ? ? O
a ? ? O
sustained ? ? O
change ? ? O
in ? ? O
expression ? ? O
of ? ? O
UPR ? ? I-gene
genes ? ? O
in ? ? O
the ? ? O
steatogenesis ? ? I-disease
of ? ? O
HCVGT3 ? ? I-disease
infected ? ? O
human ? ? O
liver ? ? O
. ? ? O

Role 21878646 ? O
of ? ? O
the ? ? O
endoplasmic ? ? I-disease
reticulum-associated ? ? I-disease
degradation ? ? I-disease
( ? ? O
ERAD ? ? I-disease
) ? ? O
pathway ? ? O
in ? ? O
degradation ? ? O
of ? ? O
hepatitis ? ? I-disease
C ? ? I-disease
virus ? ? O
envelope ? ? O
proteins ? ? O
and ? ? O
production ? ? O
of ? ? O
virus ? ? O
particles ? ? O
. ? ? O

Viral 21878646 ? I-disease
infections ? ? I-disease
frequently ? ? O
cause ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
( ? ? I-disease
ER ? ? I-disease
) ? ? I-disease
stress ? ? I-disease
in ? ? O
host ? ? O
cells ? ? O
leading ? ? O
to ? ? O
stimulation ? ? O
of ? ? O
the ? ? O
ER-associated ? ? I-disease
degradation ? ? I-disease
( ? ? O
ERAD ? ? I-disease
) ? ? O
pathway ? ? O
, ? ? O
which ? ? O
subsequently ? ? O
targets ? ? O
unassembled ? ? O
glycoproteins ? ? O
for ? ? O
ubiquitylation ? ? O
and ? ? O
proteasomal ? ? O
degradation ? ? O
. ? ? O

However 21878646 ? O
, ? ? O
the ? ? O
role ? ? O
of ? ? O
the ? ? O
ERAD ? ? I-disease
pathway ? ? O
in ? ? O
the ? ? O
viral ? ? O
life ? ? O
cycle ? ? O
is ? ? O
poorly ? ? O
defined ? ? O
. ? ? O

In 21878646 ? O
this ? ? O
paper ? ? O
, ? ? O
we ? ? O
demonstrate ? ? O
that ? ? O
hepatitis ? ? I-disease
C ? ? I-disease
virus ? ? I-disease
( ? ? O
HCV ? ? I-disease
) ? ? O
infection ? ? O
activates ? ? O
the ? ? O
ERAD ? ? I-disease
pathway ? ? O
, ? ? O
which ? ? O
in ? ? O
turn ? ? O
controls ? ? O
the ? ? O
fate ? ? O
of ? ? O
viral ? ? O
glycoproteins ? ? O
and ? ? O
modulates ? ? O
virus ? ? O
production ? ? O
. ? ? O

ERAD 21878646 ? I-disease
proteins ? ? O
, ? ? O
such ? ? O
as ? ? O
EDEM1 ? ? I-gene
and ? ? O
EDEM3 ? ? I-gene
, ? ? O
were ? ? O
found ? ? O
to ? ? O
increase ? ? O
ubiquitylation ? ? O
of ? ? O
HCV ? ? I-disease
envelope ? ? O
proteins ? ? O
via ? ? O
direct ? ? O
physical ? ? O
interaction ? ? O
. ? ? O

Knocking 21878646 ? O
down ? ? O
of ? ? O
EDEM1 ? ? I-gene
and ? ? O
EDEM3 ? ? I-gene
increased ? ? O
the ? ? O
half-life ? ? O
of ? ? O
HCV ? ? I-gene
E2 ? ? I-gene
, ? ? O
as ? ? O
well ? ? O
as ? ? O
virus ? ? O
production ? ? O
, ? ? O
whereas ? ? O
exogenous ? ? O
expression ? ? O
of ? ? O
these ? ? O
proteins ? ? O
reduced ? ? O
the ? ? O
production ? ? O
of ? ? O
infectious ? ? O
virus ? ? O
particles ? ? O
. ? ? O

Further 21878646 ? O
investigation ? ? O
revealed ? ? O
that ? ? O
only ? ? O
EDEM1 ? ? I-gene
and ? ? O
EDEM3 ? ? I-gene
bind ? ? O
with ? ? O
SEL1L ? ? I-gene
, ? ? O
an ? ? O
ER ? ? O
membrane ? ? O
adaptor ? ? O
protein ? ? O
involved ? ? O
in ? ? O
translocation ? ? O
of ? ? O
ERAD ? ? I-disease
substrates ? ? O
from ? ? O
the ? ? O
ER ? ? O
to ? ? O
the ? ? O
cytoplasm ? ? O
. ? ? O

When 21878646 ? O
HCV-infected ? ? I-disease
cells ? ? O
were ? ? O
treated ? ? O
with ? ? O
kifunensine ? ? I-treatment
, ? ? O
a ? ? O
potent ? ? O
inhibitor ? ? O
of ? ? O
the ? ? O
ERAD ? ? I-disease
pathway ? ? O
, ? ? O
the ? ? O
half-life ? ? O
of ? ? O
HCV ? ? I-gene
E2 ? ? I-gene
increased ? ? O
and ? ? O
so ? ? O
did ? ? O
virus ? ? O
production ? ? O
. ? ? O

Kifunensine 21878646 ? I-treatment
inhibited ? ? O
the ? ? O
binding ? ? O
of ? ? O
EDEM1 ? ? I-gene
and ? ? O
EDEM3 ? ? I-gene
with ? ? O
SEL1L ? ? I-gene
, ? ? O
thus ? ? O
blocking ? ? O
the ? ? O
ubiquitylation ? ? O
of ? ? O
HCV ? ? I-gene
E2 ? ? I-gene
protein ? ? O
. ? ? O

Chemical 21878646 ? O
inhibition ? ? O
of ? ? O
the ? ? O
ERAD ? ? I-disease
pathway ? ? O
neither ? ? O
affected ? ? O
production ? ? O
of ? ? O
the ? ? O
Japanese ? ? I-disease
encephalitis ? ? I-disease
virus ? ? I-disease
( ? ? O
JEV ? ? I-disease
) ? ? O
nor ? ? O
stability ? ? O
of ? ? O
the ? ? O
JEV ? ? I-gene
envelope ? ? I-gene
protein ? ? I-gene
. ? ? O

A 21878646 ? O
co-immunoprecipitation ? ? O
assay ? ? O
showed ? ? O
that ? ? O
EDEM ? ? I-gene
orthologs ? ? O
do ? ? O
not ? ? O
bind ? ? O
with ? ? O
JEV ? ? I-gene
envelope ? ? I-gene
protein ? ? I-gene
. ? ? O

These 21878646 ? O
findings ? ? O
highlight ? ? O
the ? ? O
crucial ? ? O
role ? ? O
of ? ? O
the ? ? O
ERAD ? ? I-disease
pathway ? ? O
in ? ? O
the ? ? O
life ? ? O
cycle ? ? O
of ? ? O
specific ? ? O
viruses ? ? O
. ? ? O

Bypass 21917589 ? O
of ? ? O
glycan-dependent ? ? O
glycoprotein ? ? O
delivery ? ? O
to ? ? O
ERAD ? ? I-gene
by ? ? O
up-regulated ? ? O
EDEM1 ? ? I-gene
. ? ? O

Trimming 21917589 ? O
of ? ? O
mannose ? ? O
residues ? ? O
from ? ? O
the ? ? O
N-linked ? ? O
oligosaccharide ? ? I-treatment
precursor ? ? O
is ? ? O
a ? ? O
stringent ? ? O
requirement ? ? O
for ? ? O
glycoprotein ? ? O
endoplasmic ? ? I-gene
reticulum ? ? I-gene
( ? ? I-gene
ER ? ? I-gene
) ? ? I-gene
-associated ? ? I-gene
degradation ? ? I-gene
( ? ? O
ERAD ? ? I-gene
) ? ? O
. ? ? O

In 21917589 ? O
this ? ? O
paper ? ? O
, ? ? O
we ? ? O
show ? ? O
that ? ? O
, ? ? O
surprisingly ? ? O
, ? ? O
overexpression ? ? O
of ? ? O
ER ? ? I-gene
degradation-enhancing ? ? I-gene
alpha-mannosidase-like ? ? I-gene
protein ? ? I-gene
1 ? ? O
( ? ? O
EDEM1 ? ? I-gene
) ? ? O
or ? ? O
its ? ? O
up-regulation ? ? O
by ? ? O
IRE1 ? ? I-gene
, ? ? O
as ? ? O
occurs ? ? O
in ? ? O
the ? ? O
unfolded ? ? O
protein ? ? O
response ? ? O
, ? ? O
overrides ? ? O
this ? ? O
requirement ? ? O
and ? ? O
renders ? ? O
unnecessary ? ? O
the ? ? O
expression ? ? O
of ? ? O
ER ? ? I-gene
mannosidase ? ? I-gene
I ? ? I-gene
. ? ? O

An 21917589 ? O
EDEM1 ? ? I-gene
deletion ? ? O
mutant ? ? O
lacking ? ? O
most ? ? O
of ? ? O
the ? ? O
carbohydrate-recognition ? ? O
domain ? ? O
also ? ? O
accelerated ? ? O
ERAD ? ? I-gene
, ? ? O
delivering ? ? O
the ? ? O
substrate ? ? O
to ? ? O
XTP3-B ? ? I-gene
and ? ? O
OS9 ? ? I-gene
. ? ? O

EDEM1 21917589 ? I-gene
overexpression ? ? O
also ? ? O
accelerated ? ? O
the ? ? O
degradation ? ? O
of ? ? O
a ? ? O
mutant ? ? O
nonglycosylated ? ? O
substrate ? ? O
. ? ? O

Upon 21917589 ? O
proteasomal ? ? O
inhibition ? ? O
, ? ? O
EDEM1 ? ? I-gene
concentrated ? ? O
together ? ? O
with ? ? O
the ? ? O
ERAD ? ? I-gene
substrate ? ? O
in ? ? O
the ? ? O
pericentriolar ? ? O
ER-derived ? ? I-gene
quality ? ? I-gene
control ? ? I-gene
compartment ? ? I-gene
( ? ? O
ERQC ? ? I-gene
) ? ? O
, ? ? O
where ? ? O
ER ? ? I-gene
mannosidase ? ? I-gene
I ? ? I-gene
and ? ? O
ERAD ? ? I-gene
machinery ? ? O
components ? ? O
are ? ? O
localized ? ? O
, ? ? O
including ? ? O
, ? ? O
as ? ? O
we ? ? O
show ? ? O
here ? ? O
, ? ? O
OS9 ? ? I-gene
. ? ? O

We 21917589 ? O
suggest ? ? O
that ? ? O
a ? ? O
nascent ? ? O
glycoprotein ? ? O
can ? ? O
normally ? ? O
dissociate ? ? O
from ? ? O
EDEM1 ? ? I-gene
and ? ? O
be ? ? O
rescued ? ? O
from ? ? O
ERAD ? ? I-gene
by ? ? O
reentering ? ? O
calnexin-refolding ? ? I-gene
cycles ? ? O
, ? ? O
a ? ? O
condition ? ? O
terminated ? ? O
by ? ? O
mannose ? ? O
trimming ? ? O
. ? ? O

At 21917589 ? O
high ? ? O
EDEM1 ? ? I-gene
levels ? ? O
, ? ? O
glycoprotein ? ? O
release ? ? O
is ? ? O
prevented ? ? O
and ? ? O
glycan ? ? O
interactions ? ? O
are ? ? O
no ? ? O
longer ? ? O
required ? ? O
, ? ? O
canceling ? ? O
the ? ? O
otherwise ? ? O
mandatory ? ? O
ERAD ? ? I-gene
timing ? ? O
by ? ? O
mannose ? ? O
trimming ? ? O
and ? ? O
accelerating ? ? O
the ? ? O
targeting ? ? O
to ? ? O
degradation ? ? O
. ? ? O

Unconventional 21994798 ? O
use ? ? O
of ? ? O
LC3 ? ? I-gene
by ? ? O
coronaviruses ? ? I-disease
through ? ? O
the ? ? O
alleged ? ? O
subversion ? ? O
of ? ? O
the ? ? O
ERAD ? ? I-gene
tuning ? ? O
pathway ? ? O
. ? ? O

Pathogens 21994798 ? O
of ? ? O
bacterial ? ? O
and ? ? O
viral ? ? O
origin ? ? O
hijack ? ? O
pathways ? ? O
operating ? ? O
in ? ? O
eukaryotic ? ? O
cells ? ? O
in ? ? O
many ? ? O
ways ? ? O
in ? ? O
order ? ? O
to ? ? O
gain ? ? O
access ? ? O
into ? ? O
the ? ? O
host ? ? O
, ? ? O
to ? ? O
establish ? ? O
themselves ? ? O
and ? ? O
to ? ? O
eventually ? ? O
produce ? ? O
their ? ? O
progeny ? ? O
. ? ? O

The 21994798 ? O
detailed ? ? O
molecular ? ? O
characterization ? ? O
of ? ? O
the ? ? O
subversion ? ? O
mechanisms ? ? O
devised ? ? O
by ? ? O
pathogens ? ? O
to ? ? O
infect ? ? O
host ? ? O
cells ? ? O
is ? ? O
crucial ? ? O
to ? ? O
generate ? ? O
targets ? ? O
for ? ? O
therapeutic ? ? O
intervention ? ? O
. ? ? O

Here 21994798 ? O
we ? ? O
review ? ? O
recent ? ? O
data ? ? O
indicating ? ? O
that ? ? O
coronaviruses ? ? I-disease
probably ? ? O
co-opt ? ? O
membranous ? ? O
carriers ? ? O
derived ? ? O
from ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
, ? ? O
which ? ? O
contain ? ? O
proteins ? ? O
that ? ? O
regulate ? ? O
disposal ? ? O
of ? ? O
misfolded ? ? I-gene
polypeptides ? ? I-gene
, ? ? O
for ? ? O
their ? ? O
replication ? ? O
. ? ? O

In 21994798 ? O
addition ? ? O
, ? ? O
we ? ? O
also ? ? O
present ? ? O
models ? ? O
describing ? ? O
potential ? ? O
mechanisms ? ? O
that ? ? O
coronaviruses ? ? I-disease
could ? ? O
employ ? ? O
for ? ? O
this ? ? O
hijacking ? ? O
. ? ? O

In 22160784 ? O
vitro ? ? O
mannose ? ? O
trimming ? ? O
property ? ? O
of ? ? O
human ? ? O
ER ? ? I-gene
alpha-1,2 ? ? I-gene
mannosidase ? ? I-gene
I ? ? I-gene
. ? ? O

Endoplasmic 22160784 ? I-gene
reticulum ? ? I-gene
alpha-1,2 ? ? I-gene
mannosidase ? ? I-gene
I ? ? I-gene
( ? ? O
ERManI ? ? I-gene
) ? ? O
is ? ? O
an ? ? O
enzyme ? ? O
, ? ? O
which ? ? O
removes ? ? O
alpha ? ? I-gene
( ? ? I-gene
1-2 ? ? I-gene
) ? ? I-gene
linked ? ? I-gene
mannoses ? ? I-gene
from ? ? O
asparagine-linked ? ? I-treatment
oligosaccharides ? ? I-treatment
on ? ? O
glycoproteins ? ? O
in ? ? O
the ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
( ? ? O
ER ? ? I-disease
) ? ? O
. ? ? O

ERManI 22160784 ? I-gene
preferentially ? ? O
removes ? ? O
one ? ? O
alpha ? ? I-gene
( ? ? I-gene
1-2 ? ? I-gene
) ? ? I-gene
linked ? ? I-gene
mannose ? ? I-gene
from ? ? O
B-chain ? ? O
of ? ? O
Man ? ? I-treatment
( ? ? I-treatment
9 ? ? I-treatment
) ? ? I-treatment
GlcNAc ? ? I-treatment
( ? ? O
2 ? ? O
) ? ? O
. ? ? O

When 22160784 ? O
glycoproteins ? ? O
fail ? ? O
to ? ? O
achieve ? ? O
properly ? ? O
folding ? ? O
, ? ? O
increased ? ? O
removal ? ? O
of ? ? O
alpha ? ? I-gene
( ? ? I-gene
1-2 ? ? I-gene
) ? ? I-gene
linked ? ? I-gene
mannoses ? ? I-gene
on ? ? O
their ? ? O
oligosaccharides ? ? O
is ? ? O
induced ? ? O
and ? ? O
leads ? ? O
them ? ? O
to ? ? O
be ? ? O
disposed ? ? O
and ? ? O
degraded ? ? O
by ? ? O
ER-associated ? ? O
degradation ? ? O
pathway ? ? O
. ? ? O

However 22160784 ? O
, ? ? O
it ? ? O
is ? ? O
still ? ? O
inconclusive ? ? O
whether ? ? O
accelerated ? ? O
removal ? ? O
of ? ? O
alpha ? ? I-gene
( ? ? I-gene
1-2 ? ? I-gene
) ? ? I-gene
linked ? ? I-gene
mannoses ? ? I-gene
on ? ? O
those ? ? O
glycoproteins ? ? O
is ? ? O
catalyzed ? ? O
by ? ? O
the ? ? O
alpha-1,2 ? ? I-gene
mannosidase ? ? I-gene
I ? ? I-gene
, ? ? O
proteins ? ? O
similar ? ? O
to ? ? O
mannosidase ? ? I-gene
I ? ? I-gene
[ ? ? O
e.g ? ? O
. ? ? O

ER 22160784 ? O
degradation-enhancing ? ? O
alpha-1,2 ? ? I-gene
mannosidase-like ? ? I-gene
protein ? ? I-gene
( ? ? O
EDEM ? ? I-gene
) ? ? O
] ? ? O
, ? ? O
or ? ? O
both ? ? O
of ? ? O
them ? ? O
. ? ? O

Therefore 22160784 ? O
, ? ? O
to ? ? O
approach ? ? O
this ? ? O
issue ? ? O
, ? ? O
we ? ? O
have ? ? O
investigated ? ? O
its ? ? O
in ? ? O
vitro ? ? O
activities ? ? O
using ? ? O
various ? ? O
oligosaccharides ? ? O
and ? ? O
glycoproteins ? ? O
as ? ? O
substrates ? ? O
. ? ? O

A 22160784 ? O
recombinant ? ? O
form ? ? O
of ? ? O
human ? ? I-gene
ERManI ? ? I-gene
( ? ? O
hERManI ? ? I-gene
) ? ? O
was ? ? O
prepared ? ? O
by ? ? O
using ? ? O
Escherichia ? ? I-treatment
coli ? ? I-treatment
. ? ? O

First 22160784 ? O
, ? ? O
the ? ? O
enzyme ? ? O
generated ? ? O
Man ? ? I-gene
( ? ? I-gene
6 ? ? I-gene
) ? ? I-gene
GlcNAc ? ? I-gene
( ? ? I-gene
2 ? ? I-gene
) ? ? I-gene
-PA ? ? I-gene
and ? ? O
Man ? ? I-gene
( ? ? I-gene
5 ? ? I-gene
) ? ? I-gene
GlcNAc ? ? I-gene
( ? ? I-gene
2 ? ? I-gene
) ? ? O
-PA ? ? O
from ? ? O
100 ? ? O
muM ? ? O
Man ? ? I-treatment
( ? ? I-treatment
9 ? ? I-treatment
) ? ? I-treatment
GlcNAc ? ? I-treatment
( ? ? I-treatment
2 ? ? I-treatment
) ? ? I-treatment
-PA ? ? I-treatment
after ? ? O
a ? ? O
one-hour ? ? O
reaction ? ? O
. ? ? O

Second 22160784 ? O
, ? ? O
we ? ? O
have ? ? O
exposed ? ? O
bovine ? ? I-treatment
thyroglobulin ? ? I-treatment
and ? ? O
soybean ? ? I-treatment
agglutinin ? ? I-treatment
to ? ? O
denaturing ? ? O
conditions ? ? O
, ? ? O
e.g ? ? O
. ? ? O

8 22160784 ? I-treatment
M ? ? I-treatment
urea ? ? I-treatment
, ? ? O
and ? ? O
used ? ? O
those ? ? O
glycoproteins ? ? O
as ? ? O
substrates ? ? O
. ? ? O

Sugar 22160784 ? O
moieties ? ? O
were ? ? O
released ? ? O
from ? ? O
the ? ? O
reactant ? ? O
by ? ? O
PNGase ? ? I-gene
F ? ? I-gene
and ? ? O
their ? ? O
structures ? ? O
and ? ? O
amounts ? ? O
were ? ? O
elucidated ? ? O
by ? ? O
HPLC ? ? I-treatment
analysis ? ? O
. ? ? O

Intriguingly 22160784 ? O
, ? ? O
the ? ? O
enzyme ? ? O
was ? ? O
shown ? ? O
to ? ? O
remove ? ? O
mannoses ? ? O
from ? ? O
bovine ? ? I-treatment
thyroglobulin ? ? I-treatment
and ? ? O
soybean ? ? I-treatment
agglutinin ? ? I-treatment
to ? ? O
larger ? ? O
extents ? ? O
when ? ? O
they ? ? O
were ? ? O
exposed ? ? O
to ? ? O
a ? ? O
denaturant ? ? I-treatment
. ? ? O

Therefore 22160784 ? O
, ? ? O
our ? ? O
results ? ? O
suggested ? ? O
that ? ? O
hERManI ? ? I-gene
could ? ? O
recognize ? ? O
tertiary ? ? I-treatment
and ? ? I-treatment
/ ? ? I-treatment
or ? ? I-treatment
quaternary ? ? I-treatment
structures ? ? I-treatment
of ? ? I-treatment
glycoproteins ? ? I-treatment
and ? ? O
remove ? ? O
more ? ? O
alpha-1,2 ? ? I-gene
linked ? ? I-gene
mannoses ? ? I-gene
from ? ? O
misfolded ? ? O
glycoproteins ? ? O
in ? ? O
living ? ? O
cells ? ? O
. ? ? O

Redox-dependent 22229892 ? O
protein ? ? O
quality ? ? O
control ? ? O
in ? ? O
the ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
: ? ? O
folding ? ? O
to ? ? O
degradation ? ? O
. ? ? O

SIGNIFICANCE 22229892 ? O
: ? ? O
Nascent ? ? O
polypeptides ? ? O
entering ? ? O
the ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
( ? ? O
ER ? ? I-disease
) ? ? O
are ? ? O
co- ? ? O
and ? ? O
post-translationally ? ? O
modified ? ? O
by ? ? O
N-glycosylation ? ? I-gene
and ? ? O
the ? ? O
oxidation ? ? O
/ ? ? O
isomerization ? ? O
of ? ? O
cysteine ? ? O
residues ? ? O
followed ? ? O
by ? ? O
folding ? ? O
with ? ? O
the ? ? O
aid ? ? O
of ? ? O
molecular ? ? O
chaperones ? ? O
. ? ? O

Only 22229892 ? O
properly ? ? O
folded ? ? O
proteins ? ? O
reach ? ? O
their ? ? O
final ? ? O
destination ? ? O
. ? ? O

The 22229892 ? O
oxidative ? ? O
environment ? ? O
in ? ? O
the ? ? O
ER ? ? I-disease
enables ? ? O
ER-resident ? ? I-gene
oxidoreductases ? ? I-gene
to ? ? O
facilitate ? ? O
disulfide ? ? O
bond ? ? O
formation ? ? O
, ? ? O
which ? ? O
stabilizes ? ? O
protein ? ? O
structures ? ? O
. ? ? O

ER 22229892 ? I-gene
oxidoreductases ? ? I-gene
involve ? ? O
in ? ? O
both ? ? O
the ? ? O
productive ? ? O
folding ? ? O
of ? ? O
newly ? ? O
synthesized ? ? O
proteins ? ? O
and ? ? O
ER-associated ? ? I-gene
degradation ? ? I-gene
( ? ? O
ERAD ? ? I-gene
) ? ? O
of ? ? O
misfolded ? ? O
proteins ? ? O
. ? ? O

RECENT 22229892 ? O
ADVANCES ? ? O
: ? ? O
The ? ? O
ER ? ? I-disease
luminal ? ? O
event ? ? O
of ? ? O
ERAD ? ? I-gene
is ? ? O
composed ? ? O
of ? ? O
three ? ? O
major ? ? O
steps ? ? O
: ? ? O
the ? ? O
recognition ? ? O
and ? ? O
segregation ? ? O
of ? ? O
terminally ? ? O
misfolded ? ? O
proteins ? ? O
from ? ? O
folding ? ? O
intermediates ? ? O
, ? ? O
unfolding ? ? O
of ? ? O
misfolded ? ? O
substrates ? ? O
by ? ? O
oxidoreductases ? ? O
that ? ? O
cleave ? ? O
the ? ? O
disulfide ? ? O
bonds ? ? O
to ? ? O
enable ? ? O
the ? ? O
translocation ? ? O
of ? ? O
the ? ? O
substrates ? ? O
through ? ? O
the ? ? O
retrotranslocation ? ? O
channel ? ? O
, ? ? O
and ? ? O
transport ? ? O
of ? ? O
substrates ? ? O
to ? ? O
be ? ? O
degraded ? ? O
to ? ? O
the ? ? O
dislocon ? ? O
channel ? ? O
. ? ? O

The 22229892 ? O
factors ? ? O
required ? ? O
for ? ? O
these ? ? O
three ? ? O
critical ? ? O
steps ? ? O
have ? ? O
been ? ? O
found ? ? O
to ? ? O
form ? ? O
a ? ? O
supramolecular ? ? I-disease
complex ? ? I-disease
in ? ? O
the ? ? O
ER ? ? I-disease
. ? ? O

CRITICAL 22229892 ? O
ISSUES ? ? O
: ? ? O
This ? ? O
complex ? ? O
comprises ? ? O
EDEM1 ? ? I-gene
, ? ? O
a ? ? O
lectin-like ? ? O
molecule ? ? O
that ? ? O
recognizes ? ? O
mannose-trimming ? ? O
and ? ? O
segregates ? ? O
the ? ? O
identified ? ? O
substrates ? ? O
from ? ? O
the ? ? O
productive ? ? O
folding ? ? O
pathway ? ? O
into ? ? O
the ? ? O
degradation ? ? O
pathway ? ? O
; ? ? O
ER ? ? I-gene
DnaJ ? ? I-gene
( ? ? I-gene
ERdj ? ? I-gene
) ? ? I-gene
5 ? ? I-gene
, ? ? O
a ? ? O
reductase ? ? O
that ? ? O
resides ? ? O
in ? ? O
the ? ? O
ER ? ? I-disease
and ? ? O
reduces ? ? O
disulfides ? ? O
in ? ? O
misfolded ? ? O
proteins ? ? O
; ? ? O
and ? ? O
immunoglobulin ? ? I-gene
heavy ? ? I-gene
chain ? ? I-gene
binding ? ? I-gene
protein ? ? I-gene
( ? ? O
BiP ? ? I-gene
) ? ? O
, ? ? O
an ? ? O
heat ? ? I-gene
shock ? ? I-gene
protein ? ? I-gene
( ? ? O
Hsp ? ? I-gene
) ? ? O
70 ? ? O
family ? ? O
molecular ? ? O
chaperone ? ? O
that ? ? O
recruits ? ? O
substrates ? ? O
to ? ? O
the ? ? O
dislocon ? ? O
channel ? ? O
after ? ? O
dissociation ? ? O
from ? ? O
the ? ? O
EDEM1 ? ? I-gene
/ ? ? O
ERdj5 ? ? I-gene
complex ? ? O
coupled ? ? O
with ? ? O
ATP ? ? I-gene
hydrolysis ? ? I-gene
. ? ? O

FUTURE 22229892 ? O
DIRECTIONS ? ? O
: ? ? O
The ? ? O
importance ? ? O
of ? ? O
disulfide ? ? O
bond ? ? O
reduction ? ? O
in ? ? O
misfolded ? ? O
proteins ? ? O
for ? ? O
retrotranslocation ? ? O
through ? ? O
the ? ? O
dislocon ? ? O
channel ? ? O
will ? ? O
be ? ? O
discussed ? ? O
by ? ? O
comparing ? ? O
the ? ? O
function ? ? O
of ? ? O
ERdj5 ? ? I-gene
with ? ? O
that ? ? O
of ? ? O
other ? ? O
oxidoreductases ? ? O
in ? ? O
the ? ? O
ER ? ? I-disease
. ? ? O

Role 22633958 ? O
of ? ? O
the ? ? O
SEL1L ? ? I-gene
: ? ? O
LC3-I ? ? I-gene
complex ? ? O
as ? ? O
an ? ? O
ERAD ? ? I-gene
tuning ? ? O
receptor ? ? O
in ? ? O
the ? ? O
mammalian ? ? O
ER ? ? I-gene
. ? ? O

Several 22633958 ? O
regulators ? ? O
of ? ? O
endoplasmic ? ? I-gene
reticulum ? ? I-gene
( ? ? O
ER ? ? I-gene
) ? ? O
-associated ? ? O
degradation ? ? O
( ? ? O
ERAD ? ? I-gene
) ? ? O
have ? ? O
a ? ? O
shorter ? ? O
half-life ? ? O
compared ? ? O
to ? ? O
conventional ? ? I-disease
ER ? ? I-disease
chaperones ? ? I-treatment
. ? ? O

At 22633958 ? O
steady ? ? O
state ? ? O
, ? ? O
they ? ? O
are ? ? O
selectively ? ? O
removed ? ? O
from ? ? O
the ? ? O
ER ? ? I-disease
by ? ? O
poorly ? ? O
defined ? ? O
events ? ? O
collectively ? ? O
referred ? ? O
to ? ? O
as ? ? O
ERAD ? ? I-gene
tuning ? ? O
. ? ? O

Here 22633958 ? O
we ? ? O
identify ? ? O
the ? ? O
complex ? ? O
comprising ? ? O
the ? ? O
type-I ? ? I-gene
transmembrane ? ? I-gene
protein ? ? I-gene
SEL1L ? ? I-gene
and ? ? O
the ? ? O
cytosolic ? ? O
protein ? ? O
LC3-I ? ? I-gene
as ? ? O
an ? ? O
ERAD ? ? I-gene
tuning ? ? O
receptor ? ? O
regulating ? ? O
the ? ? O
COPII-independent ? ? I-gene
, ? ? O
vesicle-mediated ? ? O
removal ? ? O
of ? ? O
the ? ? O
lumenal ? ? O
ERAD ? ? I-gene
regulators ? ? O
EDEM1 ? ? I-gene
and ? ? O
OS-9 ? ? I-gene
from ? ? O
the ? ? O
ER ? ? I-disease
. ? ? O

Expression 22633958 ? O
of ? ? O
folding-defective ? ? O
polypeptides ? ? O
enhances ? ? O
the ? ? O
lumenal ? ? O
content ? ? O
of ? ? O
EDEM1 ? ? I-gene
and ? ? O
OS-9 ? ? I-gene
by ? ? O
inhibiting ? ? O
their ? ? O
SEL1L ? ? I-gene
: ? ? O
LC3-I-mediated ? ? I-gene
segregation ? ? O
. ? ? O

This 22633958 ? O
raises ? ? O
ERAD ? ? I-gene
activity ? ? O
in ? ? O
the ? ? O
absence ? ? O
of ? ? O
UPR-induction ? ? I-gene
. ? ? O

The 22633958 ? O
mouse ? ? I-disease
hepatitis ? ? I-disease
virus ? ? I-disease
( ? ? O
MHV ? ? I-disease
) ? ? O
subverts ? ? O
ERAD ? ? I-gene
tuning ? ? O
for ? ? O
replication ? ? O
. ? ? O

Consistently 22633958 ? O
, ? ? O
SEL1L ? ? I-gene
or ? ? O
LC3 ? ? I-gene
silencing ? ? O
impair ? ? O
the ? ? O
MHV ? ? I-gene
life ? ? O
cycle ? ? O
. ? ? O

Collectively 22633958 ? O
, ? ? O
our ? ? O
data ? ? O
provide ? ? O
new ? ? O
molecular ? ? O
information ? ? O
about ? ? O
the ? ? O
ERAD ? ? I-gene
tuning ? ? O
mechanisms ? ? O
that ? ? O
regulate ? ? O
ERAD ? ? I-gene
in ? ? O
mammalian ? ? O
cells ? ? O
at ? ? O
the ? ? O
post ? ? O
translational ? ? O
level ? ? O
and ? ? O
how ? ? O
these ? ? O
mechanisms ? ? O
are ? ? O
hijacked ? ? O
by ? ? O
a ? ? O
pathogen ? ? O
. ? ? O

Tyrosinase 22905195 ? I-gene
degradation ? ? O
is ? ? O
prevented ? ? O
when ? ? O
EDEM1 ? ? I-gene
lacks ? ? O
the ? ? O
intrinsically ? ? O
disordered ? ? O
region ? ? O
. ? ? O

EDEM1 22905195 ? I-gene
is ? ? O
a ? ? O
mannosidase-like ? ? O
protein ? ? O
that ? ? O
recruits ? ? O
misfolded ? ? O
glycoproteins ? ? O
from ? ? O
the ? ? O
calnexin ? ? I-gene
/ ? ? O
calreticulin ? ? I-gene
folding ? ? O
cycle ? ? O
to ? ? O
downstream ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
associated ? ? I-disease
degradation ? ? I-disease
( ? ? O
ERAD ? ? I-disease
) ? ? O
pathway ? ? O
. ? ? O

Here 22905195 ? O
, ? ? O
we ? ? O
investigate ? ? O
the ? ? O
role ? ? O
of ? ? O
EDEM1 ? ? I-gene
in ? ? O
the ? ? O
processing ? ? O
of ? ? O
tyrosinase ? ? I-gene
, ? ? O
a ? ? O
tumour ? ? I-disease
antigen ? ? O
overexpressed ? ? O
in ? ? O
melanoma ? ? I-disease
cells ? ? O
. ? ? O

First 22905195 ? O
, ? ? O
we ? ? O
analyzed ? ? O
and ? ? O
modeled ? ? O
EDEM1 ? ? I-gene
major ? ? O
domains ? ? O
. ? ? O

The 22905195 ? O
homology ? ? O
model ? ? O
raised ? ? O
on ? ? O
the ? ? O
crystal ? ? O
structures ? ? O
of ? ? O
human ? ? O
and ? ? O
Saccharomyces ? ? I-gene
cerevisiae ? ? I-gene
ER ? ? I-gene
class ? ? I-gene
I ? ? I-gene
alpha1,2-mannosidases ? ? I-gene
reveals ? ? O
that ? ? O
the ? ? O
major ? ? O
mannosidase ? ? I-gene
domain ? ? O
located ? ? O
between ? ? O
aminoacids ? ? I-gene
121-598 ? ? I-gene
fits ? ? O
with ? ? O
high ? ? O
accuracy ? ? O
. ? ? O

We 22905195 ? O
have ? ? O
further ? ? O
identified ? ? O
an ? ? O
N-terminal ? ? O
region ? ? O
located ? ? O
between ? ? O
aminoacids ? ? I-gene
40-119 ? ? I-gene
, ? ? O
predicted ? ? O
to ? ? O
be ? ? O
intrinsically ? ? O
disordered ? ? O
( ? ? O
ID ? ? O
) ? ? O
and ? ? O
susceptible ? ? O
to ? ? O
adopt ? ? O
multiple ? ? O
conformations ? ? O
, ? ? O
hence ? ? O
facilitating ? ? O
protein-protein ? ? O
interactions ? ? O
. ? ? O

To 22905195 ? O
investigate ? ? O
these ? ? O
two ? ? O
domains ? ? O
we ? ? O
have ? ? O
constructed ? ? O
an ? ? O
EDEM1 ? ? I-gene
deletion ? ? O
mutant ? ? O
lacking ? ? O
the ? ? O
ID ? ? O
region ? ? O
and ? ? O
a ? ? O
triple ? ? O
mutant ? ? O
disrupting ? ? O
the ? ? O
glycan-binding ? ? O
domain ? ? O
and ? ? O
analyzed ? ? O
their ? ? O
association ? ? O
with ? ? O
tyrosinase ? ? I-gene
. ? ? O

Tyrosinase 22905195 ? I-gene
is ? ? O
a ? ? O
glycoprotein ? ? O
partly ? ? O
degraded ? ? O
endogenously ? ? O
by ? ? O
ERAD ? ? I-disease
and ? ? O
the ? ? O
ubiquitin ? ? I-gene
proteasomal ? ? O
system ? ? O
. ? ? O

We 22905195 ? O
found ? ? O
that ? ? O
the ? ? O
degradation ? ? I-disease
of ? ? I-disease
wild ? ? I-disease
type ? ? I-disease
and ? ? I-disease
misfolded ? ? I-disease
tyrosinase ? ? I-disease
was ? ? O
enhanced ? ? O
when ? ? O
EDEM1 ? ? I-gene
was ? ? O
overexpressed ? ? O
. ? ? O

Glycosylated 22905195 ? I-treatment
and ? ? O
non-glycosylated ? ? O
mutants ? ? O
co-immunoprecipitated ? ? O
with ? ? O
EDEM1 ? ? I-gene
even ? ? O
in ? ? O
the ? ? O
absence ? ? O
of ? ? O
its ? ? O
intact ? ? O
mannosidase-like ? ? I-gene
domain ? ? O
, ? ? O
but ? ? O
not ? ? O
when ? ? O
the ? ? O
ID ? ? O
region ? ? O
was ? ? O
deleted ? ? O
. ? ? O

In 22905195 ? O
contrast ? ? O
, ? ? O
calnexin ? ? I-gene
and ? ? O
SEL ? ? I-gene
1L ? ? I-gene
associated ? ? O
with ? ? O
the ? ? O
deletion ? ? O
mutant ? ? O
. ? ? O

Our 22905195 ? O
data ? ? O
suggest ? ? O
that ? ? O
the ? ? O
ID ? ? O
region ? ? O
identified ? ? O
in ? ? O
the ? ? O
N-terminal ? ? O
end ? ? O
of ? ? O
EDEM1 ? ? I-gene
is ? ? O
involved ? ? O
in ? ? O
the ? ? O
binding ? ? O
of ? ? O
glycosylated ? ? I-treatment
and ? ? O
non-glycosylated ? ? O
misfolded ? ? O
proteins ? ? O
. ? ? O

Accelerating 22905195 ? O
tyrosinase ? ? I-gene
degradation ? ? O
by ? ? O
EDEM1 ? ? I-gene
overexpression ? ? O
may ? ? O
lead ? ? O
to ? ? O
an ? ? O
efficient ? ? O
antigen ? ? O
presentation ? ? O
and ? ? O
enhanced ? ? O
elimination ? ? O
of ? ? O
melanoma ? ? I-disease
cells ? ? O
. ? ? O

A 23233672 ? O
shared ? ? O
endoplasmic ? ? O
reticulum-associated ? ? O
degradation ? ? O
pathway ? ? O
involving ? ? O
the ? ? O
EDEM1 ? ? I-gene
protein ? ? O
for ? ? O
glycosylated ? ? O
and ? ? O
nonglycosylated ? ? O
proteins ? ? O
. ? ? O

Studies 23233672 ? O
of ? ? O
misfolded ? ? O
protein ? ? O
targeting ? ? O
to ? ? O
endoplasmic ? ? I-disease
reticulum-associated ? ? I-disease
degradation ? ? I-disease
( ? ? O
ERAD ? ? I-disease
) ? ? O
have ? ? O
largely ? ? O
focused ? ? O
on ? ? O
glycoproteins ? ? O
, ? ? O
which ? ? O
include ? ? O
the ? ? O
bulk ? ? O
of ? ? O
the ? ? O
secretory ? ? O
proteins ? ? O
. ? ? O

Mechanisms 23233672 ? O
of ? ? O
targeting ? ? O
of ? ? O
nonglycosylated ? ? O
proteins ? ? O
are ? ? O
less ? ? O
clear ? ? O
. ? ? O

Here 23233672 ? O
, ? ? O
we ? ? O
studied ? ? O
three ? ? O
nonglycosylated ? ? O
proteins ? ? O
and ? ? O
analyzed ? ? O
their ? ? O
use ? ? O
of ? ? O
known ? ? O
glycoprotein ? ? O
quality ? ? O
control ? ? O
and ? ? O
ERAD ? ? I-disease
components ? ? O
. ? ? O

Similar 23233672 ? O
to ? ? O
an ? ? O
established ? ? O
glycosylated ? ? O
ERAD ? ? I-disease
substrate ? ? O
, ? ? O
the ? ? O
uncleaved ? ? O
precursor ? ? O
of ? ? O
asialoglycoprotein ? ? I-gene
receptor ? ? I-gene
H2a ? ? I-gene
, ? ? O
its ? ? O
nonglycosylated ? ? O
mutant ? ? O
, ? ? O
makes ? ? O
use ? ? O
of ? ? O
calnexin ? ? I-gene
, ? ? O
EDEM1 ? ? I-gene
, ? ? O
and ? ? O
HRD1 ? ? I-gene
, ? ? O
but ? ? O
only ? ? O
glycosylated ? ? O
H2a ? ? I-gene
is ? ? O
a ? ? O
substrate ? ? O
for ? ? O
the ? ? O
cytosolic ? ? O
SCF ? ? I-gene
( ? ? O
Fbs2 ? ? I-gene
) ? ? O
E3 ? ? I-gene
ubiquitin ? ? I-gene
ligase ? ? I-gene
with ? ? O
lectin ? ? I-gene
activity ? ? O
. ? ? O

Two 23233672 ? O
nonglycosylated ? ? O
BiP ? ? I-gene
substrates ? ? O
, ? ? O
NS-1kappa ? ? I-gene
light ? ? I-gene
chain ? ? I-gene
and ? ? O
truncated ? ? O
Iggamma ? ? I-gene
heavy ? ? I-gene
chain ? ? I-gene
, ? ? O
interact ? ? O
with ? ? O
the ? ? O
ERAD ? ? I-disease
complex ? ? O
lectins ? ? O
OS-9 ? ? I-gene
and ? ? O
XTP3-B ? ? I-gene
and ? ? O
require ? ? O
EDEM1 ? ? I-gene
for ? ? O
degradation ? ? O
. ? ? O

EDEM1 23233672 ? I-gene
associates ? ? O
through ? ? O
a ? ? O
region ? ? O
outside ? ? O
of ? ? O
its ? ? O
mannosidase-like ? ? O
domain ? ? O
with ? ? O
the ? ? O
nonglycosylated ? ? O
proteins ? ? O
. ? ? O

Similar 23233672 ? O
to ? ? O
glycosylated ? ? O
substrates ? ? O
, ? ? O
proteasomal ? ? O
inhibition ? ? O
induced ? ? O
accumulation ? ? O
of ? ? O
the ? ? O
nonglycosylated ? ? O
proteins ? ? O
and ? ? O
ERAD ? ? I-disease
machinery ? ? O
in ? ? O
the ? ? O
endoplasmic ? ? O
reticulum-derived ? ? O
quality ? ? O
control ? ? O
compartment ? ? O
. ? ? O

Our 23233672 ? O
results ? ? O
suggest ? ? O
a ? ? O
shared ? ? O
ERAD ? ? I-disease
pathway ? ? O
for ? ? O
glycosylated ? ? O
and ? ? O
nonglycosylated ? ? O
proteins ? ? O
composed ? ? O
of ? ? O
luminal ? ? O
lectin ? ? I-gene
machinery ? ? O
components ? ? O
also ? ? O
capable ? ? O
of ? ? O
protein-protein ? ? O
interactions ? ? O
. ? ? O

Glycosylation-independent 23966469 ? O
ERAD ? ? I-disease
pathway ? ? O
serves ? ? O
as ? ? O
a ? ? O
backup ? ? O
system ? ? O
under ? ? O
ER ? ? I-disease
stress ? ? I-disease
. ? ? O

During 23966469 ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
( ? ? I-disease
ER ? ? I-disease
) ? ? I-disease
-associated ? ? I-disease
degradation ? ? I-disease
( ? ? O
ERAD ? ? I-disease
) ? ? O
, ? ? O
terminally ? ? O
misfolded ? ? O
proteins ? ? O
are ? ? O
retrotranslocated ? ? O
from ? ? O
the ? ? O
ER ? ? O
to ? ? O
the ? ? O
cytosol ? ? O
and ? ? O
degraded ? ? O
by ? ? O
the ? ? O
ubiquitin-proteasome ? ? I-gene
system ? ? O
. ? ? O

Misfolded 23966469 ? O
glycoproteins ? ? O
are ? ? O
recognized ? ? O
by ? ? O
calnexin ? ? I-gene
and ? ? O
transferred ? ? O
to ? ? O
EDEM1 ? ? I-gene
, ? ? O
followed ? ? O
by ? ? O
the ? ? O
ER ? ? I-gene
disulfide ? ? I-gene
reductase ? ? I-gene
ERdj5 ? ? I-gene
and ? ? O
the ? ? O
BiP ? ? I-gene
complex ? ? I-gene
. ? ? O

The 23966469 ? O
mechanisms ? ? O
involved ? ? O
in ? ? O
ERAD ? ? I-disease
of ? ? O
nonglycoproteins ? ? O
, ? ? O
however ? ? O
, ? ? O
are ? ? O
poorly ? ? O
understood ? ? O
. ? ? O

Here 23966469 ? O
we ? ? O
show ? ? O
that ? ? O
nonglycoprotein ? ? O
substrates ? ? O
are ? ? O
captured ? ? O
by ? ? O
BiP ? ? I-gene
and ? ? O
then ? ? O
transferred ? ? O
to ? ? O
ERdj5 ? ? I-gene
without ? ? O
going ? ? O
through ? ? O
the ? ? O
calnexin ? ? I-gene
/ ? ? O
EDEM1 ? ? I-gene
pathway ? ? O
; ? ? O
after ? ? O
cleavage ? ? O
of ? ? O
disulfide ? ? O
bonds ? ? O
by ? ? O
ERdj5 ? ? I-gene
, ? ? O
the ? ? O
nonglycoproteins ? ? O
are ? ? O
transferred ? ? O
to ? ? O
the ? ? O
ERAD ? ? I-disease
scaffold ? ? O
protein ? ? O
SEL1L ? ? I-gene
by ? ? O
the ? ? O
aid ? ? O
of ? ? O
BiP ? ? I-gene
for ? ? O
dislocation ? ? O
into ? ? O
the ? ? O
cytosol ? ? O
. ? ? O

When 23966469 ? O
glucose ? ? I-treatment
trimming ? ? O
of ? ? O
the ? ? O
N-glycan ? ? O
groups ? ? O
of ? ? O
the ? ? O
substrates ? ? O
is ? ? O
inhibited ? ? O
, ? ? O
glycoproteins ? ? O
are ? ? O
also ? ? O
targeted ? ? O
to ? ? O
the ? ? O
nonglycoprotein ? ? O
ERAD ? ? I-disease
pathway ? ? O
. ? ? O

These 23966469 ? O
results ? ? O
indicate ? ? O
that ? ? O
two ? ? O
distinct ? ? O
pathways ? ? O
for ? ? O
ERAD ? ? I-disease
of ? ? O
glycoproteins ? ? O
and ? ? O
nonglycoproteins ? ? O
exist ? ? O
in ? ? O
mammalian ? ? O
cells ? ? O
, ? ? O
and ? ? O
these ? ? O
pathways ? ? O
are ? ? O
interchangeable ? ? O
under ? ? O
ER ? ? I-disease
stress ? ? I-disease
conditions ? ? O
. ? ? O

Inhibition 24694610 ? O
of ? ? O
cancer ? ? I-disease
cell ? ? O
growth ? ? O
by ? ? O
GRP78 ? ? I-gene
siRNA ? ? I-gene
lipoplex ? ? I-gene
via ? ? O
activation ? ? O
of ? ? O
unfolded ? ? O
protein ? ? O
response ? ? O
. ? ? O

Proteasome 24694610 ? I-treatment
inhibitors ? ? I-treatment
are ? ? O
a ? ? O
novel ? ? O
class ? ? O
of ? ? O
molecular-targeted ? ? O
anti-cancer ? ? I-treatment
drugs ? ? I-treatment
that ? ? O
suppress ? ? O
the ? ? O
degradation ? ? I-disease
of ? ? I-disease
malfolded ? ? I-disease
proteins ? ? I-disease
, ? ? O
trigger ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
( ? ? I-disease
ER ? ? I-disease
) ? ? I-disease
stress ? ? I-disease
, ? ? O
and ? ? O
activate ? ? O
apoptosis ? ? I-disease
signals ? ? I-disease
. ? ? O

Glucose-regulated 24694610 ? I-gene
protein ? ? I-gene
78 ? ? I-gene
( ? ? O
GRP78 ? ? I-gene
) ? ? O
, ? ? O
a ? ? O
major ? ? O
ER ? ? O
chaperone ? ? I-treatment
, ? ? O
is ? ? O
one ? ? O
of ? ? O
the ? ? O
most ? ? O
important ? ? O
molecules ? ? O
for ? ? O
transduction ? ? O
of ? ? O
unfolded ? ? O
protein ? ? O
response ? ? O
( ? ? O
UPR ? ? I-gene
) ? ? O
signals ? ? O
. ? ? O

In 24694610 ? O
accordance ? ? O
with ? ? O
past ? ? O
findings ? ? O
that ? ? O
expression ? ? O
of ? ? O
GRP78 ? ? I-gene
is ? ? O
elevated ? ? O
in ? ? O
cancer ? ? I-disease
cells ? ? O
and ? ? O
helps ? ? O
to ? ? O
resist ? ? O
stress-induced ? ? I-disease
apoptosis ? ? I-disease
, ? ? O
GRP78 ? ? I-gene
knockdown ? ? O
could ? ? O
be ? ? O
effective ? ? O
in ? ? O
anticancer ? ? I-treatment
therapy ? ? I-treatment
. ? ? O

We 24694610 ? O
tested ? ? O
this ? ? O
hypothesis ? ? O
and ? ? O
found ? ? O
that ? ? O
transfection ? ? O
of ? ? O
small ? ? I-gene
interfering ? ? I-gene
RNA ? ? I-gene
( ? ? O
siRNA ? ? O
) ? ? O
targeting ? ? O
GRP78 ? ? I-gene
inhibited ? ? O
the ? ? O
growth ? ? O
of ? ? O
RENCA ? ? I-disease
renal ? ? I-disease
carcinoma ? ? I-disease
cells ? ? I-disease
, ? ? O
in ? ? O
association ? ? O
with ? ? O
elevated ? ? O
gene ? ? O
expression ? ? O
of ? ? O
UPR ? ? I-gene
downstream ? ? O
signaling ? ? O
molecules ? ? O
( ? ? O
CHOP ? ? I-gene
, ? ? O
EDEM1 ? ? I-gene
, ? ? O
and ? ? O
ERdj4 ? ? I-gene
mRNA ? ? I-gene
) ? ? O
. ? ? O

In 24694610 ? O
addition ? ? O
, ? ? O
the ? ? O
combinatorial ? ? O
effect ? ? O
of ? ? O
GRP78 ? ? I-gene
siRNA ? ? I-gene
with ? ? O
ER ? ? I-treatment
stress ? ? I-treatment
inducers ? ? I-treatment
( ? ? O
tunicamycin ? ? I-treatment
, ? ? O
MG132 ? ? I-treatment
, ? ? O
and ? ? O
2-deoxyglucose ? ? I-treatment
) ? ? O
on ? ? O
survival ? ? O
was ? ? O
measured ? ? O
. ? ? O

Combination 24694610 ? O
of ? ? O
GRP78 ? ? I-gene
siRNA ? ? I-gene
and ? ? O
the ? ? O
ER ? ? I-treatment
stress ? ? I-treatment
inducers ? ? I-treatment
more ? ? O
extensively ? ? O
reduced ? ? O
cell ? ? O
viability ? ? O
than ? ? O
combination ? ? O
with ? ? O
scrambled ? ? I-gene
siRNA ? ? I-gene
. ? ? O

Besides 24694610 ? O
RENCA ? ? I-disease
, ? ? O
B16BL6 ? ? I-gene
melanoma ? ? I-disease
cells ? ? O
were ? ? O
also ? ? O
shown ? ? O
to ? ? O
be ? ? O
sensitive ? ? O
to ? ? O
GRP78 ? ? I-gene
siRNA ? ? I-gene
. ? ? O

These 24694610 ? O
results ? ? O
suggest ? ? O
that ? ? O
GRP78 ? ? I-gene
knockdown ? ? O
might ? ? O
be ? ? O
an ? ? O
effective ? ? O
strategy ? ? O
for ? ? O
cancer ? ? I-disease
therapy ? ? O
targeting ? ? O
UPR-induced ? ? I-treatment
apoptosis ? ? I-treatment
. ? ? O

Postprandial 24870697 ? I-disease
inflammation ? ? I-disease
is ? ? O
not ? ? O
associated ? ? O
with ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
stress ? ? I-disease
in ? ? O
peripheral ? ? O
blood ? ? O
mononuclear ? ? O
cells ? ? O
from ? ? O
healthy ? ? O
lean ? ? O
men ? ? O
. ? ? O

The 24870697 ? O
consumption ? ? O
of ? ? O
lipids ? ? O
and ? ? O
simple ? ? O
sugars ? ? O
induces ? ? O
an ? ? O
inflammatory ? ? I-disease
response ? ? I-disease
whose ? ? O
exact ? ? O
molecular ? ? O
trigger ? ? O
remains ? ? O
elusive ? ? O
. ? ? O

The 24870697 ? O
aims ? ? O
of ? ? O
the ? ? O
present ? ? O
study ? ? O
were ? ? O
to ? ? O
investigate ? ? O
( ? ? O
1 ? ? O
) ? ? O
whether ? ? O
inflammation ? ? I-disease
induced ? ? O
by ? ? O
a ? ? O
single ? ? O
high-energy ? ? O
, ? ? O
high-fat ? ? I-treatment
meal ? ? I-treatment
( ? ? O
HFM ? ? I-treatment
) ? ? O
is ? ? O
associated ? ? O
with ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
stress ? ? I-disease
( ? ? O
ERS ? ? I-disease
) ? ? O
in ? ? O
peripheral ? ? O
blood ? ? O
mononuclear ? ? O
cells ? ? O
( ? ? O
PBMC ? ? O
) ? ? O
and ? ? O
( ? ? O
2 ? ? O
) ? ? O
whether ? ? O
these ? ? O
inflammatory ? ? I-disease
and ? ? O
ERS ? ? I-disease
responses ? ? O
could ? ? O
be ? ? O
prevented ? ? O
by ? ? O
the ? ? O
chemical ? ? O
chaperone ? ? I-treatment
ursodeoxycholic ? ? I-treatment
acid ? ? I-treatment
( ? ? O
UDCA ? ? I-treatment
) ? ? O
. ? ? O

A 24870697 ? O
total ? ? O
of ? ? O
ten ? ? O
healthy ? ? O
lean ? ? O
men ? ? O
were ? ? O
recruited ? ? O
to ? ? O
a ? ? O
randomised ? ? O
, ? ? O
blind ? ? O
, ? ? O
cross-over ? ? O
trial ? ? O
. ? ? O

Subjects 24870697 ? O
were ? ? O
given ? ? O
two ? ? O
doses ? ? O
of ? ? O
placebo ? ? O
( ? ? O
lactose ? ? I-treatment
) ? ? O
or ? ? O
UDCA ? ? I-treatment
before ? ? O
the ? ? O
consumption ? ? O
of ? ? O
a ? ? O
HFM ? ? I-treatment
( ? ? O
6151 ? ? O
kJ ? ? O
; ? ? O
47.4 ? ? O
% ? ? O
lipids ? ? O
) ? ? O
. ? ? O

Blood 24870697 ? O
was ? ? O
collected ? ? O
at ? ? O
baseline ? ? O
and ? ? O
4 ? ? O
h ? ? O
after ? ? O
the ? ? O
HFM ? ? I-treatment
challenge ? ? O
. ? ? O

Cell 24870697 ? O
populations ? ? O
and ? ? O
their ? ? O
activation ? ? O
were ? ? O
analysed ? ? O
using ? ? O
flow ? ? O
cytometry ? ? O
, ? ? O
and ? ? O
plasma ? ? O
levels ? ? O
of ? ? O
inflammatory ? ? I-gene
cytokines ? ? I-gene
were ? ? O
assessed ? ? O
by ? ? O
ELISA ? ? I-treatment
and ? ? O
Luminex ? ? I-treatment
technology ? ? O
. ? ? O

Gene 24870697 ? O
expression ? ? O
levels ? ? O
of ? ? O
inflammatory ? ? I-disease
and ? ? O
ERS ? ? I-disease
markers ? ? O
were ? ? O
analysed ? ? O
in ? ? O
CD14 ? ? I-gene
( ? ? O
+ ? ? O
) ? ? O
and ? ? O
CD14 ? ? I-gene
( ? ? O
- ? ? O
) ? ? O
PBMC ? ? O
using ? ? O
quantitative ? ? O
RT-PCR ? ? O
. ? ? O

The 24870697 ? O
HFM ? ? I-treatment
induced ? ? O
an ? ? O
increase ? ? O
in ? ? O
the ? ? O
mRNA ? ? I-gene
expression ? ? O
levels ? ? O
of ? ? O
pro-inflammatory ? ? I-gene
cytokines ? ? I-gene
( ? ? O
IL-1beta ? ? I-gene
, ? ? O
2.1-fold ? ? I-gene
; ? ? O
IL-8 ? ? I-gene
, ? ? O
2.4-fold ? ? I-gene
; ? ? O
TNF-alpha ? ? I-gene
, ? ? O
1.4-fold ? ? I-gene
; ? ? O
monocyte ? ? I-gene
chemoattractant ? ? I-gene
protein ? ? I-gene
1 ? ? O
, ? ? O
2.1-fold ? ? O
) ? ? O
and ? ? O
a ? ? O
decrease ? ? O
in ? ? O
the ? ? O
expression ? ? O
levels ? ? O
of ? ? O
miR181 ? ? I-gene
( ? ? O
0.8-fold ? ? O
) ? ? O
in ? ? O
CD14 ? ? I-gene
( ? ? O
+ ? ? O
) ? ? O
monocytes ? ? O
. ? ? O

The 24870697 ? O
HFM ? ? I-treatment
challenge ? ? O
did ? ? O
not ? ? O
up-regulate ? ? O
the ? ? O
expression ? ? O
of ? ? O
ERS ? ? I-disease
markers ? ? O
( ? ? O
XBP1 ? ? I-gene
, ? ? O
HSPA5 ? ? I-gene
, ? ? O
EDEM1 ? ? I-gene
, ? ? O
DNAJC3 ? ? I-gene
and ? ? O
ATF4 ? ? I-gene
) ? ? O
in ? ? O
either ? ? O
CD14 ? ? I-gene
( ? ? O
+ ? ? O
) ? ? O
or ? ? O
CD14 ? ? I-gene
( ? ? O
- ? ? O
) ? ? O
cell ? ? O
populations ? ? O
, ? ? O
except ? ? O
for ? ? O
ATF3 ? ? I-gene
( ? ? O
2.3-fold ? ? O
) ? ? O
. ? ? O

The 24870697 ? O
administration ? ? O
of ? ? O
UDCA ? ? I-treatment
before ? ? O
the ? ? O
consumption ? ? O
of ? ? O
the ? ? O
HFM ? ? I-treatment
did ? ? O
not ? ? O
alter ? ? O
the ? ? O
HFM-induced ? ? I-treatment
change ? ? O
in ? ? O
the ? ? O
expression ? ? O
levels ? ? O
of ? ? O
ERS ? ? I-disease
or ? ? O
inflammatory ? ? I-disease
markers ? ? O
. ? ? O

In 24870697 ? O
conclusion ? ? O
, ? ? O
HFM-induced ? ? I-disease
inflammation ? ? I-disease
detectable ? ? O
on ? ? O
the ? ? O
level ? ? O
of ? ? O
gene ? ? O
expression ? ? O
in ? ? O
PBMC ? ? O
was ? ? O
not ? ? O
associated ? ? O
with ? ? O
the ? ? O
concomitant ? ? O
increase ? ? O
in ? ? O
the ? ? O
expression ? ? O
levels ? ? O
of ? ? O
ERS ? ? I-disease
markers ? ? O
and ? ? O
could ? ? O
not ? ? O
be ? ? O
prevented ? ? O
by ? ? O
UDCA ? ? I-treatment
. ? ? O

EDEM2 24910992 ? I-gene
and ? ? O
OS-9 ? ? I-gene
are ? ? O
required ? ? O
for ? ? O
ER-associated ? ? I-disease
degradation ? ? I-disease
of ? ? O
non-glycosylated ? ? I-gene
sonic ? ? I-gene
hedgehog ? ? I-gene
. ? ? O

Misfolded 24910992 ? O
proteins ? ? O
of ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
( ? ? O
ER ? ? O
) ? ? O
are ? ? O
eliminated ? ? O
by ? ? O
the ? ? O
ER-associated ? ? I-disease
degradation ? ? I-disease
( ? ? O
ERAD ? ? I-disease
) ? ? O
in ? ? O
eukaryotes ? ? O
. ? ? O

In 24910992 ? O
S. ? ? I-disease
cerevisiae ? ? I-disease
, ? ? O
ER-resident ? ? I-gene
lectins ? ? I-gene
mediate ? ? O
substrate ? ? O
recognition ? ? O
through ? ? O
bipartite ? ? O
signals ? ? O
consisting ? ? O
of ? ? O
an ? ? O
unfolded ? ? O
local ? ? O
structure ? ? O
and ? ? O
the ? ? O
adjacent ? ? O
glycan ? ? I-treatment
. ? ? O

Trimming 24910992 ? O
of ? ? O
the ? ? O
glycan ? ? I-treatment
is ? ? O
essential ? ? O
for ? ? O
the ? ? O
directional ? ? O
delivery ? ? O
of ? ? O
the ? ? O
substrates ? ? O
. ? ? O

Whether 24910992 ? O
a ? ? O
similar ? ? O
recognition ? ? O
and ? ? O
delivery ? ? O
mechanism ? ? O
exists ? ? O
in ? ? O
mammalian ? ? O
cells ? ? O
is ? ? O
unknown ? ? O
. ? ? O

In 24910992 ? O
this ? ? O
study ? ? O
, ? ? O
we ? ? O
systematically ? ? O
study ? ? O
the ? ? O
function ? ? O
and ? ? O
substrate ? ? O
specificity ? ? O
of ? ? O
known ? ? O
mammalian ? ? O
ER ? ? I-gene
lectins ? ? I-gene
, ? ? O
including ? ? O
EDEM1 ? ? I-gene
/ ? ? I-gene
2 ? ? I-gene
/ ? ? I-gene
3 ? ? I-gene
, ? ? I-gene
OS-9 ? ? I-gene
and ? ? O
XTP-3B ? ? I-gene
using ? ? O
the ? ? O
recently ? ? O
identified ? ? O
ERAD ? ? I-disease
substrate ? ? O
sonic ? ? I-gene
hedgehog ? ? I-gene
( ? ? O
SHH ? ? I-gene
) ? ? O
, ? ? O
a ? ? O
soluble ? ? O
protein ? ? O
carrying ? ? O
a ? ? O
single ? ? O
N-glycan ? ? O
, ? ? O
as ? ? O
well ? ? O
as ? ? O
its ? ? O
nonglycosylated ? ? O
mutant ? ? O
N278A ? ? I-gene
. ? ? O

Efficient 24910992 ? O
ERAD ? ? I-disease
of ? ? O
N278A ? ? I-gene
requires ? ? O
the ? ? O
core ? ? O
processing ? ? O
complex ? ? O
of ? ? O
HRD1 ? ? I-gene
, ? ? O
SEL1L ? ? I-gene
and ? ? O
p97 ? ? I-gene
, ? ? O
similar ? ? O
to ? ? O
the ? ? O
glycosylated ? ? O
SHH ? ? I-gene
. ? ? O

While 24910992 ? O
EDEM2 ? ? I-gene
was ? ? O
required ? ? O
for ? ? O
ERAD ? ? I-disease
of ? ? O
both ? ? O
glycosylated ? ? O
and ? ? O
non-glycosylated ? ? O
SHHs ? ? I-gene
, ? ? O
EDEM3 ? ? I-gene
was ? ? O
only ? ? O
necessary ? ? O
for ? ? O
glycosylated ? ? O
SHH ? ? I-gene
and ? ? O
EDEM1 ? ? I-gene
was ? ? O
dispensable ? ? O
for ? ? O
both ? ? O
. ? ? O

Degradation 24910992 ? O
of ? ? O
SHH ? ? I-gene
and ? ? O
N278A ? ? I-gene
also ? ? O
required ? ? O
OS-9 ? ? I-gene
, ? ? O
but ? ? O
not ? ? O
the ? ? O
related ? ? O
lectin ? ? O
XTP3-B ? ? I-gene
. ? ? O

Robust 24910992 ? O
interaction ? ? O
of ? ? O
both ? ? O
EDEM2 ? ? I-gene
and ? ? O
OS-9 ? ? I-gene
with ? ? O
a ? ? O
non-glycosylated ? ? O
SHH ? ? I-gene
variant ? ? O
indicates ? ? O
that ? ? O
the ? ? O
misfolded ? ? O
polypeptide ? ? O
backbone ? ? I-treatment
, ? ? O
rather ? ? O
than ? ? O
a ? ? O
glycan ? ? O
signature ? ? O
, ? ? O
functions ? ? O
as ? ? O
the ? ? O
predominant ? ? O
signal ? ? O
for ? ? O
recognition ? ? O
for ? ? O
ERAD ? ? I-disease
. ? ? O

Notably 24910992 ? O
, ? ? O
SHH-N278A ? ? I-treatment
is ? ? O
the ? ? O
first ? ? O
nonglycosylated ? ? O
substrate ? ? O
to ? ? O
require ? ? O
EDEM2 ? ? I-gene
for ? ? O
recognition ? ? O
and ? ? O
targeting ? ? O
for ? ? O
ERAD ? ? I-disease
. ? ? O

EDEM2 24910992 ? I-gene
also ? ? O
interacts ? ? O
with ? ? O
calnexin ? ? I-gene
and ? ? O
SEL1L ? ? I-gene
, ? ? O
suggesting ? ? O
a ? ? O
potential ? ? O
avenue ? ? O
by ? ? O
which ? ? O
misfolded ? ? O
glycoproteins ? ? O
may ? ? O
be ? ? O
shunted ? ? O
towards ? ? O
SEL1L ? ? I-gene
and ? ? O
ERAD ? ? I-disease
rather ? ? O
than ? ? O
being ? ? O
released ? ? O
into ? ? O
the ? ? O
secretory ? ? O
pathway ? ? O
. ? ? O

Thus 24910992 ? O
, ? ? O
ER ? ? I-gene
lectins ? ? I-gene
participate ? ? O
in ? ? O
the ? ? O
recognition ? ? O
and ? ? O
delivery ? ? O
of ? ? O
misfolded ? ? O
ER ? ? O
substrates ? ? O
differently ? ? O
in ? ? O
mammals ? ? O
, ? ? O
with ? ? O
an ? ? O
underlying ? ? O
mechanism ? ? O
distinct ? ? O
from ? ? O
that ? ? O
of ? ? O
S. ? ? I-disease
cerevisiae ? ? I-disease
. ? ? O

MicroRNA-581 24913918 ? I-gene
promotes ? ? O
hepatitis ? ? I-disease
B ? ? I-disease
virus ? ? O
surface ? ? O
antigen ? ? O
expression ? ? O
by ? ? O
targeting ? ? O
Dicer ? ? I-gene
and ? ? O
EDEM1 ? ? I-gene
. ? ? O

Hepatitis 24913918 ? I-gene
B ? ? I-gene
virus ? ? I-gene
surface ? ? I-gene
antigen ? ? I-gene
( ? ? O
HBsAg ? ? I-gene
) ? ? O
is ? ? O
an ? ? O
important ? ? O
risk ? ? O
factor ? ? O
for ? ? O
hepatocellular ? ? I-disease
carcinoma ? ? I-disease
( ? ? O
HCC ? ? I-disease
) ? ? O
and ? ? O
is ? ? O
downregulated ? ? O
during ? ? O
hepatocarcinogenesis ? ? I-disease
. ? ? O

MicroRNAs 24913918 ? I-gene
( ? ? O
miRNAs ? ? O
) ? ? O
are ? ? O
frequently ? ? O
deregulated ? ? O
in ? ? O
HCC ? ? I-disease
tissues ? ? O
. ? ? O

However 24913918 ? O
, ? ? O
whether ? ? O
the ? ? O
deregulation ? ? O
of ? ? O
certain ? ? O
miRNAs ? ? I-gene
in ? ? O
HCC ? ? I-disease
has ? ? O
an ? ? O
impact ? ? O
on ? ? O
HBsAg ? ? I-gene
expression ? ? O
remains ? ? O
unclear ? ? O
. ? ? O

We 24913918 ? O
found ? ? O
here ? ? O
that ? ? O
microRNA-581 ? ? I-gene
( ? ? O
miR-581 ? ? I-gene
) ? ? O
, ? ? O
which ? ? O
is ? ? O
deregulated ? ? O
during ? ? O
hepatocarcinogenesis ? ? I-disease
, ? ? O
promoted ? ? O
HBsAg ? ? I-gene
expression ? ? O
. ? ? O

Additionally 24913918 ? O
, ? ? O
miR-581 ? ? I-gene
targeted ? ? O
Dicer ? ? I-gene
and ? ? O
endoplasmic ? ? I-gene
reticulum ? ? I-gene
degradation-enhancing ? ? I-gene
alpha-mannosidase-like ? ? I-gene
protein ? ? I-gene
1 ? ? I-gene
( ? ? O
EDEM1 ? ? I-gene
) ? ? O
and ? ? O
repressed ? ? O
their ? ? O
expression ? ? O
. ? ? O

Although 24913918 ? O
Dicer ? ? I-gene
can ? ? O
not ? ? O
process ? ? O
HBV ? ? I-disease
transcripts ? ? O
, ? ? O
Dicer ? ? I-gene
knockdown ? ? O
led ? ? O
to ? ? O
increased ? ? O
HBsAg ? ? I-gene
secretion ? ? O
, ? ? O
most ? ? O
likely ? ? O
due ? ? O
to ? ? O
a ? ? O
reduction ? ? O
in ? ? O
the ? ? O
levels ? ? O
of ? ? O
Dicer-processed ? ? I-gene
7SL ? ? I-gene
RNA ? ? O
fragments ? ? O
. ? ? O

Moreover 24913918 ? O
, ? ? O
Dicer-processed ? ? I-gene
7SL ? ? I-gene
RNA ? ? O
fragments ? ? O
partially ? ? O
inhibited ? ? O
the ? ? O
ability ? ? O
of ? ? O
miR-581 ? ? I-gene
to ? ? O
stimulate ? ? O
HBsAg ? ? I-gene
expression ? ? O
. ? ? O

Furthermore 24913918 ? O
, ? ? O
we ? ? O
found ? ? O
that ? ? O
forced ? ? O
EDEM1 ? ? I-gene
expression ? ? O
inhibited ? ? O
miR-581-mediated ? ? I-gene
induction ? ? O
of ? ? O
HBsAg ? ? I-gene
. ? ? O

Finally 24913918 ? O
, ? ? O
transfection ? ? O
of ? ? O
miR-581 ? ? I-gene
into ? ? O
HepG2.2.15 ? ? I-gene
cells ? ? O
promoted ? ? O
cell ? ? O
proliferation ? ? O
and ? ? O
led ? ? O
to ? ? O
upregulation ? ? O
of ? ? O
genes ? ? O
involved ? ? O
in ? ? O
development ? ? O
, ? ? O
cell ? ? O
proliferation ? ? O
and ? ? O
protein ? ? O
secretion ? ? O
. ? ? O

Altogether 24913918 ? O
, ? ? O
we ? ? O
conclude ? ? O
that ? ? O
miR-581 ? ? I-gene
promotes ? ? O
HBsAg ? ? I-gene
expression ? ? O
by ? ? O
targeting ? ? O
Dicer ? ? I-gene
and ? ? O
EDEM1 ? ? I-gene
. ? ? O

Our 24913918 ? O
findings ? ? O
suggest ? ? O
that ? ? O
downregulation ? ? O
of ? ? O
miR-581 ? ? I-gene
during ? ? O
hepatocarcinogenesis ? ? I-disease
may ? ? O
lead ? ? O
to ? ? O
a ? ? O
reduction ? ? O
in ? ? O
HBsAg ? ? I-gene
expression ? ? O
and ? ? O
impede ? ? O
HCC ? ? I-disease
development ? ? O
. ? ? O

How 24990995 ? O
viruses ? ? I-disease
hijack ? ? O
the ? ? O
ERAD ? ? I-gene
tuning ? ? O
machinery ? ? O
. ? ? O

An 24990995 ? O
essential ? ? O
step ? ? O
during ? ? O
the ? ? O
intracellular ? ? O
life ? ? O
cycle ? ? O
of ? ? O
many ? ? O
positive-strand ? ? I-gene
RNA ? ? I-gene
viruses ? ? I-gene
is ? ? O
the ? ? O
rearrangement ? ? O
of ? ? O
host ? ? O
cell ? ? O
membranes ? ? O
to ? ? O
generate ? ? O
membrane-bound ? ? O
replication ? ? O
platforms ? ? O
. ? ? O

For 24990995 ? O
example ? ? O
, ? ? O
Nidovirales ? ? I-disease
and ? ? O
Flaviviridae ? ? I-disease
subvert ? ? O
the ? ? O
membrane ? ? O
of ? ? O
the ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
( ? ? O
ER ? ? I-disease
) ? ? O
for ? ? O
their ? ? O
replication ? ? O
. ? ? O

However 24990995 ? O
, ? ? O
the ? ? O
absence ? ? O
of ? ? O
conventional ? ? O
ER ? ? I-disease
and ? ? O
secretory ? ? O
pathway ? ? O
markers ? ? O
in ? ? O
virus-induced ? ? I-disease
ER-derived ? ? I-disease
membranes ? ? I-disease
has ? ? O
for ? ? O
a ? ? O
long ? ? O
time ? ? O
hampered ? ? O
a ? ? O
thorough ? ? O
understanding ? ? O
of ? ? O
their ? ? O
biogenesis ? ? O
. ? ? O

Recent 24990995 ? O
reports ? ? O
highlight ? ? O
the ? ? O
analogies ? ? O
between ? ? O
mouse ? ? O
hepatitis ? ? I-disease
virus- ? ? O
, ? ? O
equine ? ? I-disease
arteritis ? ? I-disease
virus- ? ? O
, ? ? O
and ? ? O
Japanese ? ? I-disease
encephalitis ? ? I-disease
virus-induced ? ? I-disease
replication ? ? I-disease
platforms ? ? O
and ? ? O
ER-associated ? ? I-gene
degradation ? ? I-gene
( ? ? O
ERAD ? ? I-gene
) ? ? O
tuning ? ? O
vesicles ? ? O
( ? ? O
or ? ? O
EDEMosomes ? ? I-gene
) ? ? O
that ? ? O
display ? ? O
nonlipidated ? ? O
LC3 ? ? I-gene
at ? ? O
their ? ? O
cytosolic ? ? O
face ? ? O
and ? ? O
segregate ? ? O
the ? ? O
ERAD ? ? I-gene
factors ? ? O
EDEM1 ? ? I-gene
, ? ? O
OS-9 ? ? I-gene
, ? ? O
and ? ? O
SEL1L ? ? I-gene
from ? ? O
the ? ? O
ER ? ? I-disease
lumen ? ? I-disease
. ? ? O

In 24990995 ? O
this ? ? O
Gem ? ? O
, ? ? O
we ? ? O
briefly ? ? O
summarize ? ? O
the ? ? O
current ? ? O
knowledge ? ? O
on ? ? O
ERAD ? ? I-gene
tuning ? ? O
pathways ? ? O
and ? ? O
how ? ? O
they ? ? O
might ? ? O
be ? ? O
hijacked ? ? O
for ? ? O
viral ? ? O
genome ? ? O
replication ? ? O
. ? ? O

As 24990995 ? O
ERAD ? ? I-gene
tuning ? ? O
components ? ? O
, ? ? O
such ? ? O
as ? ? O
SEL1L ? ? I-gene
and ? ? O
nonlipidated ? ? O
LC3 ? ? I-gene
, ? ? O
appear ? ? O
to ? ? O
contribute ? ? O
to ? ? O
viral ? ? O
infection ? ? O
, ? ? O
these ? ? O
cellular ? ? O
pathways ? ? O
represent ? ? O
novel ? ? O
candidate ? ? O
drug ? ? O
targets ? ? O
to ? ? O
combat ? ? O
positive-strand ? ? I-gene
RNA ? ? I-gene
viruses ? ? I-gene
. ? ? O

Japanese 25046112 ? I-disease
encephalitis ? ? I-disease
virus ? ? O
replication ? ? O
is ? ? O
negatively ? ? O
regulated ? ? O
by ? ? O
autophagy ? ? I-disease
and ? ? O
occurs ? ? O
on ? ? O
LC3-I- ? ? O
and ? ? O
EDEM1-containing ? ? I-gene
membranes ? ? O
. ? ? O

Autophagy 25046112 ? I-disease
is ? ? O
a ? ? O
lysosomal ? ? O
degradative ? ? O
pathway ? ? O
that ? ? O
has ? ? O
diverse ? ? O
physiological ? ? O
functions ? ? O
and ? ? O
plays ? ? O
crucial ? ? O
roles ? ? O
in ? ? O
several ? ? O
viral ? ? I-disease
infections ? ? I-disease
. ? ? O

Here 25046112 ? O
we ? ? O
examine ? ? O
the ? ? O
role ? ? O
of ? ? O
autophagy ? ? I-disease
in ? ? O
the ? ? O
life ? ? O
cycle ? ? O
of ? ? O
JEV ? ? I-disease
, ? ? O
a ? ? O
neurotropic ? ? I-disease
flavivirus ? ? I-disease
. ? ? O

JEV 25046112 ? I-disease
infection ? ? I-disease
leads ? ? O
to ? ? O
induction ? ? O
of ? ? O
autophagy ? ? I-disease
in ? ? O
several ? ? O
cell ? ? O
types ? ? O
. ? ? O

JEV 25046112 ? I-disease
replication ? ? O
was ? ? O
significantly ? ? O
enhanced ? ? O
in ? ? O
neuronal ? ? O
cells ? ? O
where ? ? O
autophagy ? ? I-disease
was ? ? O
rendered ? ? O
dysfunctional ? ? O
by ? ? O
ATG7 ? ? I-gene
depletion ? ? O
, ? ? O
and ? ? O
in ? ? O
Atg5-deficient ? ? I-gene
mouse ? ? I-gene
embryonic ? ? I-gene
fibroblasts ? ? I-gene
( ? ? O
MEFs ? ? I-gene
) ? ? O
, ? ? O
resulting ? ? O
in ? ? O
higher ? ? O
viral ? ? O
titers ? ? O
. ? ? O

Autophagy 25046112 ? O
was ? ? O
functional ? ? O
during ? ? O
early ? ? O
stages ? ? O
of ? ? O
infection ? ? I-disease
however ? ? O
it ? ? O
becomes ? ? O
dysfunctional ? ? I-disease
as ? ? I-disease
infection ? ? I-disease
progressed ? ? O
resulting ? ? O
in ? ? O
accumulation ? ? O
of ? ? O
misfolded ? ? O
proteins ? ? O
. ? ? O

Autophagy-deficient 25046112 ? I-disease
cells ? ? O
were ? ? O
highly ? ? O
susceptible ? ? O
to ? ? O
virus-induced ? ? I-disease
cell ? ? I-disease
death ? ? I-disease
. ? ? O

We 25046112 ? O
also ? ? O
observed ? ? O
JEV ? ? I-disease
replication ? ? O
complexes ? ? O
that ? ? O
are ? ? O
marked ? ? O
by ? ? O
nonstructural ? ? I-gene
protein ? ? I-gene
1 ? ? O
( ? ? O
NS1 ? ? I-gene
) ? ? O
and ? ? O
dsRNA ? ? I-gene
colocalized ? ? O
with ? ? O
endogenous ? ? O
LC3 ? ? I-gene
but ? ? O
not ? ? O
with ? ? O
GFP-LC3 ? ? I-gene
. ? ? O

Colocalization 25046112 ? O
of ? ? O
NS1 ? ? I-gene
and ? ? O
LC3 ? ? I-gene
was ? ? O
also ? ? O
observed ? ? O
in ? ? O
Atg5 ? ? I-gene
deficient ? ? I-gene
MEFs ? ? I-gene
, ? ? O
which ? ? O
contain ? ? O
only ? ? O
the ? ? O
nonlipidated ? ? O
form ? ? O
of ? ? O
LC3 ? ? I-gene
. ? ? O

Viral 25046112 ? O
replication ? ? O
complexes ? ? O
furthermore ? ? O
show ? ? O
association ? ? O
with ? ? O
a ? ? O
marker ? ? O
of ? ? O
the ? ? O
ER-associated ? ? I-gene
degradation ? ? I-gene
( ? ? O
ERAD ? ? I-gene
) ? ? O
pathway ? ? O
, ? ? O
EDEM1 ? ? I-gene
( ? ? O
ER ? ? I-gene
degradation ? ? I-gene
enhancer ? ? I-gene
, ? ? I-gene
mannosidase ? ? I-gene
alpha-like ? ? I-gene
1 ? ? O
) ? ? O
. ? ? O

Our 25046112 ? O
data ? ? O
suggest ? ? O
that ? ? O
virus ? ? O
replication ? ? O
occurs ? ? O
on ? ? O
ERAD-derived ? ? I-gene
EDEM1 ? ? I-gene
and ? ? O
LC3-I-positive ? ? I-gene
structures ? ? O
referred ? ? O
to ? ? O
as ? ? O
EDEMosomes ? ? I-gene
. ? ? O

While 25046112 ? O
silencing ? ? O
of ? ? O
ERAD ? ? I-gene
regulators ? ? O
EDEM1 ? ? I-gene
and ? ? O
SEL1L ? ? I-gene
suppressed ? ? O
JEV ? ? I-disease
replication ? ? O
, ? ? O
LC3 ? ? I-gene
depletion ? ? O
exerted ? ? O
a ? ? O
profound ? ? O
inhibition ? ? O
with ? ? O
significantly ? ? O
reduced ? ? O
RNA ? ? I-gene
levels ? ? O
and ? ? O
virus ? ? O
titers ? ? O
. ? ? O

Our 25046112 ? O
study ? ? O
suggests ? ? O
that ? ? O
while ? ? O
autophagy ? ? I-disease
is ? ? O
primarily ? ? O
antiviral ? ? O
for ? ? O
JEV ? ? I-disease
and ? ? O
might ? ? O
have ? ? O
implications ? ? O
for ? ? O
disease ? ? O
progression ? ? O
and ? ? O
pathogenesis ? ? O
of ? ? O
JEV ? ? I-disease
, ? ? O
nonlipidated ? ? O
LC3 ? ? I-gene
plays ? ? O
an ? ? O
important ? ? O
autophagy ? ? I-disease
independent ? ? O
function ? ? O
in ? ? O
the ? ? O
virus ? ? O
life ? ? O
cycle ? ? O
. ? ? O

Stress 25813485 ? O
of ? ? O
endoplasmic ? ? O
reticulum ? ? O
modulates ? ? O
differentiation ? ? I-disease
and ? ? O
lipogenesis ? ? I-disease
of ? ? I-disease
human ? ? I-disease
adipocytes ? ? I-disease
. ? ? O

BACKGROUND 25813485 ? O
: ? ? O
Adipocytes ? ? O
are ? ? O
cells ? ? O
specialized ? ? O
for ? ? O
storage ? ? O
of ? ? O
neutral ? ? O
lipids ? ? O
. ? ? O

This 25813485 ? O
storage ? ? O
capacity ? ? O
is ? ? O
dependent ? ? O
on ? ? O
lipogenesis ? ? O
and ? ? O
is ? ? O
diminished ? ? O
in ? ? O
obesity ? ? O
. ? ? O

The 25813485 ? O
reason ? ? O
for ? ? O
the ? ? O
decline ? ? O
in ? ? O
lipogenic ? ? O
activity ? ? O
of ? ? O
adipocytes ? ? O
in ? ? O
obesity ? ? O
remains ? ? O
unknown ? ? O
. ? ? O

Recent 25813485 ? O
data ? ? O
show ? ? O
that ? ? O
lipogenesis ? ? I-disease
in ? ? O
liver ? ? O
is ? ? O
regulated ? ? O
by ? ? O
pathways ? ? O
initiated ? ? O
by ? ? O
endoplasmic ? ? I-gene
reticulum ? ? I-gene
stress ? ? I-gene
( ? ? O
ERS ? ? I-gene
) ? ? O
. ? ? O

Thus 25813485 ? O
, ? ? O
we ? ? O
aimed ? ? O
at ? ? O
investigating ? ? O
the ? ? O
effect ? ? O
of ? ? O
ERS ? ? I-gene
on ? ? O
lipogenesis ? ? I-disease
in ? ? O
adipose ? ? O
cells ? ? O
. ? ? O

METHODS 25813485 ? O
: ? ? O
Preadipocytes ? ? O
were ? ? O
isolated ? ? O
from ? ? O
subcutaneous ? ? O
abdominal ? ? O
adipose ? ? O
tissue ? ? O
from ? ? O
obese ? ? O
volunteers ? ? O
and ? ? O
in ? ? O
vitro ? ? O
differentiated ? ? O
into ? ? O
adipocytes ? ? O
. ? ? O

ERS 25813485 ? I-gene
was ? ? O
induced ? ? O
pharmacologically ? ? O
by ? ? O
thapsigargin ? ? I-treatment
( ? ? O
TG ? ? I-treatment
) ? ? O
or ? ? O
tunicamycin ? ? I-treatment
( ? ? O
TM ? ? I-treatment
) ? ? O
. ? ? O

Activation 25813485 ? O
of ? ? O
Unfolded ? ? I-gene
Protein ? ? I-gene
Response ? ? I-gene
pathway ? ? I-gene
( ? ? O
UPR ? ? I-gene
) ? ? O
was ? ? O
monitored ? ? O
on ? ? O
the ? ? O
level ? ? O
of ? ? O
eIF2alpha ? ? I-gene
phosphorylation ? ? O
and ? ? O
mRNA ? ? O
expression ? ? O
of ? ? O
downstream ? ? O
targets ? ? O
of ? ? O
UPR ? ? I-gene
sensors ? ? O
. ? ? O

Adipogenic 25813485 ? O
and ? ? O
lipogenic ? ? O
capacity ? ? O
was ? ? O
evaluated ? ? O
by ? ? O
Oil ? ? I-treatment
Red ? ? I-treatment
O ? ? I-treatment
staining ? ? I-treatment
, ? ? O
measurement ? ? O
of ? ? O
incorporation ? ? O
of ? ? O
radio-labelled ? ? O
glucose ? ? O
or ? ? O
acetic ? ? O
acid ? ? O
into ? ? O
lipids ? ? O
and ? ? O
mRNA ? ? O
analysis ? ? O
of ? ? O
adipogenic ? ? O
/ ? ? O
lipogenic ? ? O
markers ? ? O
. ? ? O

RESULTS 25813485 ? O
: ? ? O
Exposition ? ? O
of ? ? O
adipocytes ? ? O
to ? ? O
high ? ? O
doses ? ? O
of ? ? O
TG ? ? I-treatment
( ? ? O
100 ? ? O
nM ? ? O
) ? ? O
and ? ? O
TM ? ? I-treatment
( ? ? O
1 ? ? O
mug ? ? O
/ ? ? O
ml ? ? O
) ? ? O
for ? ? O
1-24 ? ? O
h ? ? O
enhanced ? ? O
expression ? ? O
of ? ? O
several ? ? O
UPR ? ? I-gene
markers ? ? O
( ? ? O
HSPA5 ? ? I-gene
, ? ? O
EDEM1 ? ? I-gene
, ? ? O
ATF4 ? ? I-gene
, ? ? O
XBP1s ? ? I-gene
) ? ? O
and ? ? O
phosphorylation ? ? O
of ? ? O
eIF2alpha ? ? I-gene
. ? ? O

This 25813485 ? O
acute ? ? O
ERS ? ? I-gene
substantially ? ? O
inhibited ? ? O
expression ? ? O
of ? ? O
lipogenic ? ? O
genes ? ? O
( ? ? O
DGAT2 ? ? I-gene
, ? ? O
FASN ? ? I-gene
, ? ? O
SCD1 ? ? I-gene
) ? ? O
and ? ? O
glucose ? ? O
incorporation ? ? O
into ? ? O
lipids ? ? O
. ? ? O

Moreover 25813485 ? O
, ? ? O
chronic ? ? O
exposure ? ? O
of ? ? O
preadipocytes ? ? O
to ? ? O
low ? ? O
dose ? ? O
of ? ? O
TG ? ? I-treatment
( ? ? O
2.5 ? ? O
nM ? ? O
) ? ? O
during ? ? O
the ? ? O
early ? ? O
phases ? ? O
of ? ? O
adipogenic ? ? O
conversion ? ? O
of ? ? O
preadipocytes ? ? O
impaired ? ? O
both ? ? O
, ? ? O
lipogenesis ? ? O
and ? ? O
adipogenesis ? ? O
. ? ? O

On 25813485 ? O
the ? ? O
other ? ? O
hand ? ? O
, ? ? O
chronic ? ? O
low ? ? O
ERS ? ? I-gene
had ? ? O
no ? ? O
apparent ? ? O
effect ? ? O
on ? ? O
lipogenesis ? ? O
in ? ? O
mature ? ? O
adipocytes ? ? O
. ? ? O

CONCLUSIONS 25813485 ? O
: ? ? O
Acute ? ? O
ERS ? ? I-gene
weakened ? ? O
a ? ? O
capacity ? ? O
of ? ? O
mature ? ? O
adipocytes ? ? O
to ? ? O
store ? ? O
lipids ? ? O
and ? ? O
chronic ? ? O
ERS ? ? I-gene
diminished ? ? O
adipogenic ? ? O
potential ? ? O
of ? ? O
preadipocytes ? ? O
. ? ? O

ERManI 26205822 ? I-gene
( ? ? O
Endoplasmic ? ? I-gene
Reticulum ? ? I-gene
Class ? ? I-gene
I ? ? I-gene
alpha-Mannosidase ? ? I-gene
) ? ? O
Is ? ? O
Required ? ? O
for ? ? O
HIV-1 ? ? I-gene
Envelope ? ? I-gene
Glycoprotein ? ? O
Degradation ? ? O
via ? ? O
Endoplasmic ? ? I-gene
Reticulum-associated ? ? I-gene
Protein ? ? I-gene
Degradation ? ? O
Pathway ? ? O
. ? ? O

Previously 26205822 ? O
, ? ? O
we ? ? O
reported ? ? O
that ? ? O
the ? ? O
mitochondrial ? ? I-gene
translocator ? ? I-gene
protein ? ? I-gene
( ? ? O
TSPO ? ? I-gene
) ? ? O
induces ? ? O
HIV-1 ? ? I-gene
envelope ? ? I-gene
( ? ? O
Env ? ? I-gene
) ? ? O
degradation ? ? O
via ? ? O
the ? ? O
endoplasmic ? ? I-gene
reticulum ? ? I-gene
( ? ? I-gene
ER ? ? I-gene
) ? ? I-gene
-associated ? ? I-gene
protein ? ? I-gene
degradation ? ? O
( ? ? O
ERAD ? ? I-gene
) ? ? O
pathway ? ? O
, ? ? O
but ? ? O
the ? ? O
mechanism ? ? O
was ? ? O
not ? ? O
clear ? ? O
. ? ? O

Here 26205822 ? O
we ? ? O
investigated ? ? O
how ? ? O
the ? ? O
four ? ? O
ER-associated ? ? O
glycoside ? ? I-gene
hydrolase ? ? I-gene
family ? ? O
47 ? ? O
( ? ? O
GH47 ? ? I-gene
) ? ? O
alpha-mannosidases ? ? I-gene
, ? ? O
ERManI ? ? I-gene
, ? ? O
and ? ? O
ER-degradation ? ? I-gene
enhancing ? ? I-gene
alpha-mannosidase-like ? ? I-gene
( ? ? I-gene
EDEM ? ? I-gene
) ? ? I-gene
proteins ? ? I-gene
1 ? ? I-gene
, ? ? I-gene
2 ? ? I-gene
, ? ? I-gene
and ? ? I-gene
3 ? ? I-gene
, ? ? O
are ? ? O
involved ? ? O
in ? ? O
the ? ? O
Env ? ? I-gene
degradation ? ? O
process ? ? O
. ? ? O

Ectopic 26205822 ? I-disease
expression ? ? I-disease
of ? ? O
these ? ? O
four ? ? O
alpha-mannosidases ? ? I-gene
uncovers ? ? O
that ? ? O
only ? ? O
ERManI ? ? I-gene
inhibits ? ? O
HIV-1 ? ? I-gene
Env ? ? I-gene
expression ? ? O
in ? ? O
a ? ? O
dose-dependent ? ? O
manner ? ? O
. ? ? O

In 26205822 ? O
addition ? ? O
, ? ? O
genetic ? ? O
knock-out ? ? O
of ? ? O
the ? ? O
ERManI ? ? I-gene
gene ? ? O
MAN1B1 ? ? I-gene
using ? ? O
CRISPR ? ? I-gene
/ ? ? O
Cas9 ? ? I-gene
technology ? ? O
disrupts ? ? O
the ? ? O
TSPO-mediated ? ? I-gene
Env ? ? I-gene
degradation ? ? O
. ? ? O

Biochemical 26205822 ? O
studies ? ? O
show ? ? O
that ? ? O
HIV-1 ? ? I-gene
Env ? ? I-gene
interacts ? ? O
with ? ? O
ERManI ? ? I-gene
, ? ? O
and ? ? O
between ? ? O
the ? ? O
ERManI ? ? I-gene
cytoplasmic ? ? O
, ? ? O
transmembrane ? ? O
, ? ? O
lumenal ? ? O
stem ? ? O
, ? ? O
and ? ? O
lumenal ? ? O
catalytic ? ? O
domains ? ? O
, ? ? O
the ? ? O
catalytic ? ? O
domain ? ? O
plays ? ? O
a ? ? O
critical ? ? O
role ? ? O
in ? ? O
the ? ? O
Env-ERManI ? ? I-gene
interaction ? ? O
. ? ? O

In 26205822 ? O
addition ? ? O
, ? ? O
functional ? ? O
studies ? ? O
show ? ? O
that ? ? O
inactivation ? ? O
of ? ? O
the ? ? O
catalytic ? ? O
sites ? ? O
by ? ? O
site-directed ? ? O
mutagenesis ? ? O
disrupts ? ? O
the ? ? O
ERManI ? ? I-gene
activity ? ? O
. ? ? O

These 26205822 ? O
studies ? ? O
identify ? ? O
ERManI ? ? I-gene
as ? ? O
a ? ? O
critical ? ? O
GH47 ? ? I-gene
alpha-mannosidase ? ? O
in ? ? O
the ? ? O
ER-associated ? ? I-gene
protein ? ? I-gene
degradation ? ? O
pathway ? ? O
that ? ? O
initiates ? ? O
the ? ? O
Env ? ? I-gene
degradation ? ? O
and ? ? O
suggests ? ? O
that ? ? O
its ? ? O
catalytic ? ? O
domain ? ? O
and ? ? O
enzymatic ? ? O
activity ? ? O
play ? ? O
an ? ? O
important ? ? O
role ? ? O
in ? ? O
this ? ? O
process ? ? O
. ? ? O

[ 26602803 ? O
Experience ? ? O
in ? ? O
molecular ? ? O
diagnostic ? ? O
in ? ? O
hereditary ? ? I-disease
neuropathies ? ? I-disease
in ? ? O
a ? ? O
pediatric ? ? O
tertiary ? ? O
hospital ? ? O
] ? ? O
. ? ? O

INTRODUCTION 26602803 ? O
: ? ? O
Charcot-Marie-Tooth ? ? I-disease
( ? ? O
CMT ? ? I-disease
) ? ? O
is ? ? O
the ? ? O
most ? ? O
common ? ? O
hereditary ? ? I-disease
sensory ? ? I-disease
motor ? ? I-disease
neuropathy ? ? I-disease
. ? ? O

Advances 26602803 ? O
in ? ? O
molecular ? ? O
diagnosis ? ? O
have ? ? O
increased ? ? O
the ? ? O
diagnostic ? ? O
possibilities ? ? O
of ? ? O
these ? ? O
patients ? ? O
. ? ? O

PATIENTS 26602803 ? O
AND ? ? O
METHODS ? ? O
: ? ? O
Retrospective ? ? O
study ? ? O
of ? ? O
36 ? ? O
pediatric ? ? O
patients ? ? O
diagnosed ? ? O
with ? ? O
CMT ? ? I-disease
in ? ? O
a ? ? O
tertiary ? ? O
center ? ? O
in ? ? O
2003-2015 ? ? O
. ? ? O

RESULTS 26602803 ? O
: ? ? O
We ? ? O
found ? ? O
16 ? ? O
patients ? ? O
were ? ? O
diagnosed ? ? O
by ? ? O
a ? ? O
duplication ? ? O
in ? ? O
PMP22 ? ? I-gene
; ? ? O
two ? ? O
cases ? ? O
were ? ? O
diagnosed ? ? O
of ? ? O
hereditary ? ? I-disease
neuropathy ? ? I-disease
with ? ? O
liability ? ? O
to ? ? O
pressure ? ? O
palsies ? ? O
, ? ? O
one ? ? O
with ? ? O
a ? ? O
point ? ? O
mutation ? ? O
in ? ? O
PMP22 ? ? I-gene
; ? ? O
a ? ? O
male ? ? O
with ? ? O
a ? ? O
mild ? ? I-disease
demyelinating ? ? I-disease
phenotype ? ? O
, ? ? O
without ? ? O
family ? ? I-disease
history ? ? I-disease
, ? ? O
was ? ? O
diagnosed ? ? O
with ? ? O
GJB1 ? ? I-gene
mutation ? ? O
; ? ? O
in ? ? O
a ? ? O
patient ? ? O
with ? ? O
a ? ? O
peripheral ? ? I-disease
hypotonia ? ? I-disease
at ? ? O
birth ? ? O
and ? ? O
axonal ? ? I-disease
pattern ? ? I-disease
in ? ? I-disease
EMG ? ? I-disease
by ? ? O
mutation ? ? O
in ? ? O
MFN2 ? ? I-gene
; ? ? O
a ? ? O
gypsy ? ? O
patient ? ? O
, ? ? O
with ? ? O
consanguineous ? ? I-disease
family ? ? O
, ? ? O
CMT4D ? ? I-gene
, ? ? O
was ? ? O
identified ? ? O
by ? ? O
a ? ? O
mutation ? ? O
in ? ? O
the ? ? O
gene ? ? O
NDRG1 ? ? I-gene
; ? ? O
a ? ? O
patient ? ? O
with ? ? O
multiplex ? ? I-disease
congenital ? ? I-disease
arthrogryposis ? ? I-disease
and ? ? O
vocal ? ? I-disease
cord ? ? I-disease
paralysis ? ? I-disease
, ? ? O
whose ? ? O
mother ? ? O
had ? ? O
a ? ? O
scapular-peroneal ? ? I-disease
syndrome ? ? I-disease
, ? ? O
had ? ? O
a ? ? O
congenital ? ? I-disease
spinal ? ? I-disease
muscular ? ? I-disease
atrophy ? ? I-disease
with ? ? O
mild ? ? I-disease
distal ? ? I-disease
axonal ? ? I-disease
neuropathy ? ? I-disease
by ? ? O
mutation ? ? O
in ? ? O
gene ? ? O
TRPV4 ? ? I-gene
; ? ? O
three ? ? O
girls ? ? O
, ? ? O
from ? ? O
a ? ? O
gypsy ? ? O
consanguineous ? ? I-disease
family ? ? O
, ? ? O
with ? ? O
axonal ? ? I-disease
CMT ? ? I-disease
with ? ? O
neuromyotonic ? ? I-disease
discharges ? ? I-disease
were ? ? O
diagnosed ? ? O
by ? ? O
a ? ? O
mutation ? ? O
in ? ? O
the ? ? O
gene ? ? O
HINT1 ? ? I-gene
; ? ? O
twelve ? ? O
patients ? ? O
have ? ? O
n't ? ? O
molecular ? ? I-disease
diagnosis ? ? I-disease
currently ? ? O
. ? ? O

CONCLUSIONS 26602803 ? O
: ? ? O
CMT1A ? ? I-gene
predominated ? ? O
in ? ? O
our ? ? O
series ? ? O
( ? ? O
44 ? ? O
% ? ? O
) ? ? O
, ? ? O
as ? ? O
previous ? ? O
studies ? ? O
. ? ? O

We 26602803 ? O
emphasize ? ? O
the ? ? O
description ? ? O
of ? ? O
a ? ? O
patient ? ? O
with ? ? O
a ? ? O
mutation ? ? O
in ? ? O
TRPV4 ? ? I-gene
recently ? ? O
described ? ? O
as ? ? O
a ? ? O
cause ? ? O
of ? ? O
CMT2C ? ? I-gene
and ? ? O
three ? ? O
cases ? ? O
, ? ? O
of ? ? O
gypsy ? ? O
consanguineous ? ? I-disease
family ? ? O
, ? ? O
with ? ? O
the ? ? O
same ? ? O
mutation ? ? O
in ? ? O
HINT1 ? ? I-gene
gene ? ? O
, ? ? O
recently ? ? O
described ? ? O
as ? ? O
a ? ? O
cause ? ? O
of ? ? O
axonal ? ? I-disease
neuropathy ? ? I-disease
with ? ? O
neuromyotonia ? ? I-disease
, ? ? O
autosomal ? ? I-disease
recessive ? ? I-disease
( ? ? O
AR-CMT2 ? ? I-gene
) ? ? O
. ? ? O

The 26602803 ? O
proportion ? ? O
of ? ? O
patients ? ? O
without ? ? O
molecular ? ? I-disease
diagnosis ? ? I-disease
is ? ? O
similar ? ? O
to ? ? O
main ? ? O
European ? ? O
series ? ? O
. ? ? O

Posttranscriptional 27570074 ? O
Regulation ? ? O
of ? ? O
Glycoprotein ? ? I-gene
Quality ? ? O
Control ? ? O
in ? ? O
the ? ? O
Endoplasmic ? ? I-disease
Reticulum ? ? I-disease
Is ? ? O
Controlled ? ? O
by ? ? O
the ? ? O
E2 ? ? I-gene
Ub-Conjugating ? ? I-gene
Enzyme ? ? O
UBC6e ? ? I-gene
. ? ? O

ER-associated 27570074 ? I-disease
degradation ? ? I-disease
( ? ? O
ERAD ? ? I-gene
) ? ? O
is ? ? O
essential ? ? O
for ? ? O
protein ? ? O
quality ? ? O
control ? ? O
in ? ? O
the ? ? O
ER ? ? I-disease
, ? ? O
not ? ? O
only ? ? O
when ? ? O
the ? ? O
ER ? ? I-disease
is ? ? O
stressed ? ? O
, ? ? O
but ? ? O
also ? ? O
at ? ? O
steady ? ? O
state ? ? O
. ? ? O

We 27570074 ? O
report ? ? O
a ? ? O
new ? ? O
layer ? ? O
of ? ? O
homeostatic ? ? O
control ? ? O
, ? ? O
in ? ? O
which ? ? O
ERAD ? ? I-disease
activity ? ? O
itself ? ? O
is ? ? O
regulated ? ? O
posttranscriptionally ? ? O
and ? ? O
independently ? ? O
of ? ? O
the ? ? O
unfolded ? ? O
protein ? ? O
response ? ? O
by ? ? O
adjusting ? ? O
the ? ? O
endogenous ? ? O
levels ? ? O
of ? ? O
EDEM1 ? ? I-gene
, ? ? O
OS-9 ? ? I-gene
, ? ? O
and ? ? O
SEL1L ? ? I-gene
( ? ? O
ERAD ? ? I-gene
enhancers ? ? O
) ? ? O
. ? ? O

Functional 27570074 ? O
UBC6e ? ? I-gene
requires ? ? O
its ? ? O
precise ? ? O
location ? ? O
in ? ? O
the ? ? O
ER ? ? I-disease
to ? ? O
form ? ? O
a ? ? O
supramolecular ? ? O
complex ? ? O
with ? ? O
Derlin2 ? ? I-gene
. ? ? O

This 27570074 ? O
complex ? ? O
targets ? ? O
ERAD ? ? I-gene
enhancers ? ? O
for ? ? O
degradation ? ? O
, ? ? O
a ? ? O
function ? ? O
that ? ? O
depends ? ? O
on ? ? O
UBC6e ? ? I-gene
's ? ? O
enzymatic ? ? O
activity ? ? O
. ? ? O

Ablation 27570074 ? O
of ? ? O
UBC6e ? ? I-gene
causes ? ? O
upregulation ? ? O
of ? ? O
active ? ? O
ERAD ? ? I-gene
enhancers ? ? O
and ? ? O
so ? ? O
increases ? ? O
clearance ? ? O
not ? ? O
only ? ? O
of ? ? O
terminally ? ? O
misfolded ? ? O
substrates ? ? O
, ? ? O
but ? ? O
also ? ? O
of ? ? O
wild-type ? ? O
glycoproteins ? ? I-treatment
that ? ? O
fold ? ? O
comparatively ? ? O
slowly ? ? O
in ? ? O
vitro ? ? O
and ? ? O
in ? ? O
vivo ? ? O
. ? ? O

The 27570074 ? O
levels ? ? O
of ? ? O
proteins ? ? O
that ? ? O
comprise ? ? O
the ? ? O
ERAD ? ? I-gene
machinery ? ? O
are ? ? O
thus ? ? O
carefully ? ? O
tuned ? ? O
and ? ? O
adjusted ? ? O
to ? ? O
prevailing ? ? O
needs ? ? O
. ? ? O

Activation 27587023 ? O
of ? ? O
the ? ? O
EIF2alpha ? ? I-gene
/ ? ? O
ATF4 ? ? I-gene
and ? ? O
ATF6 ? ? I-gene
Pathways ? ? O
in ? ? O
DU-145 ? ? O
Cells ? ? O
by ? ? O
Boric ? ? I-treatment
Acid ? ? I-treatment
at ? ? O
the ? ? O
Concentration ? ? O
Reported ? ? O
in ? ? O
Men ? ? O
at ? ? O
the ? ? O
US ? ? O
Mean ? ? O
Boron ? ? I-treatment
Intake ? ? O
. ? ? O

Fruits 27587023 ? O
, ? ? O
nuts ? ? O
, ? ? O
legumes ? ? O
, ? ? O
and ? ? O
vegetables ? ? O
are ? ? O
rich ? ? O
sources ? ? O
of ? ? O
boron ? ? I-treatment
( ? ? O
B ? ? O
) ? ? O
, ? ? O
an ? ? O
essential ? ? O
plant ? ? O
nutrient ? ? O
with ? ? O
chemopreventive ? ? O
properties ? ? O
. ? ? O

Blood 27587023 ? O
boric ? ? I-treatment
acid ? ? I-treatment
( ? ? O
BA ? ? I-treatment
) ? ? O
levels ? ? O
reflect ? ? O
recent ? ? O
B ? ? O
intake ? ? O
, ? ? O
and ? ? O
men ? ? O
at ? ? O
the ? ? O
US ? ? O
mean ? ? O
intake ? ? O
have ? ? O
a ? ? O
reported ? ? O
non-fasting ? ? O
level ? ? O
of ? ? O
10 ? ? O
muM ? ? O
. ? ? O

Treatment 27587023 ? O
of ? ? O
DU-145 ? ? I-disease
prostate ? ? I-disease
cancer ? ? I-disease
cells ? ? O
with ? ? O
physiological ? ? O
concentrations ? ? O
of ? ? O
BA ? ? I-treatment
inhibits ? ? O
cell ? ? O
proliferation ? ? O
without ? ? O
causing ? ? O
apoptosis ? ? O
and ? ? O
activates ? ? O
eukaryotic ? ? I-gene
initiation ? ? I-gene
factor ? ? I-gene
2 ? ? O
( ? ? O
eIF2alpha ? ? I-gene
) ? ? O
. ? ? O

EIF2alpha 27587023 ? I-gene
induces ? ? O
cell ? ? O
differentiation ? ? O
and ? ? O
protects ? ? O
cells ? ? O
by ? ? O
redirecting ? ? O
gene ? ? O
expression ? ? O
to ? ? O
manage ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
stress ? ? I-disease
. ? ? O

Our 27587023 ? O
objective ? ? O
was ? ? O
to ? ? O
determine ? ? O
the ? ? O
temporal ? ? O
expression ? ? O
of ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
( ? ? I-disease
ER ? ? I-disease
) ? ? I-disease
stress-activated ? ? I-disease
genes ? ? O
in ? ? O
DU-145 ? ? I-disease
prostate ? ? I-disease
cells ? ? O
treated ? ? O
with ? ? O
10 ? ? O
muM ? ? O
BA ? ? I-treatment
. ? ? O

Immunoblots 27587023 ? O
showed ? ? O
post-treatment ? ? O
increases ? ? O
in ? ? O
eIF2alpha ? ? I-gene
protein ? ? O
at ? ? O
30 ? ? O
min ? ? O
and ? ? O
ATF4 ? ? I-gene
and ? ? O
ATF6 ? ? I-gene
proteins ? ? O
at ? ? O
1 ? ? O
h ? ? O
and ? ? O
30 ? ? O
min ? ? O
, ? ? O
respectively ? ? O
. ? ? O

The 27587023 ? O
increase ? ? O
in ? ? O
ATF4 ? ? I-gene
was ? ? O
accompanied ? ? O
by ? ? O
an ? ? O
increase ? ? O
in ? ? O
the ? ? O
expression ? ? O
of ? ? O
its ? ? O
downstream ? ? O
genes ? ? O
growth ? ? I-gene
arrest ? ? I-gene
and ? ? I-gene
DNA ? ? I-gene
damage-induced ? ? I-gene
protein ? ? I-gene
34 ? ? I-gene
( ? ? O
GADD34 ? ? I-gene
) ? ? O
and ? ? O
homocysteine-induced ? ? I-gene
ER ? ? I-gene
protein ? ? I-gene
( ? ? O
Herp ? ? I-gene
) ? ? O
, ? ? O
but ? ? O
a ? ? O
decrease ? ? O
in ? ? O
GADD153 ? ? I-gene
/ ? ? O
CCAAT ? ? I-gene
/ ? ? I-gene
enhancer-binding ? ? I-gene
protein ? ? I-gene
homologous ? ? I-gene
protein ? ? I-gene
( ? ? O
CHOP ? ? I-gene
) ? ? O
, ? ? O
a ? ? O
pro-apoptotic ? ? O
gene ? ? O
. ? ? O

The 27587023 ? O
increase ? ? O
in ? ? O
ATF6 ? ? I-gene
was ? ? O
accompanied ? ? O
by ? ? O
an ? ? O
increase ? ? O
in ? ? O
expression ? ? O
of ? ? O
its ? ? O
downstream ? ? O
genes ? ? O
GRP78 ? ? I-gene
/ ? ? O
BiP ? ? I-gene
, ? ? O
calreticulin ? ? I-gene
, ? ? O
Grp94 ? ? I-gene
, ? ? O
and ? ? O
EDEM ? ? I-gene
. ? ? O

BA 27587023 ? I-treatment
did ? ? O
not ? ? O
activate ? ? O
IRE1 ? ? I-gene
or ? ? O
induce ? ? O
cleavage ? ? O
of ? ? O
XBP1 ? ? I-gene
mRNA ? ? I-gene
, ? ? O
a ? ? O
target ? ? O
of ? ? O
IRE1 ? ? I-gene
. ? ? O

Low 27587023 ? O
boron ? ? I-treatment
status ? ? O
has ? ? O
been ? ? O
associated ? ? O
with ? ? O
increased ? ? O
cancer ? ? I-disease
risk ? ? O
, ? ? O
low ? ? I-disease
bone ? ? I-disease
mineralization ? ? I-disease
, ? ? O
and ? ? O
retinal ? ? I-disease
degeneration ? ? I-disease
. ? ? O

ATF4 27587023 ? I-gene
and ? ? O
BiP ? ? I-gene
/ ? ? O
GRP78 ? ? I-gene
function ? ? O
in ? ? O
osteogenesis ? ? I-disease
and ? ? O
bone ? ? O
remodeling ? ? O
, ? ? O
calreticulin ? ? I-gene
is ? ? O
required ? ? O
for ? ? O
tumor ? ? I-disease
suppressor ? ? O
p53 ? ? I-gene
function ? ? O
and ? ? O
mineralization ? ? O
of ? ? O
teeth ? ? O
, ? ? O
and ? ? O
BiP ? ? I-gene
/ ? ? O
GRP78 ? ? I-gene
and ? ? O
EDEM ? ? I-gene
prevent ? ? O
the ? ? O
aggregation ? ? O
of ? ? O
misfolded ? ? I-disease
opsins ? ? I-disease
which ? ? O
leads ? ? O
to ? ? O
retinal ? ? I-disease
degeneration ? ? I-disease
. ? ? O

The 27587023 ? O
identification ? ? O
of ? ? O
BA-activated ? ? I-treatment
genes ? ? O
that ? ? O
regulate ? ? O
its ? ? O
phenotypic ? ? O
effects ? ? O
provides ? ? O
a ? ? O
molecular ? ? O
underpinning ? ? O
for ? ? O
boron ? ? I-treatment
nutrition ? ? O
and ? ? O
biology ? ? O
. ? ? O

